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ABSTRACT 
CLIENT CHARACTERISTICS AND TREATMENT RETENTION IN AN 
OUTPATIENT DRUG-FREE CHEMICAL  
DEPENDENCY PROGRAM  
 
 
Jessica A. Thull, B. A., M.A. 
 
Marquette University, 2009 
 
 
 Substance abuse and dependence have detrimental effects at both micro and 
macro societal levels. Even so, these disorders appear to be amenable to treatment and 
persons who receive treatment for such problems generally achieve positive outcomes. 
However, reported substance abuse treatment dropout rates have varied greatly and no 
consistent “treatment dropout” profile has been detected. This study aimed to describe the 
characteristics of clients entering an intensive outpatient chemical dependency treatment 
program and to examine how these variables differed between clients who were retained 
in treatment to completion and clients who dropped out of treatment prematurely. 
Additionally, it explored whether meaningful subgroups of this sample could be 
identified. Results indicated that age, marital status, income, psychological comorbidity, 
substance(s) of use, and extent of substance use were related to treatment retention. 
Cluster analysis findings delineated four subgroups of clients based on age, negative 
consequences related to substance use, and ASI composite scores across medical, 
employment, alcohol and drug, legal, social, and psychiatric domains. Identified 
subgroups appeared to vary along two broad dimensions: degree of functional 
impairment and type(s) of substance use. Results are compared and contrasted with the 
existing substance abuse treatment literature. Study limitations are discussed, along with 
implications regarding theory building, assessment, and treatment interventions. Future 
investigations at the individual program level are recommended to guide the design, 
implementation, and evaluation of clinically-relevant and empirically-driven assessment 
procedures and treatment interventions to enhance substance abuse treatment retention 
and outcomes within a particular program. 
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Chapter I: Introduction 
 
 
 
Substance Use Disorders in the United States  
Definition of Substance Use Disorders  
 Substance use disorders have typically been defined as either symptom-based or 
diagnosis-based. Symptom-based conceptualizations focus on the types and severity of 
problems related to the use of a particular substance, while diagnosis-based descriptions 
are based on whether or not a person meets a specified set of criteria generally associated 
with the use of a particular substance (Sobell, Wagner, & Sobell, 2003). Practitioners and 
researchers have tended to utilize the diagnostic classification of substance use disorders 
to maintain consistency in their clinical nomenclature. This study will use the term 
substance use disorder when referring to one of the two categories of substance-related 
disorders delineated in the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text-Revision (DSM-IV-TR): substance abuse and substance dependence 
(American Psychiatric Association, 2000).  
 The DSM-IV diagnostic criteria for substance abuse are: 
A. A maladaptive pattern of substance use leading to clinically significant 
impairment or distress, as manifested by one (or more) of the following, 
occurring within a 12 month period: 
(1) recurrent substance use resulting in a failure to fulfill major role 
obligations at work, school or home (e.g., repeated absences or poor work 
performance related to substance use; substance-related absences, 
suspensions, or expulsions from school; neglect of children or household) 
(2) recurrent substance use in situations in which it is physically hazardous 
(e.g., driving an automobile or operating a machine when impaired by 
substance use) 
(3) recurrent substance-related legal problems (e.g., arrests for substance-
related disorderly conduct) 
(4) continued substance use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of the 
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substance (e.g., arguments with spouse about consequences of 
intoxication, physical fights) 
B. The symptoms have never met the criteria for Substance Dependence for this 
class of substance. (APA, 2000, p. 199) 
 
 The DSM-IV diagnostic criteria for substance dependence are: 
 
A maladaptive pattern of substance use, leading to clinically significant 
impairment or distress, as manifested by three (or more) of the following, 
occurring at any time in the same 12-month period: 
       (1) tolerance, as defined by either of the following:  
(a) a need for markedly increased amounts of the substance to 
achieve intoxication   or desired effect 
(b) markedly diminished effect with continued use of the same 
amount of the substance 
      (2) withdrawal, as manifested by either of the following:  
(a) the characteristic withdrawal syndrome for the substance [For 
example, with alcohol withdrawal, two or more of the following 
symptoms are necessary: autonomic hyperactivity, increased hand 
tremor, insomnia, psychomotor agitation, anxiety, nausea or 
vomiting; and rarely, grand mal seizures or transient visual, tactile, 
or auditory hallucinations or illusions.]  
(b) the same or closely related substance is taken to relieve or 
avoid withdrawal symptoms 
(3) substance is often taken in larger amounts or over a longer period than 
intended 
(4) there is persistent desire or unsuccessful efforts to cut down or control 
the substance use 
(5) a great deal of time is spent in activities necessary to obtain the 
substance, use the substance, or recover from its effects 
(6) important social, occupational, or recreational activities are given up or 
reduced because of substance use 
(7) the substance use is continued despite knowledge of having a 
persistent or recurrent physical or psychological problem that is likely to 
have been caused or exacerbated by the substance (e.g., current cocaine 
use despite recognition of cocaine-induced depression, or continued 
drinking despite recognition that an ulcer was made worse by alcohol 
consumption). (APA, 2000, p. 197) 
 
Prevalence of Substance Use Disorders 
The annual National Survey on Drug Use and Health (NSDUH) is the primary 
source of statistical information on the use of alcohol and illicit drugs in the civilian, non-
institutionalized population of the United States aged 12 years old or older (Substance 
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Abuse and Mental Health Services Administration [SAMHSA], 2007). The most recent 
NSDUH survey estimated that 22.6 million persons met criteria for a 
substance use disorder in the past year. Of these, 3.2 million were 
classified with dependence on or abuse of both alcohol and illicit 
drugs, 3.8 million were dependent on or abused illicit drugs but not 
alcohol, and 15.6 million were dependent on or abused alcohol but not 
illicit drugs. These estimates have remained relatively stable since 
2002 (SAMHSA, 2007). 
The Cost of Substance Use Disorders 
Estimates of annual overall economic costs of substance abuse and dependence in 
the United States, including health- and crime-related costs as well as losses in 
productivity, approach approximately $185 billion for alcohol and $181 billion for illicit 
drugs (Harwood, 2000; Office of National Drug Policy, 2004). Detrimental societal 
consequences include, though are not limited to, the spread of infectious disease, deaths 
due to drug and alcohol use complications, effects of use on unborn children of pregnant 
substance users, child abuse and neglect, accidents, homelessness, diminished work 
productivity, and crime (Harwood, 2000; Office of National Drug Policy, 2004). 
Considering the extent of this burden, which permeates the lives of substance users, the 
family systems they are a part of, the communities they live in, the health care system, 
the criminal justice system, and the economy, substance use disorders are of great public 
concern (Fletcher, Tims, & Brown, 1997; Simpson, 1993). 
The Value of Substance Abuse Treatment 
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An upside to this seemingly dim state of affairs is that substance abuse treatment 
evaluation studies conducted over the past 40 years have consistently found that 
treatment “works.” In other words, when treatment is delivered to clients seeking services 
for substance use problems, alcohol and drug use decreases, engagement in crime is 
reduced, and other social functioning measures improve during and following treatment 
(Anton et al., 2006; Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997; Hubbard 
et al., 1989; Moyer & Finney, 2002; Project MATCH Research Group, 1998b; Simpson, 
1993; Simpson & Sells, 1982; Weisner, Matzger, & Kaskutas, 2003). Furthermore, many 
of these studies and numerous others have reported a positive relationship between length 
of time spent in treatment and favorable outcomes, a finding that spans treatment 
modalities, programs, and treatment models (Hubbard et al., 1997; Hubbard et al., 1989; 
McLellan, Luborsky, Woody, O’Brien, & Duley, 1983; Moos & Moos, 2003; Simpson, 
1981; Simpson & Sells, 1982).  
Substance Abuse Treatment Dropout 
At the same time, many clients do not remain in substance abuse treatment long 
enough to reap its benefits. Although the percentage of clients who do not complete 
substance abuse treatment due to dropout or expulsion varies widely and can be difficult 
to measure because treatment modalities have diverse treatment expectations, some 
general trends have been observed. Lower estimates of the dropout rates for inpatient 
alcohol and drug treatment programs are around 20%, while upper estimates can reach 
70% (Rabinowitz & Marjefsky, 1998; Stark, 1992; Wickizer et al., 1994). Outpatient 
alcohol and drug treatments tend to fare much worse and often exhibit dropout rates 
exceeding 60% to 70% (Stark, 1992; Wickizer et al., 1994). Overall, approximately 50% 
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of clients involved in substance abuse treatment drop out within the first month (Stark, 
1992). Despite these alarming statistics, they correspond to attrition rates in other health 
service sectors. In a meta-analysis of 125 studies on psychotherapy dropout, Wierzbicki 
and Pekarik (1993) found mean dropout rates of 47%. More recent studies conducted in 
mental health centers in various countries found dropout rates routinely fluctuate between 
35% and 55% (Barkham et al., 2006; Berghofer, Schmidl, Rudas, Steiner, & Schmitz, 
2002). Estimates for medical treatment are even higher with attrition rates ranging from 
50% to 80% (Meichenbaum & Turk, 1987). Nevertheless, clients who drop out of 
treatment prematurely often incur high “front-end” costs due to the amount of program 
resources that need to be dedicated to initial assessments and the treatment planning 
process, and high attrition can reduce the operational efficiency and overall effectiveness 
of a treatment program (Simpson, Joe, et al., 1997, p. 280). In light of these observations, 
treatment retention has emerged as an important intermediate outcome measure in the 
study of substance abuse treatment (Chou, Hser, & Anglin, 1998). 
Importance of Evaluating Substance Abuse Treatment Retention and Outcomes 
The increased utilization of research methodologies, assessment procedures, and 
statistical analyses designed to evaluate the inherent complexities of treatment processes 
(i.e., engagement, participation, therapeutic relationship) and how they relate to treatment 
retention and outcomes is allowing researchers to expand areas of inquiry and to continue 
building the theoretical and applied knowledge base in the treatment for substance use 
disorders. Contemporary questions of interest have focused on identifying relationships 
amongst client-, counselor-, and program-level variables and investigating how they 
relate to treatment retention and outcomes; devising and evaluating innovative 
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interventions to improve retention and outcomes; determining if certain modalities or 
treatment philosophies are more appropriate for particular clients; ascertaining the 
amount of treatment needed to be effective for certain clients; determining if specific 
ingredients are necessary for treatment to be effective; and examining how treatment 
systems and the clients they serve have transformed over time (Fletcher et al., 1997; 
Moyer & Finney, 2002; Leshner, 1997; Simpson, 1993; Swearingen, Moyer, & Finney, 
2003). It is the answers to these queries that have impacted and will continue to influence 
substance abuse policy and decisions regarding the development of treatment service 
components, evaluation methodologies, the allocation of funds, and third-party payer 
guidelines (Etheridge, Hubbard, Anderson, Craddock, & Flynn, 1997; Fletcher et al., 
1997). 
Importance of Program-Level Research 
Despite these advances, uncertainties remain regarding the extent to which such 
empirical evidence can be applied to substance abuse treatment programs at the local 
level. Client attributes, problems, and treatment needs are highly diverse, leading to 
systematic variations in the respective clientele served by individual substance abuse 
treatment programs (Simpson, Joe et al., 1997). Additional programmatic heterogeneity 
exists with reference to treatment approaches and services offered. Not surprisingly, these 
inherent complexities of real-world clinical settings do not often correspond to the 
homogeneous samples and manual-driven treatment conditions in efficacy trials and 
controlled therapy research (Carroll & Rounsaville, 2003; Persons & Silberschatz, 1998; 
Tucker & Roth, 2006). Since data from large-scale randomized trials and naturalistic 
investigations are often collapsed across certain types of clients, sites, and even treatment 
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modalities, relevant between- and within-program differences that might be of value to a 
specific program are potentially masked. Consequently, individual substance abuse 
treatment programs need to deduce if and how assorted research findings regarding 
treatment effectiveness, retention, and outcomes pertain to their respective programs in 
order to make informed decisions regarding interventions, policies, and resource 
allocation (Etheridge et al., 1997). Ultimately, program-level investigations can help 
shape substance abuse treatment practices and contribute to the general knowledge base 
regarding the treatment of these disorders, both vital activities in trying to narrow the 
observed science-practice gap that exists within the substance abuse treatment field 
(Persons & Silberschatz, 1998; Tucker & Roth, 2006). 
Importance of Group-Level Research 
 The characteristics of individuals participating in alcohol and drug treatment 
programs have dramatically changed over the past several decades (Anglin, Hser, & 
Grella, 1997). Considering the shifts in substances of abuse and demographic profiles of 
individuals participating in treatment, an initial step in determining the relevance of 
assorted research findings to a particular treatment program is to identify who is 
participating in that program. Traditionally, the examination of client characteristics and 
description of samples has remained at the individual level of analysis. However, Rapkin 
and Dumont (2000) suggest it may be more meaningful to study multiple dimensions of 
identity and behavior and to “discover the variables that define and delimit” meaningful 
groups within a heterogeneous set of individuals (p. S396). More specifically, “a deeper 
understanding of natural groupings would help us fine-tune questions about causes and 
treatment of problem behaviors” and identify groups that may be responsive to certain 
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types of treatment interventions, programs, or modalities (Rapkin & Dumont, 2000, p. 
S396). Moreover, exploring different patterns of variables and their prevalence within a 
certain population may also provide insight into potential complex relationships that exist 
amongst those variables.  
Statement of the Problem 
 Substance abuse and dependence have detrimental effects at micro and macro 
societal levels, accruing both measurable economic costs (e.g., lost productivity, 
increased health care utilization, and criminal justice involvement) and immeasurable 
losses (e.g., premature death, child abuse, and relationship strain). Even so, these 
disorders appear to be amenable to treatment. Based on the wealth of the extant substance 
abuse treatment literature, when clients receive treatment for substance use problems, 
they generally achieve positive outcomes (i.e., reduced alcohol and drug use, decreased 
involvement in crime, improved social functioning). Although time spent in treatment is 
positively related to more favorable outcomes, clients often are not retained in treatment 
long enough to attain its benefits. Reported substance abuse treatment dropout rates have 
varied greatly (20% - 74%) depending on factors such as treatment modality, program 
philosophy, and clientele served, prompting researchers to examine how these 
components affect whether or not a client stays in treatment. Diverse methodological 
techniques have been employed across various programs serving assorted clients to 
investigate the relationships amongst client, program, and treatment attributes, treatment 
retention, and eventual outcomes. Unfortunately, no consistent “treatment dropout” 
profile has been detected, and the generalizability of these findings are often questioned 
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at the local level because of the stark differences that exist between particular treatment 
programs and their clientele and those studied. 
Purpose of the Study 
      A primary purpose of this study is to describe the characteristics of clients 
entering an intensive outpatient chemical dependency treatment program and to examine 
how these variables differ between clients who complete treatment and clients who drop 
out of treatment prematurely. Additionally, in an effort to accurately depict this particular 
treatment program population, this study will explore whether a classification system can 
be used to categorize individuals into meaningful groups based on important pretreatment 
characteristics. From a clinical perspective, it is difficult for a program to examine 
treatment outcomes without first learning about who is entering treatment and who is 
staying in treatment. The identification of variables that positively and negatively relate 
to retention will further assist in the creation of an assessment procedure that allows 
clinicians to quickly and efficiently detect clients who may be at risk for dropout. 
Ultimately, such knowledge can begin to inform the design of interventions aimed at 
enhancing treatment retention, which can potentially improve treatment outcomes as the 
positive relationship between retention and outcomes is well-established in the literature. 
Furthermore, exploring whether meaningful client subgroups exist in this population is an 
initial step in determining if and how such information can be useful to the clinical staff. 
For example, if treatment completion status emerges as a distinguishing variable amongst 
subgroups, similarity to a particular profile may serve as a more comprehensive means to 
identify clients at risk of premature treatment dropout, as opposed the presence of one or 
more discrete variables associated with retention. Additionally, certain combinations of 
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variables may relate to whether or not a client completes treatment, thus retention-
enhancing interventions should target multiple areas to address the inherent complexity 
of the presenting problems of clients engaging in substance abuse treatment. 
From an empirical standpoint, this study will add to the existing literature that 
aims to describe the characteristics of clients who participate in intensive outpatient 
chemical dependency treatment programs at nonprofit, freestanding mental health 
hospitals and elucidate the extent to which current scientific evidence regarding client 
characteristics and their relationship to treatment retention applies to this particular 
program and the clients it serves. Moreover, if meaningful subgroups of clients can be 
identified, this study has the potential to provide insight into the complex relationships 
amongst the variables of interest and provide evidence in support of or in opposition to 
the existence of various subtypes of individuals with substance use disorders.  
Research Questions 
      Considering the stated problem and purpose of this investigation, this study will 
address the following research questions: 
(1)  How do clients who complete an intensive outpatient chemical dependency treatment 
program at a nonprofit, freestanding mental health clinic differ from clients who do not 
complete treatment on pretreatment variables including: 
a. Patient attributes: gender, age, ethnicity/race, education, income 
b. Substance use severity 
c. Psychiatric symptom severity 
d. Motivation for treatment 
e. General functioning: health, employment, social relationships, legal issues 
11 
(2) Can meaningful subgroups of this client population be identified based on important 
pretreatment characteristics and treatment variables? 
Overview of the Remainder of the Study 
 Chapter II begins with a brief history of substance abuse treatment evaluation in 
the United States, and is followed by an overview and critique of large-scale drug and 
alcohol treatment research that has been carried out. Major findings and implications are 
reviewed, with an emphasis being placed on those related to pretreatment client 
characteristics, treatment retention, and the relationship between these factors and 
treatment outcomes. Focus then turns to the application of these large-scale research 
findings to small-scale settings, and the inherent benefits and challenges of this endeavor. 
A treatment model (The Texas Christian University Treatment Model) designed to assist 
researchers and practitioners conceptualize the complex components of substance abuse 
treatment is then described. Additional research related to this model is outlined 
according to identified factors related treatment retention and outcomes including patient 
attributes (e.g., gender, psychiatric symptoms, motivation) and treatment factors. An 
alternative approach to organizing and analyzing such data, the utilization of taxonomic 
methods, is then proposed, and then followed up with a review of research on typologies 
of addiction. 
 Chapter III describes the methodology of this study including a detailed 
description of the sample, assessment procedures, assessment instruments, and variables 
of interest. The proposed statistical analyses for use in this study, including descriptive 
statistics, comparative analyses, profile analysis, and cluster analysis, are also described. 
Chapter IV outlines results of the statistical procedures, while Chapter V discusses the 
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implications of these findings, limitations of the current study, and future research 
directions.   
Definition of Terms 
Chemical Dependency – This term is used interchangeably with the diagnostic category  
of substance dependence. 
Dual Diagnosis – The presence of both a psychiatric disorder(s) and a substance use  
disorders. 
Polysubstance Use History –This term will be used to describe the use of more than one  
substance (e.g., alcohol, illicit drugs). The use of this term in this study diverges 
from the DSM-IV definition: type of substance dependence disorder in which an 
individual uses at least three different classes of substances indiscriminately and 
does not have a favorite drug that qualifies for dependence on its own. 
Retention – For the purposes of this study, a client was considered retained in treatment if  
s/he persisted to treatment completion. 
Substance Use Disorder (SUD) – This term encompasses substance abuse and substance  
    dependence diagnoses. 
Treatment Completion – For the purposes of this study, a participant who is discharged  
from the treatment program due to the completion of treatment will be considered 
to have completed treatment. This determination was made by a combination of 
clinician report and chart review and will be described in detail in Chapter III.    
Treatment Dropout – “A client who terminates treatment before it is completed”  
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(VandenBos, 2007, p. 302). For the purposes of this study, a participant was 
considered a dropout if s/he is discharged from the treatment program before 
completing treatment. This term is used interchangeably with attrition. 
Treatment Repeater – For the purposes of this study, a participant was considered a  
repeater if s/he completed the treatment program and was subsequently admitted 
for at least one inpatient and/or outpatient treatment at the same facility. 
Treatment Stopout – For the purposes of this study, a participant was considered a  
stopout if s/he was discharged from the treatment program before completing 
treatment and was subsequently admitted for at least one inpatient and/or 
outpatient treatment at the same facility. 
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Chapter II: Review of the Literature 
 
 
 
Overview 
This section begins with a brief history of substance abuse treatment research in 
the United States and descriptions of several large-scale drug and alcohol treatment 
research studies and meta-analyses. Major findings and implications are reviewed, with 
an emphasis on the relationship amongst pretreatment client characteristics, treatment 
retention, and treatment outcomes. The focus then shifts to how this large-scale research 
pertains to small-scale settings, and the inherent challenges of this endeavor. The Texas 
Christian University Treatment Model, a model designed to assist researchers and 
practitioners conceptualize the complex processes involved in substance abuse treatment, 
is described and evaluated. Research related to this model is outlined according to 
identified factors related treatment retention and outcomes including patient attributes, 
gender, psychiatric symptoms, motivation, and treatment factors. Lastly, arguments for 
more comprehensive descriptive and exploratory investigations regarding the patient 
attributes that contribute to treatment processes are elucidated. 
Brief History of Substance Abuse Treatment Research 
 The establishment of the National Institute of Health (NIH), and its divisions of 
alcohol and drug abuse, can be traced back to the alarming rates of psychological 
disorders that were detected among service men and women and veterans following 
World War II. By the 1970s, it became apparent that the NIMH and its alcohol and drug 
divisions were not adequately dealing with the rampant alcohol and drug problems 
sweeping the nation. Multiple indicators of alcohol abuse and dependence, including 
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hepatic cirrhosis and violence-related mortality, had been increasing since World War II; 
moreover, relatively localized abuse of cocaine and heroin abuse transformed into an 
epidemic in the late 1960s and was followed by the emergence of hallucinogen and 
stimulant abuse (Westermeyer, 2005). In response, the National Institute of Alcohol 
Abuse and Alcoholism (NIAAA) and National Institute of Drug Abuse (NIDA) were 
formed under the Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA) 
located within the Department of Health and Human Services. ADAMHA promoted the 
development of substance abuse research, training, clinical treatment services, and 
prevention. To a large extent, governmental support for these endeavors stemmed from 
elected officials who were personally affected by substance use disorders, through either 
first-hand or familial experiences (Westermeyer, 2005).  
 Collaborative research efforts of NIDA and NIAAA have addressed critical 
empirical and clinical questions regarding the treatment of substance use disorders 
including treatment outcomes and how they relate to program type, client characteristics, 
treatment received, therapeutic approaches, and aftercare. The components of effective 
treatment and treatment processes, including factors that engage and retain clients in 
programs, have also been explored (Fletcher et al., 1997; Project MATCH Research 
Group, 1997a; The COMBINE Study Research Group, 2003). At the same time, macro-
level studies of alcohol and drug use disorders and their treatment have remained 
relatively separate endeavors, with each faction adopting distinct research programs, 
modes of inquiries, and questions of interest. Consequently, comprehensive substance 
abuse treatment research will be reviewed and critiqued separately below. 
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Comprehensive Substance Abuse Treatment Research 
The Drug Abuse Reporting Program 
The Drug Abuse Reporting Program (DARP) represented the first evaluation 
program of the federally-funded, community-based drug abuse treatment system that 
began to emerge in the late 1960s (Simson & Sells, 1982). Data were collected on nearly 
44,000 clients from 52 federally-funded programs representing four modalities of 
treatment: methadone maintenance (MM), therapeutic community (TC), outpatient drug-
free (ODF), and detoxification (DT). The primary data collection period spanned from 
1969 to 1974. Information was gathered through intake interviews, during-treatment 
progress reports, and a series of follow-up interviews at 3 to 12 years posttreatment. The 
extensive research program consisted of multiple studies that essentially aimed to 
describe the types of drug users entering treatment in the early 1970s, the types of 
treatment that were provided to these clients, and what happened to these clients during 
and after treatment. DARP also moved the field toward a more objective and 
behaviorally-based orientation and away from a focus on clinical impressions by utilizing 
a standardized assessment design for data collection and a set of standardized outcome 
criteria. Furthermore, effective procedures for ensuring high respondent compliance rates 
and maintaining quality control in the data were established (Simpson, 1993).   
DARP findings demonstrated the effectiveness of three of the treatment 
modalities (MM, TC, and ODF) in reducing the prevalence of daily opiate use and 
involvement in criminal behavior, and increasing employment levels. Moreover, a 
significantly higher percentage of clients participating in these programs for longer than 
90 days had more favorable outcomes than those who did not stay in treatment this long. 
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In fact, clients who remained in drug abuse treatment for less than 90 days actually had 
similar drug use outcomes at the one-year follow-up point than clients who did not attend 
treatment sessions following DT or only completed an intake session (Simpson, 1981; 
Simpson & Sells, 1982). Longer-term outcomes were more ambiguous. Simpson, Joe, 
and Bracy (1982) reported that similar statistically significant differences in outcomes 
continued to be observed through the first three years following treatment, though these 
effects were no longer statistically significant by the six-year follow-up point due to the 
collective effects of subsequent treatments, incarcerations, and other life events. 
Fletcher and colleagues (1997) noted the DARP research program contributed 
much to the field of drug treatment evaluation. It delineated types of treatment; 
established a well-founded methodology for longitudinal treatment evaluation research; 
identified outcome patterns related to treatment readmissions, criminality, and 
employment; and provided data on the natural history of opiate addiction in a population 
of individuals who received drug treatment. DARP also proved that carrying out 
methodologically rigorous, longitudinal, field-based research with a challenging 
population could be accomplished. Consequently, periodic national multi-site evaluations 
of drug abuse treatment have become part of federal research. Together with initiatives 
examining changing drug use trends and their effects on the health care and criminal 
justice systems, such strategies have continued to inform researchers, practitioners, 
policymakers, and other key stakeholders of patterns, problems, and progress in the study 
of drug use and the treatment of drug use disorders throughout the past four decades 
(Fletcher et al., 1997; Simpson, Chatham, & Brown, 1995). 
The Treatment Outcome Prospective Study 
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 The Treatment Outcome Prospective Study (TOPS) was the second national 
study of community-based drug abuse treatment programs undertaken in the United 
States (Hubbard et al., 1989). Similar to DARP, it was designed to provide longitudinal 
information on clients entering federally-funded programs in order to allow the 
evaluation of short- and long-term treatment outcomes. The data collection period 
spanned from 1979-1981. Information was gathered on more than 11,000 clients admitted 
to over 40 treatment programs purposely selected to yield a sample of stable, established 
programs within three main modalities: MM, ODF, and long-term residential (LTR), 
which included therapeutic communities. TOPS aimed to obtain more data on patient 
attributes, program environments, and services delivered in treatment as compared to 
DARP and it was expected that it would also provide a model framework for 
investigating a variety of emerging topics in the field at that time including changing drug 
use patterns, psychiatric comorbidity, criminal behavior, the impact of legal involvement 
on treatment, the effects of posttreatment aftercare, cost-benefit analyses, and overall 
cost-effectiveness of drug abuse treatment (Fletcher et al., 1997; Hubbard et al., 1989).   
As in DARP, results suggested that MM, LTR, and ODF treatment was effective 
in reducing the use of heroin and other illicit drugs and decreasing levels of predatory 
crime during and after treatment. Length of time spent in treatment was positively related 
to favorable posttreatment outcomes, with clients staying in treatment for a minimum of 
three months faring better than clients participating in detoxification treatment and those 
who entered, but failed to continue to the three-month point. TOPS researchers also noted 
that patterns of drug use had changed considerably from DARP, with less daily use of 
heroin and other opiates and more polysubstance use. It appeared that client legal status, 
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including pressure to enter treatment, affected the length of treatment stay as clients with 
legal involvement were more likely to stay longer in treatment than those without legal 
involvement (Hubbard et al., 1989; Simpson, 1993). Furthermore, pretreatment indicators 
of poor social compliance and adjustment, such as criminal history, unemployment, 
marital problems, and psychiatric comorbidity, were also related to higher treatment 
dropout and drug-use relapse rates. Cost-effectiveness and cost-benefit investigations 
carried out across modalities showed that when crime-related costs were calculated, 
treatment was both cost-effective and cost-beneficial. More specifically, in the year 
before treatment admission, crime-related economic costs to society were an average of 
$15,262 per client and fell to $14,089, an 8% reduction, in the year after treatment 
discharge. Costs to law-abiding citizens fell from $9,190 per client to $7,379, an 
approximate 20% reduction (Harwood, Collins, Hubbard, Marsden, & Rachal, 1988). In 
most cases, the cost of treatment was regained during treatment and further cost-benefits 
accrued as a result of decreased posttreatment drug use (Harwood et al., 1988).  
 The 1980s witnessed several noteworthy changes within the drug abuse treatment 
community. Drug use patterns eventually shifted to increased use of cocaine, the 
HIV/AIDS epidemic surfaced along with concern about needle sharing, and major 
modifications in the organization and structure of the treatment system materialized as 
federal funding was cut and the bulk of the financial responsibility was turned over to 
state governments in the form of block grants (Craddock, Rounds-Bryant, Flynn, & 
Hubbard, 1997; Fletcher et al, 1997). This changeover resulted in a reduction in state 
financial support and seemed to negatively affect community-based treatment programs 
as they consequently experienced increased strain from excessive demand, understaffing, 
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and a persistent lack of adequate resources to address the complex problems of clients 
entering treatment (Fletcher et al., 1997). Such dynamic shifts within the population of 
drug users and the treatment programs that served them called into question the 
applicability of the previous research findings of DARP and TOPS, thus setting the stage 
for a third national treatment study. 
The Drug Abuse Treatment Outcome Study  
The Drug Abuse Treatment Outcome Study (DATOS) was initiated by the NIDA 
in 1989.  Similar to its predecessors, a primary objective of this research program was to 
determine drug abuse treatment effectiveness for contemporary treatment populations and 
drug use patterns through the collective examination of how client factors, treatment 
processes, and program structure affect outcomes (Fletcher et al., 1997; Leshner, 1997). 
Data were collected on 10,010 clients in 99 programs between 1991 and 1993. As was 
the case in TOPS, programs were purposely selected to represent treatment delivered in 
established, stable programs across the main modalities: outpatient methadone treatment 
(OMT), short-term inpatient (STI), LTR, and ODF. Extensive client-level information 
was obtained in a variety of domains including demographics; alcohol and drug use; 
mental and physical health; legal status; income and employment; cognitive functioning; 
motivation and readiness for treatment; and engagement in AIDS risk behaviors. An 
array of in-treatment variables were also collected along with information regarding 
program structure and services offered. Data were collected at intake, during treatment (1 
and 3 months), and after treatment (12 months) (Fletcher et al., 1997; Leshner, 1997).  
In order to fully capitalize upon the wealth of data DATOS produced, a 
cooperative study was eventually launched in the mid 1990s involving NIDA and three 
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collaborating grantees: the National Development and Research Institutes (NDRI), the 
Drug Abuse Research Center of the University of California at Los Angeles (UCLA), and 
the Institute of Behavioral Research at Texas Christian University (IBR-TCU). Based 
upon the expertise of the researchers at these respective institutions, each arm of the 
expanded research program focused on different themes. Fletcher et al. (1997) provides a 
synopsis of this breakdown. NDRI delved into health services research and investigated 
issues concerning access to and use of drug treatment services such as need for services 
by client subtype, access to services, service use by modality and client profile, and 
factors related to treatment selection and entry. IBR-TCU concentrated their efforts on 
treatment engagement and retention. This division examined client and program variables 
related to retention and program adherence and the impact of motivation and treatment 
readiness indicators on engagement and retention. UCLA explored the addiction and 
treatment careers of treated individuals via the development and testing of models 
describing the stages in the process of addiction, the interaction of program and client 
variables in treatment outcomes across a client’s career, and the background and drug 
history factors that relate to treatment entry and reentry. NIDA assumed responsibility for 
considering the policy-relevant aspects of such a large-scale evaluation of drug abuse 
treatment by developing studies that described the evolving treatment system, determined 
the effectiveness of treatment as it is typically delivered for current treatment 
populations, and estimated the cost-effectiveness and cost-benefits of treatment. 
  TOPS to DATOS 
Craddock and colleagues (1997) documented the notable changes in pretreatment 
behaviors and characteristics of clients entering drug abuse treatment during the period of 
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TOPS data collection as compared to DATOS. The TOPS era had witnessed an increase 
in the use of multiple drugs, while DATOS findings documented a decrease in the 
numbers of types of drugs used. Nevertheless, reports of cocaine use since TOPS more 
than doubled among clients entering LTR and ODF treatment modalities, and increased 
one and one-half times among OMT clients. DATOS clients were generally older, had 
higher educational attainment, less full-time employment, and more dependence on 
public assistance than TOPS clients. Although there was evidence of a decrease in 
involvement in predatory crime, significantly greater proportions of DATOS clients were 
involved in the criminal justice system and had reported engaging in illegal activity in the 
year prior to treatment to get money for drugs than TOPS clients. Additional evidence 
that the clients of DATOS presented with new and difficult combinations of problems to 
treat included the salience of health problems, histories of physical and sexual abuse, 
needle injection practices, sexual risk behaviors, and child custody concerns. “The 
changing nature of the drug treatment client population – from sociodemographics to 
drug use and multiple treatment problem severities – highlights the complexity of issues 
and difficulties encountered by those attempting to treat clients or plan treatment 
strategies” (Craddock et al., 1997, p. 44). Such dynamic shifts underscored the 
importance of continuous examination and assessment of the drug treatment-seeking 
population. 
 Treatment Outcomes 
In addition to documenting such notable changes in treatment clientele, DATOS 
investigations proffered a wealth of information in an array of areas. In accordance with 
its predecessors, DATOS outcome data indicated that treatment was generally effective in 
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reducing drug use across all four modalities (Hubbard et al., 1997). For OMT clients, 
those still engaged in treatment at the one-year follow-up point reported significantly less 
weekly or daily heroin and marijuana use than clients who left treatment prior to the one-
year marker; this difference was statistically significant. A 20% reduction in weekly 
cocaine use during the follow-up year was also noted for OMT treatment clients. LTR, 
ODF, and STI clients reported 50% less weekly or more frequent cocaine use in the 
follow-up year as compared to the year prior to admission. The overall percentage of 
clients reporting weekly or more frequent use of alcohol, marijuana, and heroin during 
the year prior to admission was also reduced by at least half at one-year follow-up. Long-
term outcomes for a subsample of cocaine-dependent clients demonstrate sustained 
treatment effects (Simpson, Joe, & Broome, 2002). Weekly cocaine use and daily alcohol 
use were significantly reduced during the fifth year of follow-up as compared to the 
pretreatment year and were comparable to figures reported for the year following 
treatment. 
Treatment duration appeared to be an important factor in producing positive 
outcomes as reductions in cocaine and alcohol use were significantly greater for clients 
treated for at least three months in LTR and ODF. Significant declines in marijuana use 
were also noted for clients remaining in LTR for three months or more. Further logistic 
regression analyses that controlled for 10 independent predictor variables chosen because 
of known associations with important outcomes (e.g., gender, ethnicity, age, education) 
demonstrated that a treatment stay of at least six months in LTR and ODF treatment was 
associated with statistically significant reductions in cocaine, marijuana, and alcohol use 
for these modalities. Hubbard et al. (1997) noted that the time-in-treatment effect related 
24 
to reduced cocaine and marijuana use for clients enrolled in LTR programs mirrored 
results obtained in TOPS. However, the additional findings of a significant decline in 
alcohol use for LTR clients and substantial reductions in cocaine, marijuana, and alcohol 
for ODF clients provide strong evidence for a treatment duration effect for various types 
of substance use that was not identified in the TOPS research.   
Measures of behavioral outcome results were more mixed (Hubbard et al., 1997). 
Percentages of engagement in predatory illegal activity and high risk sexual behaviors at 
follow-up were one-half the rate as compared to the preadmission year for OMT clients 
(28.6% to 13.7% and 25.2% to 12.9%, respectively); however, little change was noted in 
the endorsement of suicidal ideation, less than full-time employment, and health 
limitations. For LTR, ODF, and STI clients, percentages in the follow-up year were 
typically lower than in the preadmission year for suicidal thoughts or attempts, predatory 
illegal activity, and sexual risk behavior, but little change was reported for employment 
and health outcomes (Hubbard et al., 1997). Upon further examination, LTR clients 
remaining in treatment for at least six months exhibited a statistically significant 
reduction in illegal activity (50%) and increase in full-time employment (10%). ODF 
clients staying in treatment for at least six months also displayed a small, but statistically 
significant increase in full-time employment and reduction in suicidal ideation. No 
statistically significant effects of stays longer than two weeks in STI were found for any 
of the behaviors measured. Generally speaking, DATOS behavioral outcomes appeared 
to only replicate TOPS findings within the LTR modality, as there was not a statistically 
significant reduction in illegal activity for clients enrolled in OMT and ODF treatments. 
Hubbard and colleagues (1997) noted that these findings were not a surprise given the 
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decline in comprehensive services offered within OMT and ODF programs since TOPS 
was conducted.    
Programmatic Differences  
Taken as a whole, the DATOS outcome data suggested that longer treatment stays 
are associated with more favorable outcomes, a finding that is consistent with previous 
large-scale treatment evaluation studies despite considerable changes in drug use patterns 
and characteristics of clients entering treatment over time (Craddock et al., 1997; 
Hubbard et al., 1997). However, multi-site treatment outcomes studies are accompanied 
by a variety of complexities associated with aggregating data across a broad range of 
treatment settings and clientele (Simpson, Brown, Joe, 1997; Simpson, Joe et al., 1997). 
“Wide program variation may mask clinically meaningful treatment effects in large-scale 
outcome studies such as DATOS and offers methodological challenges in identifying 
meaningful strategies for clustering programs to account for potential impacts at the 
client level” (Etheridge et al., 1997, p. 259). Thus, a comprehensive review of program 
data was undertaken before programmatic differences in treatment outcome and retention 
were examined. This appraisal aimed to describe the varying structures and 
characteristics of the treatment programs included in DATOS and to examine treatment 
and programmatic changes over time as this information compared to TOPS data 
(Etheridge et al., 1997). The program-level data were derived from a self-administered 
questionnaire completed by the program director or a senior counselor assessing a variety 
of domains including program structure, client characteristics, staffing, job preparation, 
treatment structure, treatment content, available services, treatment planning, program 
policies, and indicators of success in treatment.  
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Results indicated that DATOS programs typically emphasized supportive therapy 
delivered in group and individual sessions, with a notable increase in the percentage of 
counseling delivered in the group format as compared to TOPS. LTR and ODF programs 
also tended to incorporate problem solving techniques while OMT and STF integrated 
more case management approaches (Etheridge et al., 1997). Secondary treatment foci 
diverged across modalities, reflecting the uniqueness of each modality. LTR programs 
often included milieu therapy and 12-step strategies. STI also integrated milieu therapy 
along with problem solving. In addition to 12-step approaches, ODF programs tended to 
incorporate psychotherapy and cognitive-behavioral techniques into their treatment. 
Treatment goals across modalities and programs focused primarily on abstinence from 
illicit substances and alcohol. Consistent with these objectives, nearly all programs 
employed urine monitoring and incorporated some type of relapse prevention component 
into treatment, although relapse prevention was emphasized less strongly in OMT 
programs (Etheridge et al., 1997). In terms of physical make-up, STI and LTR programs 
were generally smaller in capacity and staff carried smaller client caseloads than OMT 
and ODF programs, allowing for longer and more frequent contact with clients. The ODF 
modality varied the most with regards to treatment intensity as some programs scheduled 
a single one to two-hour session per week (“regular”) while others scheduled at least two 
three-hour sessions per week (“intensive”).  
Nearly all DATOS programs indicated that individualized treatment was 
provided, at least to some clients, based on client needs. The majority of programs also 
aimed to match clients to particular types of treatment or counselors, with many of these 
decisions based mainly on counselor style and expertise as opposed to client 
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characteristics (Etheridge et al., 1997). Almost 86% of the participating programs 
reported they utilized either a general program-developed assessment or a widely used 
standardized assessment to assess client needs across a variety of domains. Considering 
that state and federal regulations and accrediting and licensing bodies require written 
treatment plans, such plans were common across programs, and the majority of programs 
involved the client in treatment plan development process (Etheridge et al., 1997). Many 
programs also faced cuts in funding and resources, resulting in programmatic 
reorganization and downsizing during the DATOS data collection period. Of the eight 
primary services areas assessed (medical, psychological, educational, vocational, 
financial, legal, family, and aftercare), nearly three-fourths of the programs were “very 
much” in need of aftercare and about two-thirds were ”very much” in need of medical 
services. Some of the DATOS programs appeared to be relying primarily on 12-step 
groups as the continuing-care component of treatment as a trend of increased and more 
widespread posttreatment 12-step participation was observed. Even though the majority 
of programs reported that they referred clients for such services, the number of actual 
referrals made was generally low, especially in OMT and ODF programs (Etheridge et 
al., 1997). Overall, less than 10% of clients in these programs received psychological, 
family, legal, educational, vocational, or financial services.  
These data brought attention to an obvious reduction in number of resources and 
types of services provided and accessible to clients entering drug treatment from the 
TOPS era to the DATOS era. Etheridge and colleagues (1997) suggested that possible 
factors that may have offset the potential negative effects of such a decline included 
increased client involvement in the treatment planning process, a rise in 12-step 
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participation during the posttreatment follow-up year, and higher levels of client 
satisfaction with treatment. At the same time, the majority of programs had only begun to 
experience the effects of cost containment strategies and managed care policies. Most 
change during the DATOS data collection period was reported by STI and ODF 
programs. ODF program directors accentuated challenges related to decreased lengths of 
stay, the third-party authorization process, and the ability to secure appropriate levels of 
care as many clients were being referred to ODF programs after being denied LTR and 
STI treatment by third-party reimbursement plans (Etheridge et al., 1997). Moreover, 
some programs reported feeling pressure to develop and implement brief treatment 
interventions and other resource-saving strategies (e.g., substituting individual sessions 
with structured, topic-oriented groups) in order to better fit with abbreviated treatment 
durations. The primary concern raised by Etheridge et al. (1997) at this time related to the 
apparent contradiction between research and managed care policies. In particular, third 
party payers were shortening treatment stays and making it difficult for providers to 
obtain authorization to secure additional sessions, while research studies continued to 
generate empirical support that suggested treatment stays of at least 90 days resulted in 
more positive outcomes. 
Treatment Retention 
Upon describing the general differences across programs within each treatment 
modality, DATOS researchers proceeded to examine how these discrepancies affected 
treatment retention rates. Although retention rates varied from program to program, a 
consistent finding across programs was that clients regularly dropped out of treatment 
long before reaching the planned length of stay. OMT programs expected clients to stay 
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for least two years, though the actual median length of stay was only one year. 
Recommended lengths of stay for LTR programs hovered around a minimum of nine 
months and at six months for ODF programs, though actual median treatment stays for 
both of these modalities was only three months (Simpson, Joe et al., 1997). Both client-
level variables (sex, age, previous treatment, psychological problems, cocaine 
dependence, alcohol dependence, legal status, and needle-sharing) and program 
characteristics (counseling frequency and use of ancillary services) were examined to 
further elucidate how they relate to the observed variations in treatment retention across 
modalities and programs. Results indicated that LTR, ODF, and OMT programs that 
treated a higher percentage of clients who met criteria for cocaine dependence tended to 
have poorer retention rates, while a higher percentage of clients diagnosed with alcohol 
dependence was related to higher retention rates in LTR programs and lower retention 
rates in ODF and OMT programs (Simpson, Joe et al., 1997). LTR and OMT programs 
with lower retention rates were also more likely to serve clients younger than 35 years of 
age, while ODF programs with lower retention rates had more clients with significant 
legal histories. Furthermore, OMT programs with poorer retention rates tended to have 
more female clients, more previous treatment episodes, and more clients with 
psychological problems (Simpson, Joe et al., 1997).  
Further analyses considered whether diversity in client composition was a 
sufficient explanation for the observed differences in program retention rates (Simpson, 
Joe et al., 1997). Results implied that retention rates would still vary even if all programs 
within the same modality would treat highly similar clientele. Thus, focus turned toward 
possible program-level characteristics and treatment process variables that may account 
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for the observed variations in retention, and ultimately treatment outcomes (Simpson, 
Brown et al., 1997; Simpson, Joe et al., 1997). Frequency of client use of additional 
treatment services was not related to retention for any of the modalities, nor was 
counseling frequency in LTR and OMT programs. However, ODF programs with higher 
frequency of counseling (three or more sessions per week) had significantly lower 90-day 
retention rates than ODF programs that had two or fewer sessions per week (Simpson, 
Joe et al., 1997). A possible explanation for this finding is that clients enrolled in ODF 
programs with a high level of treatment contact may interpret this intensity as too 
demanding or restrictive. Consequently, such programs may be more susceptible to 
dropout, especially if clients have the option to seek treatment with a less stringent 
commitment (Simpson, Joe et al., 1997). The relationship between treatment process 
variables, as described by the client, and key retention thresholds – 360 days for OMT 
and 90 days for LTR and ODF – (Hubbard et al., 1989; Simpson, 1981; Simpson & Sells, 
1982) was also explored in a series of analyses (Simpson, Brown et al., 1997). In line 
with prior research, staying in LTR treatment for at least 90 days was associated with a 
constructive counselor-client relationship, client satisfaction with treatment, attendance in 
education classes during treatment, and participation in continuing care programming 
(e.g., 12-step meetings, other support groups). For clients enrolled in ODF programs, 90-
day retention was positively related to compliance with program requirements; referral 
for ancillary services (e.g., vocational instruction, social services, and alcohol treatment); 
and engagement in continuing care programming. For OMT, remaining in treatment 
beyond the 360-day threshold was associated with treatment satisfaction, referral for 
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medical or mental health services, and compliance with program policies (Simpson, 
Brown et al., 1997).  
Upon further examination of retention and its relationship to treatment outcome, 
evidence suggested that clients remaining in LTR treatment beyond 90 days had 
significantly better outcomes (e.g., reduced cocaine use and alcohol use; improved legal 
status, and more employment) than those who stayed less than 90 days. In particular, 
reported cocaine use dropped from 82% to 3%, daily alcohol use decreased from 23% to 
1%, the arrest rate was reduced from 53% to 32%, and the employment rate increased 
from 54% to 68%. Outcome comparisons for ODF clients were inconclusive due to vast 
variation in pretreatment drug use between clients who continued in treatment to the 90-
day threshold and those who discontinued prior to this point. Simpson, Brown, et al. 
(1997) noted that clients who were not retained in treatment for 90 days had more 
extensive pretreatment drug use; however, the relationship between severity of drug use 
and retention could not be ascertained because of program-specific disparities in client 
attributes and retention rates across subsamples that could not be controlled for. 
Furthermore, though results were in the predicted direction, no statistically significant 
differences were found between short- and long-term retention OMT clients (Simpson, 
Brown et al., 1997).  
Despite these mixed findings across modalities, the identification of key client 
characteristics, program attributes, and treatment process elements that relate to retention 
remain imperative within drug treatment evaluation as this information can improve our 
understanding of what impacts the length of stay in drug treatment, which can potentially 
affect treatment outcomes. Moreover, drug use trends and the drug abuse treatment 
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milieu continue to change over time and such transformations need to be documented in 
order to ascertain whether prior empirical findings are applicable to contemporary 
conditions.  
Summary of Large-Scale Drug Treatment Research 
 A considerable amount of empirical evidence related to drug treatment outcomes 
has been derived from large-scale, national evaluations of community-based treatment 
programs representing the four main modalities of drug treatment. Over the course of 
nearly four decades, DARP, TOPS, and DATOS research teams were able to develop and 
refine research methodologies and quasi-experimental techniques that demonstrated the 
feasibility of studying drug treatment in field settings and ultimately generated a wealth 
of scientific knowledge regarding drug abuse treatment and its outcomes. More 
specifically, these investigations described the characteristics of clients entering drug 
abuse treatment during their respective eras and explored the features of the assorted 
treatment programs included in the sample. Moreover, DARP, TOPS, and DATOS 
established that drug abuse treatment is effective in reducing drug use and improving 
social functioning and detected the positive relationship between length of time spent in 
treatment and the achievement of positive treatment outcomes (Simpson, 1993, 2004).  
At the same time, such research is not without limitations. When examining its 
usefulness and applicability in the treatment of drug abuse and the programs that deliver 
such services, methodological aspects of this work must be considered carefully. For 
example, although the samples in DARP, TOPS, and DATOS were gathered from actual 
treatment programs, they were relatively confined to individuals with a drug use disorder, 
which affects the generalizability of findings (i.e., if and/or how these results pertain to 
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those who abuse both alcohol and drugs or alcohol only?). Similarly, since participants 
were extracted from publicly-funded drug abuse treatment programs, it is not known if 
similar result patterns emerge for privately-funded agencies. Data from these large-scale, 
federally-funded research projects was also collapsed across programs within the 
respective treatment modalities, which can potentially conceal notable between-program 
differences that might be of value to a specific treatment program that shares certain 
commonalities (e.g., clientele, services offered) with a subgroup of study programs. At a 
broader level, aggregating data across treatment programs and trying to detect trends 
amongst the various treatment modalities has produced a myriad of results. The task of 
interpreting and deciphering significance of such findings is saturated with layers of 
complexity and generates innumerable additional questions. Ultimately though, DARP, 
TOPS, and DATOS “comprise only part of the large body of evidence from natural and 
experimental studies…that supports the general effectiveness of drug treatment” 
(Simpson, 2004, p. 100). In order to maximize the value of these findings, they need to be 
integrated with additional drug treatment effectiveness research.      
Meta-Analytic Studies of Drug Abuse Treatment 
 Appraising an expanded evidence base for drug treatment effectiveness and 
quantifying the diverse findings obtained via varied research methods have been possible 
through the application of meta-analytic review strategies (Rosenthal, 1995). Meta-
analyses conducted in the past decade have provided empirical support for the 
effectiveness of particular types of drug abuse treatment including methadone 
maintenance (Brewer, Catalano, Haggerty, Gainey, & Fleming, 1998; Marsch, 1998), 
contingency management (Griffith, Rowan-Szal, Roark, & Simpson, 2000) and family-
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couples therapy (Stanton & Shadish, 1997). Additionally, researchers have opted to 
examine variables that may influence the magnitude of effects detected. Prendergast, 
Podus, Chang and Urada (2002) conducted a meta-analysis of 78 drug treatment studies 
carried out between 1965 and 1996 that employed a treatment-comparison group design 
where one group received an intervention and the other(s) received minimal treatment or 
none at all. To calculate, combine, and analyze effect sizes, the authors utilized the 
statistical methods outlined by Hedges and Olkin and Cooper and Hedges (as cited in 
Prendergast et al., 2002). The overall results were first summarized in terms of 
descriptive statistics using inverse-weighted techniques for combining effect sizes. 
Subsequently, moderators of effect size were examined using multivariate modeling of 
client characteristics and program characteristics, with effect sizes adjusted for 
methodological differences across studies. Statistically significant and clinically 
meaningful positive effect sizes were detected utilizing a fixed-effects model for drug use 
outcomes (fixed effects weighted mean = .30) and criminal activity outcomes (fixed 
effects weighted mean = .13). These figures actually increased after adjustments were 
made for variations in methodological features using a random-effects model amongst the 
studies (random-effects weighted means = .34 and .16, respectively). In other words, 
results indicated that on average, clients who participated in drug treatment had more 
favorable outcomes than those who did not receive treatment or only received nominal 
treatment (Prendergast et al., 2002). Nevertheless, treatment effect sizes ranged across 
individual studies, prompting further examination of methodological, client, program, 
and treatment variables that may influence treatment effect sizes.  
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 Four methodological characteristics emerged as statistically significant predictors 
of larger effect sizes. Larger effect sizes were associated with studies that had smaller 
numbers of dependent variables; that detected statistically significant differences between 
treatment groups at baseline; had low levels of attrition in the treatment group; and 
measured drug use by means of urinalysis screens (Prendergast et al., 2002). Upon 
controlling for these methodological differences, the only demographic variable that was 
related to outcome was age: studies with older participants reduced crime involvement to 
a greater degree than those consisting of younger adults (Prendergast, Podus, Chang, & 
Urada, 2006). Consistent with previous research, there were no statistically significant 
differences detected for effect size based on treatment modality, suggesting that no one 
treatment modality is clearly superior to others (Prendergast et al., 2002). In examining 
treatment characteristics, more favorable drug use outcomes tended to be found in studies 
in which treatment was rated to be well-implemented and allegiance to the treatment 
procedures was high. Surprisingly, better drug use outcomes were negatively related to 
theoretical development of the treatment, drawing attention to the existence of a possible 
rift between theory and practice. In this case, it could be argued that “theoretically based 
interventions may not have been adequately developed for the realities of practical 
application, or the application of these interventions may have diverged from what was 
theoretically intended” (Prendergast et al., 2002, p. 63).  
Meta-analytic studies of drug abuse treatment provide additional evidence that 
treatment is effective in reducing drug use and other problematic behaviors. Such 
techniques have been successful in identifying possible variables that moderate and 
mediate drug treatment effects that complement the findings of the large-scale, federally-
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funded projects undertaken in the United States (Prendergast et al., 2002). Nevertheless, 
the aforementioned research has concentrated on only a fraction of the available scientific 
evidence within the substance abuse treatment field as the treatment of alcohol use 
disorders has largely remained a separate and distinct mode of inquiry. Focus will now 
shift to the concurrent national comprehensive alcohol treatment research programs that 
have been undertaken. 
Expansion of Alcohol Treatment Studies  
 In contrast to the quasi-experimental methodological approaches notably 
associated with the DARP, TOPS, and DATOS initiatives, large-scale research in the 
alcohol field has increasingly utilized randomized clinical trials (RCTs) in the evaluation 
of alcohol treatment. Widely acknowledged as the most rigorous method to evaluate 
comparative efficacy of treatments (Chambless & Hollon, 1998), RCTs employ 
randomization and other procedures to assign participants to treatment conditions in order 
to equate treatment groups on pretreatment characteristics that might influence outcome 
(Institute of Medicine, 1990; Moyer & Finney, 2002). When properly executed, RCTs are 
able to elucidate what treatment is best for a particular disorder and can consequently 
assist practitioners in deciding amongst alternative treatments (Persons & Silberschatz, 
1998). However, following a comprehensive review of alcohol treatment outcome 
research, the Institute of Medicine (1990) proposed that basic inquiries concerning 
whether or not treatment for alcohol use disorders works and which treatment(s) works 
the best may not be as pertinent to the field as the expanded question: “Which kinds of 
individuals, with what kinds of alcohol problems, are likely to respond to what kinds of 
treatments by achieving which kinds of goals when delivered by which kinds of 
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practitioners?” (p. 143). More specifically, considering the array of alcohol treatments 
available, might prescribing particular types of treatment for clients possessing a certain 
profile of background variables and treatment needs produce better treatment outcomes, 
increase cost-effectiveness, and reduce therapeutic mismatches that may affect treatment 
response or treatment dropout? (Allen & Kadden, 1995; Donovan & Mattson, 1994; 
Institute of Medicine, 1990; Project MATCH Research Group, 1997a). By the late 1980s, 
empirical research in support of this “matching hypothesis” was promising, though not 
entirely convincing or fully understood (Longabaugh, Wirtz, DiClemente, & Litt, 1994; 
Mattson et al., 1994). In response the National Institute on Alcohol Abuse and 
Alcoholism (NIAAA) launched a large-scale, RCT investigation named Matching 
Alcoholism Treatment to Client Heterogeneity (Project MATCH). 
Project MATCH 
 Project MATCH aimed to test the most promising matching hypotheses to date by 
determining if various subgroups of alcohol dependent clients would respond differently 
to three manual-guided, individually-delivered treatments: Cognitive Behavioral Coping 
Skills Therapy (CBT), Twelve-Step Facilitation Therapy (TSF) and Motivational 
Enhancement Therapy (MET; Project MATCH Research Group, 1997a). In addition to 
improving upon the methodological limitations of its predecessors, DiClemente (2003) 
notes that Project MATCH aspired to understand treatment processes and behavioral 
change components as well as drinking outcomes in its evaluation of matching 
hypotheses. The three study treatments were chosen because of their diverging 
conceptualizations of behavior change and the techniques they employed to influence this 
process (DiClemente, 2003). CBT consisted of 12 sessions over the 12-week treatment 
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period. It was derived from social learning theory wherein the focus was on the 
development of coping skills that would enable clients to deal with situations that 
commonly precipitate relapse. TSF was also delivered on a weekly basis throughout the 
treatment period. It viewed alcoholism as a spiritual and medical disease, fostered client 
acceptance of this disease, encouraged the development of a commitment to participate in 
Alcoholics Anonymous (AA), and promoted the working of the 12 steps associated with 
the AA paradigm. MET consisted of four treatment sessions held during the first, second, 
sixth, and twelfth weeks of treatment. It employed techniques aimed at increasing 
intrinsic motivation and initiating change through the mobilization of the client’s own 
assets and coping resources (Project Match Research Group, 1997a; 1997b).  
 Project MATCH was actually comprised of two parallel, though independent, 
examinations of clients recruited at nine clinical research units that were affiliated with 
multiple treatment facilities. Clients were solicited directly from outpatient treatment 
clinics and the community through advertisements (outpatient arm) and via inpatient or 
intensive day hospital treatment programs who referred clients for aftercare (aftercare 
arm). Randomization procedures, assessment instruments, treatment protocols, follow-up 
evaluations, matching hypotheses, and data analyses were identical in both branches of 
the study (Project MATCH Research Group, 1997a). Participants were recruited over a 
two-year period using strategies to maximize sample heterogeneity. To be included in the 
study, potential participants had to meet the following criteria: current diagnosis of 
alcohol abuse or dependence; alcohol as the primary drug of abuse; active drinking 
during the three months prior to entrance into the study; minimum age of 18; and a 
minimum sixth-grade reading level. Additionally, aftercare participants had to complete 
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an inpatient or intensive day hospital treatment program lasting at least seven days and be 
referred for aftercare treatment. Exclusion criteria included a concurrent diagnosis of 
dependence on sedatives/hypnotics, stimulants, cocaine, or opiates; intravenous drug use 
in the previous six months; presently being a danger to self or others; probation/parole 
requirements that may interfere with study participation; lack of clear possibilities for 
stable residency; inability to identify at least one “locator” person to assist in follow-up 
tracking; acute psychosis; severe organic impairment; or planned or current involvement 
in alternative treatments for alcohol problems. Further general requirements were 
willingness to accept randomization to any treatment condition, residence within 
reasonable commuting distance with available transportation, and completion of prior 
detoxification when medically advised (Project MATCH Research Group, 1997a).    
 The research protocol involved an initial screening to determine if a person was 
eligible, followed by completion of informed consent documentation. Participants then 
underwent a series of three comprehensive intake sessions that lasted a total of 
approximately eight hours. These sessions consisted of personal interviews, computer-
assisted assessments, and self-administered questionnaires assessing an array of domains: 
demographic information, alcohol and drug use history, legal status, family and social 
relationships, psychological history, cognitive functioning, and motivation for treatment 
(Project MATCH Research Group, 1997a). Participants were then randomly assigned to a 
treatment condition and participated in treatment for 12 weeks. Follow-up assessments 
were carried out at 3 (end of treatment), 6, 9, 12, and 15 months after the first therapy 
session. Collateral information was collected from identified informants and laboratory 
tests were carried out to substantiate the participants’ self-report of alcohol use. A 
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number of procedures (e.g., standardized therapist certification, session monitoring, blind 
videotape ratings of sessions) were utilized to evaluate treatment fidelity and prevent 
therapist variation from the protocol (Project MATCH Research Group, 1997a). With 
regards to treatment retention and compliance, outpatient participants completed 68% of 
their scheduled visits while aftercare participants competed 66%. For both arms of the 
study, data for over 90% of the participants were collected at all five follow-up points 
during the posttreatment year (Project MATCH Research Group, 1997a). 
 The selection of primary and secondary a priori matching variables was based on 
strength of empirical support and theoretical justification (Project MATCH Research 
Group, 1997a; 1997c). Primary client-level variables utilized to test the matching 
hypotheses included: severity of alcohol involvement; cognitive impairment; conceptual 
level; gender; meaning seeking; motivation; psychiatric severity; social support for 
drinking; sociopathy; and alcoholic typology (Project MATCH Research Group, 1997a). 
Secondary variables, though they had less backing in the scientific literature, were 
included to test matching hypotheses that appeared promising: severity of alcohol 
dependence, anger, antisocial personality disorder, assertion of autonomy, diagnosis of an 
Axis I disorder, prior engagement in AA, religiosity, self-efficacy, social functioning, and 
readiness to change. The main outcome measures were percentage of abstinent days per 
month and average number of drinks per drinking day, while secondary outcome 
measures encompassed negative alcohol-related consequences, psychiatric status, social 
behavior, days paid for working, and a category-based composite measure of client 
functioning during treatment (e.g., abstinent, moderate drinking without recurrent 
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problems, heaving drinking or recurrent problems, and heavy drinking and recurrent 
problems) (Project MATCH Research Group, 1997a). 
 Treatment Outcomes 
 Treatment outcomes were assessed during treatment, throughout the first year 
following treatment, and again three years after treatment completion. In the outpatient 
arm of the study, both the CBT and TSF conditions resulted in a higher frequency of 
abstinent days than MET during the 12-week treatment phase, and CBT was also 
associated with fewer drinks per drinking day in the final month of treatment as 
compared to MET. Furthermore, participants in the MET-condition experienced more 
alcohol-related negative consequences and were more likely to be classified as drinking 
heavily and/or having recurrent alcohol problems during treatment than participants in 
the other treatment conditions (Project MATCH Research Group, 1997b). No treatment 
main effects during treatment materialized for the aftercare arm, which may have been 
the result of these participants being exposed to an intensive initial treatment (e.g., 
detoxification or day hospital) before Project MATCH randomization occurred. An 
alternative explanation of this observation relates to the fact that treatment may have been 
geared more towards relapse prevention in the aftercare arm because clients commenced 
the study with a sustained period of abstinence, whereas more outpatient clients were 
likely working to establish initial clean time. Thus, the more intensive CBT and TSF 
treatments (i.e., 12 sessions over 12 weeks) may have a greater influence on the initiation 
of abstinence as opposed to the maintenance of abstinence than the less intensive MET 
condition (i.e., 4 sessions over 12 weeks) (Project Match Research Group, 1997b). Taken 
together, it was suggested that when there is a need to quickly reduce heavy drinking and 
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negative alcohol-related consequences, as is often the case in outpatient settings, there 
appears to be a temporary advantage to recommending CBT or TSF over MET (Project 
MATCH Research Group, 1997b). 
 This indication proved to be provisional because the outpatient treatment 
differences initially detected faded soon after the end of treatment and were not 
maintained during the follow-up year (Project MATCH Research Group 1997a; 1997b). 
The three treatments had favorable and fairly similar effects on treatment outcome as 
minimal discrepancies were found for drinking and related outcome measures across the 
follow-up period. Consequently, the Project MATCH Research Group (1997a; 1998a) 
concluded that these variations were not clinically significant and alcohol-dependent 
clients appeared to respond equally well to the three treatment methods. Overall, outcome 
results indicated that the percentage of abstinent days per month significantly increased 
for both aftercare and outpatient participants from intake through each of the follow-up 
periods. More specifically, clients were abstinent around 20% of the days in the three 
months prior to participating in the study, while this rate climbed to over 85% during the 
month immediately treatment. These results were sustained over the course of the year 
following the completion of treatment as only a slight deterioration in abstinence rates 
were reported for all participants (Project MATCH Research Group 1997a; 1998a). Even 
participants who continued to drink exhibited a considerable decline in the frequency and 
quantity of drinking. Prior to treatment, these clients averaged nearly 25 drinking days 
per month and would usually consume approximately 15 drinks per drinking day. These 
figures were reduced to 6 and 3 drinks, respectively, during the month after treatment and 
were reasonably maintained throughout the one-year follow-up period (Project MATCH 
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Research Group, 1997a; 1998a). In addition to improved drinking outcomes, participants 
showed significant reductions in depression, use of other drugs, and alcohol-related 
problems. Improvements in social functioning and liver function tests were also noted 
(Project MATCH Research Group, 1997a; 1998a). 
 Similar drinking outcome patterns were noted at the three-year follow-up point 
for the outpatients in the study. Abstinence rates paralleled those found in other long-term 
treatment follow-up studies with nearly 30% of outpatient participants remaining totally 
abstinent in the three months prior to the three-year follow-up assessment (Project 
MATCH Research Group, 1998a; 1998b). Even participants who reported drinking 
remained abstinent nearly 66% of the time at three years posttreatment, which is a 150% 
improvement from baseline estimates. Furthermore, when these participants drank, they 
reported consuming an average of between 6 and 7 drinks, which had decreased from a 
baseline average of about 11 drinks (Project MATCH Research Group, 1998a; 1998b).  
 Prognostic Indicators of Outcomes  
 Separate analyses were conducted to examine the effects of primary and 
secondary client matching attributes on drinking outcomes, regardless of the type of 
treatment received. For aftercare participants, gender was associated with abstinence rates 
throughout the one-year posttreatment phase with males having significantly fewer 
abstinent days than females. Psychological severity also interacted with time to predict 
abstinence. Near the end of the one-year follow-up phase, aftercare clients with more 
severe psychological problems at intake had fewer abstinent days than those who 
reported less severe psychological problems (Project MATCH Research Group, 1997a). 
Primary client attributes seemed to have a greater influence on the amount of alcohol 
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consumed on drinking days. Results indicated that being male, having a higher level of 
alcohol involvement, reporting more severe psychological problems, and possessing 
more social support for drinking was associated with more drinks per drinking during the 
one-year follow-up period. Furthermore, the effects for gender (male) and psychological 
severity (greater) became more pronounced over time during this posttreatment phase 
(Project MATCH Research Group, 1997a). When examining secondary variables, a self-
efficacy measure (i.e., difference between temptation to drink and confidence to remain 
abstinent) and religiosity were related to drinking outcome. A higher discrepancy 
between temptation and confidence was associated with lower abstinence rates and 
higher levels of consumption, whereas a stronger religious background was positively 
related to increased abstinence (Project MATCH Research Group, 1997c). 
 A slightly different prognostic profile emerged for outpatient participants. The 
more motivated a client was prior to treatment and the less social support s/he had for 
drinking, the better the drinking outcomes (i.e., higher abstinence rate and lower 
consumption level) during the year following treatment. Sociopathy was also a predictor 
of outcome, though it interacted with time: higher levels of sociopathy were associated 
with poorer outcomes early in the follow-up phase but not in the latter stages (Project 
MATCH Research Group, 1997a). In analysis of secondary attributes, two self-efficacy 
measures (i.e., confidence to maintain abstinence, difference between temptation to drink 
and confidence to remain abstinent) and readiness to change were related to better overall 
outcomes. As in the aftercare arm, a larger gap between temptation and confidence was 
associated with more frequent and larger amounts of drinking; whereas, when confidence 
was considered alone, the higher the client’s confidence, the greater the amount of 
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abstinence and the less alcohol consumed on drinking days (Project MATCH Research 
Group, 1997c). Other prognostic indicators suggested that greater readiness to change 
and higher levels of alcohol dependence were associated with increased abstinent days, 
while stronger religious background was related to less heavy consumption (Project 
MATCH Research Group, 1997c). 
 By the three-year follow-up point, several of these relationships were sustained 
and a total of 11 of the 21 client matching attributes had prognostic value for the 
outpatient arm of the study. It should be noted that the aftercare sample was not assessed 
at three years posttreatment. The most consistent finding across these intervals was that 
motivation and readiness to change continued to have a favorable main effect on both 
drinking outcomes (Project MATCH Research Group, 1998b). Though the self-efficacy 
variables had been related to both abstinence rates and consumption levels at the one-year 
follow-up point, they remained predictive of consumption levels three years 
posttreatment. The alcohol dependence and religiosity findings were sustained as well. 
Additionally, outpatient participants who experienced more severe alcohol-related 
problems (i.e., greater alcohol involvement, greater dependence, and type B alcoholic) or 
had poorer social functioning before treatment actually had better drinking outcomes at 
the three-year follow-up point (Project MATCH Research Group, 1998b). In summary, 
the authors noted that these findings suggest that “the most successful predictors are 
‘state’ variables (e.g., motivation, self-efficacy) that are thought to be changeable, thus 
holding out the hope that treatment focusing on them can change drinking behavior” 
(Project MATCH Research Group, 1998b, p. 1309). 
 Treatment Matching Effects 
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 None of the ten a priori primary matching hypotheses garnered irrefutable support 
for effect on drinking outcomes during treatment and throughout the follow-up period, 
though trends were detected. In the first month of treatment, outpatients who had social 
networks that were more supportive of drinking prior to treatment consumed significantly 
less alcohol when treated in the TSF condition as opposed to MET, though this effect 
dissipated in the latter months of treatment (Project MATCH Research Group, 1997b). It 
was suggested that this observation may have occurred because an initial focus in TSF is 
helping clients separate themselves from the social network that supports drinking and 
begin forming a new network that reinforces abstinence (Project MATCH Research 
Group, 1997b). Throughout the one-year posttreatment follow-up, only three primary 
matching hypotheses found support in the data, though only one of these had an effect 
that was not time dependent (Project MATCH Research Group, 1997a). Outpatients who 
did not report concurrent psychological problems had significantly higher rates of 
abstinence when treated in TSF than those treated in CBT in 7 of the 12 follow-up 
months. This divergence peaked at nine months posttreatment where TSF participants 
had approximately 87% days abstinent versus 73% for CBT participants. However, as the 
severity of concurrent psychological problems increased, the observed TSF advantage 
disappeared. Since only a small proportion of outpatient participants fell at the high end 
of the psychological severity spectrum, it was not possible to fully evaluate whether the 
observed matching trend reversed itself (i.e., if CBT, as compared to TSF, led to 
significantly more abstinent days for outpatients reporting more severe psychological 
problems) (Project MATCH Research Group, 1997a).   
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 The other client attributes that interacted with treatment types as hypothesized 
were meaning seeking and motivation, although statistical support was meager and was 
only detected in one arm of the study. For motivation, the interaction effect changed over 
time and emerged as significant only during the last month of the posttreatment period 
(Project MATCH Research Group, 1997a). Outpatient MET clients who had low in 
motivation to change eventually reported significantly higher abstinence rates than their 
CBT counterparts one year after treatment. However, this trend had reversed itself over 
time as CBT initially appeared to be superior to MET for clients low in motivation 
immediately following treatment, suggesting that MET may have a delayed effect 
(Project MATCH Research Group, 1997a). In the aftercare arm, the meaning seeking 
hypothesis acquired some support. Participants who aspired to experience greater 
meaning and felt less purpose in life at intake (i.e., high meaning seeking) were 
somewhat more responsive to TSF than to other treatments as evidenced by significantly 
higher rates of abstinence. However, this effect did not emerge until the latter six months 
of the follow-up period (Project MATCH Research Group, 1997a). 
 Of the secondary matching variables selected, two results of note emerged 
(Project MATCH Research Group, 1997c). Outpatient participants with greater levels of 
anger who were treated in the MET condition had a significantly higher percentage of 
days abstinent and consumed significantly less alcohol on drinking days than CBT 
participants throughout the follow-up period. In the after care arm, degree of alcohol 
dependence affected outcomes in the CBT and TSF conditions (Project MATCH 
Research Group, 1997c). Clients classified as low in alcohol dependence severity had 
significantly better abstinence rates when treated in CBT as opposed to TSF during the 
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follow-up phase. As level of client alcohol dependence increased though, the advantage 
shifted to TSF treatment. TSF clients at the high end of the dependence severity range 
were abstinent significantly more days and drank significantly less amounts on drinking 
days than their CBT counterparts (Project MATCH Research Group, 1997c). 
 In the outpatient follow-up study, only one of the initial primary and secondary 
matching effects detected was sustained three years after treatment. Findings suggested 
that outpatients who rated higher in anger and were treated in the MET condition 
sustained superior outcome effects (i.e., higher abstinence rates and lower consumption 
amounts) at the three-year follow-up than high anger clients who participated in CBT or 
TSF treatment (Project MATCH Research Group, 1998b). The initial psychological 
problem severity matching effect (i.e., advantage of TSF over CBT in clients without 
concurrent psychological problems) found at the one-year point had disappeared by three 
years posttreatment. At the same time, a primary matching hypothesis that was not 
confirmed during the one-year follow-up period gained support at the three-year point. It 
was originally predicted that clients whose social network was supportive of drinking 
would have better outcomes if they were treated in the CBT or TSF condition as opposed 
to MET because MET does emphasize coping skills or the building of a sober network 
like the other treatments (Project MATCH Research Group, 1998b). Three years 
following treatment, TSF clients who had greater support for drinking prior to treatment 
had significantly higher abstinence and lower consumption rates than their MET 
counterparts.  
 Project MATCH Conclusions 
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 The principal aim of the Project MATCH undertaking was to determine if patients 
possessing particular attributes would respond differentially to three alcohol treatments. 
When primary and secondary matching analyses are integrated, even though several 
statistically significant results emerged, no strong evidence in support of or in opposition 
to the general treatment matching hypothesis could be deduced (Project MATCH 
Research Group, 1997c; 1998a). “What can be concluded with some confidence is that 
matching clients on the basis of any single attribute hypothesized and tested in Project 
MATCH is unlikely to markedly enhance the effectiveness of any of these three 
treatments” (Project MATCH Research Group, 1998a, p. 1690). The clinical significance 
and robustness of the findings are challenged by discrepancies between findings from the 
outpatient and aftercare arms of the study and failure to find effects for both primary 
drinking outcomes for the identified attributes. Furthermore, the Project MATCH 
Research Group (1998a) reported that when comparing the difference between the top 
and bottom decile of an attribute, the strongest of the hypothesized effects accounted for 
no more than a 12% difference in abstinent days per month, which equates to about three 
to four days, and a reduction of two drinks per drinking day. Lastly, Project MATCH did 
not employ any comparison group procedures in their investigation, likely because of the 
ethical dilemma of withholding beneficial treatment from participants. This limitation 
introduces the possibility that just because participants demonstrated positive outcomes 
across the three treatments, does not necessarily imply that the treatments “work” equally 
as well; alternatively, they may not “work” at all because these outcomes were not 
compared to the outcomes of a group of individuals who did not receive any of these 
treatments. 
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 Nevertheless, the overall picture of treatment outcome was positive for 
participants across the treatment conditions. High rates of compliance were documented 
for both the research protocol and therapy, which preserved treatment integrity and 
enhanced the quality of the data (Mattson et al., 1998). Furthermore, high rates of 
participant compliance were identified (i.e., overall session attendance rate above 65% 
and the completion rate of the one-year posttreatment data collection at around 90%) and 
were positively related to favorable treatment outcomes. Ultimately, the Project MATCH 
Research Group (1997c) purported: 
Single attribute by treatment interactions alone cannot account for the complexity 
of the matching findings. Further research will be needed to put the results into a 
clinically useful formula that will also provide a theoretical basis for 
understanding how a given treatment benefits a given client. Research is needed 
to identify the common and unique active ingredients of treatments, as well as 
provide a better understanding of how these treatment variables lead to different 
client outcomes. Discovery of the variables and processes that mediate treatment 
outcomes will enhance treatment effectiveness substantially. (p. 1695) 
 
Project COMBINE 
In accordance with the aforementioned philosophy of identifying the complex 
aspects of alcohol treatment that may enhance effectiveness, NIAAA launched another 
multi-center, RCT at the turn of the century entitled Combining Medications and 
Behavioral Interventions (Project COMBINE). Primary aims were to examine the 
efficacy of pharmacological treatments, behavioral therapies, and their combinations in 
the treatment of alcohol dependence and to evaluate the placebo effects on overall 
outcomes (The COMBINE Study Research Group, 2003). Study medications included 
naltrexone and acomprosate. Selected behavioral treatments were medical management 
(MMT), a manualized 9-session intervention that concentrated on enhancing adherence to 
mediation regime and maintaining abstinence that could be adapted for primary care 
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settings, and cognitive behavioral intervention (CBI), a manual-guided, individual 
outpatient specialized alcohol treatment that merges a variety of methods and techniques 
(The COMBINE Study Research Group, 2003). Treatment groups were comprised of 
various combinations of these interventions, and participants were randomly assigned by 
a stratified random block design. Eight groups (n = 1226) received MMT, while four of 
these groups (n = 619) also received CBI. All of these participants were also assigned to a 
medication condition (e.g., placebo, acamprosate, naltrexone, or acamprosate plus 
naltrexone), yielding four medication conditions within each behavioral level (e.g., MMT 
or MMT plus CBI). A ninth group (n = 157) who only received CBI was included to 
assess placebo effects. The data collection period spanned from January 2001 through 
January 2004 (Anton et al., 2006).   
Participants were recruited from inpatient and outpatient referrals within the study 
sites and from the community through media announcements. Screening assessments 
were completed to determine study eligibility. Inclusion criteria included: age 18 years or 
older; current diagnosis of alcohol dependence; completion of informed consent 
procedures; minimum levels of drinking during the 90-day period prior to treatment 
entry; at least 4 consecutive days, but no more than 21 consecutive days, of abstinence 
prior to randomization; ability to identify a “locator” person; and ability to speak and 
understand English. Exclusion criteria included: concurrent diagnosis of bipolar disorder, 
schizophrenia, bulimia, anorexia, dementia, or another psychological disorder requiring 
medication; medication regime that would pose safety issues with study medications; 
concurrent diagnosis of dependence on another drug except nicotine, cannabis, and 
caffeine; diagnosis of opiate dependence or abuse within the past six months; chronic 
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treatment with any opiate-containing medications during the previous month; positive 
urine screens for exclusionary drugs; abnormal laboratory tests; being pregnant and 
nursing or potential to become pregnant; intention to engage in additional formal alcohol 
treatment; more than 7 days of inpatient treatment during the 30 days prior to 
randomization; and use of study medications in previous 30 days (The COMBINE Study 
Research Group, 2003). Primary comprehensive assessments were conducted at intake 
and then at various points following randomization: 8 weeks (during treatment), 16 
weeks (conclusion of treatment), 26 weeks, 52 weeks, and 68 weeks (one-year follow-
up). Measures of drinking and craving were also collected weekly or at each MMT 
appointment. Primary drinking outcomes were percentage of abstinent days and time to 
first heavy drinking day, though drinks per drinking day was also examined (The 
COMBINE Study Research Group, 2003).  
Treatment Outcomes 
Overall, all pill-taking treatment groups exhibited significant reductions in 
drinking, with percentage of abstinent days increasing from 25% during the pretreatment 
period to 73% during treatment and drinks per drinking day declining from 12.6 to 7.1. 
Participants in the naltrexone plus MMT; placebo plus MMT and CBI; or naltrexone plus 
MMT and CBI conditions had significantly higher rates of abstinence (81%, 79%, and 
77%, respectively) during the treatment phase than participants receiving placebo plus 
MMT (75%). Furthermore, over time, naltrexone reduced the risk of experiencing a 
heavy drinking day, an effect that was more pronounced in those also receiving MMT but 
not CBI (Anton et al, 2006). Contrary to the positive findings of previous trials, 
acomprosate demonstrated no significant effects on drinking as compared to placebo, 
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either by itself or when combined with naltrexone, CBI, or both. Placebo effect results 
indicated that participants receiving placebo plus MMT or placebo plus MMT and CBI 
had significantly higher percentages of abstinent days (74% and 80%, respectively) than 
their counterparts in the CBI only condition (67%). Although comparable between-group 
differences were detected at the one-year follow-up point, none of them reached a level 
of statistical significance, which challenges the sustainability of these treatment effects 
over time (Anton et al., 2006). 
Taken together, Project COMBINE results suggested that participants who 
received MMT with any combination of naltrexone and CBI had more favorable drinking 
outcomes than participants in other conditions. A lack of evidence was found for the 
efficacy of acamprosate with or without a behavioral adjunct (CBI). With regards to 
questions of comparative efficacy, MMT combined with naltrexone or CBI, but not both, 
were the only treatment combinations that garnered incremental efficacy support. 
Surprisingly, a placebo effect was also detected: meeting with a health care practitioner 
and taking placebo pills during treatment had a positive effect on drinking outcomes 
above those found for participants who only engaged in CBI (Anton et al., 2006). These 
findings provide additional evidence for the general effectiveness of alcohol treatment 
and delineate two combinations of pharmacological and behavioral therapies that may 
produce more or less favorable results. Although the comparative efficacy results were 
not as robust as researchers had hoped for, the methodological precision introduced by 
Project COMBINE allowed for the investigation of both independent and combination 
testing of medications with differentially intensive behavioral interventions, a new level 
of design complexity that is essential to the proper evaluation of the multimodal alcohol 
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treatment that is currently being delivered in treatment programs (Anton et al., 2006; The 
COMBINE Study Research Group, 2003).  
Despite its methodological rigor, a glaring omission from Project COMBINE 
publications is a discussion of study findings as they relate to the study’s theoretical 
underpinnings and hypotheses that were not supported by the results. Additionally, aside 
from mentioning that naltrexone treatment delivered in a primary care setting could 
extend patient access to effective alcohol dependence treatment and suggesting that the 
usefulness of continued or intermittent care over the longer-term should be evaluated, 
implications for clinical practice and future research directions are absent (Anton et al., 
2006). As Bergmark (2008) notes, researchers could have elaborated on potential 
treatment mechanisms that could have generated improvement in the participants’ 
drinking practices, including participant attributes, treatment context factors, intervention 
characteristics.  
Meta-Analytic Reviews of Alcohol Treatment  
 Although RCTs are a critical source of empirical evidence regarding the 
effectiveness of alcohol treatment, the value of smaller-scale randomized studies and 
nonrandomized investigations cannot be discounted. Fortunately, the inception of meta-
analytic techniques has made it possible for investigators to integrate alcohol treatment 
research across diverse methodologies and assess the magnitude, direction, and 
consistency of their respective findings (Rosenthal, 1995). Miller and Wilbourne (2002) 
aimed to summarize the existing empirical support for various treatment approaches for 
alcohol use disorders by evaluating controlled studies via a differential weighting system 
based on the methodological precision of each study (i.e., randomization to conditions, 
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quality control of treatments, follow-up length, collateral interviews, replication of 
findings at multiple sites). The review included 361 investigations and 72,052 clients and 
was the most recent installment in a series of three reviews. Results indicated that the 
overall methodological quality of a study was significantly correlated with the reporting 
of a specific effect of treatment, though this relationship was modest at best (Miller & 
Wilbourne, 2002). With regard to treatment approaches, the strongest evidence of 
efficacy was found for brief interventions, social skills training, the community 
reinforcement approach, behavior contracting, behavioral marital therapy, and case 
management. Miller and Wilbourne (2002) drew attention to the fact that it appeared that 
the common themes interwoven throughout these particular approaches included self-
efficacy related to stopping or reducing drinking, motivation for change, and attention to 
the social context and support systems. Two pharmacotherapies, opiate antagonists 
(naltrexone and nalmefene) and acamprosate, ranked fairly high on the list (3 and 4, 
respectively) and did so for the first time since the inception of this methodological 
review. Treatment techniques that generated the least support included those designed to 
create, confront, shock or foster insight regarding the nature and causes of alcoholism 
(Miller & Wilbourne, 2002). 
 Moyer and Finney (2002) set out to compare and contrast the participants, 
methodological features, and posttreatment functioning in both randomized and 
nonrandomized alcohol treatment studies conducted between 1970 and 1998. The sample 
yielded an analysis of 232 randomized and 92 nonrandomized trials. Results indicated 
that randomized investigations were significantly more likely to employ participant 
inclusion and exclusion selection criteria, to use established diagnostic criteria to 
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characterize participants, and to employ more rigorous treatment delivery and assessment 
procedures (e.g., training for providers, treatment manuals, supervision) (Moyer & 
Finney, 2002). Nonrandomized studies were significantly more likely to measure 
outcomes in a greater proportion of participants over longer follow-up periods and to 
include enough participants to ensure adequate statistical power to detect medium-sized 
(p = .05) treatment effects. Types of treatments examined also diverged between the 
methodologies. Randomized trials were significantly more likely to explore the effects of 
behavioral or pharmacological treatment whereas nonrandomized trials tended to 
examine broad or unspecified inpatient and/or outpatient treatments (Moyer & Finney, 
2002). Aside from education, no evidence was detected of baseline differences in primary 
demographic characteristics including sex, ethnicity, marital status, employment status, 
history of alcohol use, and education. Participants in randomized studies completed 
significantly more years of education than their nonrandomized counterparts. With 
regards to treatment outcomes, even when differences in study features was controlled 
for, abstinence rates and the proportion of participants who improved following treatment 
were similar for both types of investigations. Despite the contrasting strengths and 
weaknesses of randomized and nonrandomized trials, Moyer and Finney (2002) advise 
that it would behoove the field to consider them as complementary forms of treatment 
evaluation. 
 Descriptive review approaches have also been utilized to examine the nature of 
alcohol treatment research itself and provide more qualitative information about what 
types of studies have been undertaken in the field and what changes have occurred over 
time. Swearington, Moyer, and Finney (2003) reviewed 701 multiple-group (n=404) and 
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single-group alcohol (n=297) treatment outcomes studies reported between 1970 and 
1998. Findings indicated that males continued to make up the majority of research 
participants, with the percentage of women included in research (15%) not corresponding 
to the actual approximate percentage of female clients in alcohol treatment programs 
(31%) (Swearington et al., 2003). Although single- and multiple-group studies were fairly 
similar with respect to participant characteristics, there were observed differences in 
terms of treatment type, setting, and outcome assessment. Multiple-group studies 
investigated behavioral (33%) and pharmacological (23%) treatments more often than 
single-group studies (7% and 6%, respectively). On the other hand, single-group studies 
tended to focus more on multimodal or unspecified treatment (61%) as compared to their 
multiple-group counterparts (23%) (Swearington et al., 2003). Multi-group research was 
more often evaluated in outpatient settings (52% vs. 31%), while single-group research 
was more concentrated in inpatient and residential centers (53% vs. 32%). Single-group 
investigations also tended to track participants for a longer period of time for follow-up, 
nearly 20 months, as compared to just over 12 months for multiple-group investigations 
(Swearington et al., 2003). The observed methodological differences between multiple- 
and single-group designs are not surprising considering the divergent purposes of each: 
 Whereas single-group studies tend to be conducted by treatment practitioners  
within existing treatment programs in an effort to discover how patients fare 
following a particular treatment program, multiple-group studies are typically 
undertaken by academic researchers interested in exploring theory-driven models 
of alcohol treatment to identify efficacious treatments and the relative effects of 
different treatment approaches. These findings point to a schism between research 
conducted in real-world settings and research-based investigations. Closing the 
gap will require comparative investigations of the effects of theory-based 
treatments in more “real-world” settings as a follow-up to efficacy studies.” 
(Swearington et al., 2003, p.432)   
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 Regardless of this divide, researchers have refined statistical techniques to 
combine data from both randomized and nonrandomized investigations to determine 
average outcomes for a person who is treated for an alcohol use disorder. Miller, Walters, 
and Bennett (2001) examined over 8000 clients who participated in four RCTs (e.g., the 
VA collaborative trial of lithium, the VA collaborative study of disulfiram, two Project 
MATCH studies) and three uncontrolled studies (e.g., the Relapse Replication and 
Extension Project, the VA study of treatment for substance use disorders, the Rand 
corporation reports) of treatment as usual and converted outcome findings to derive 
estimates of average effectiveness for alcohol treatment.  
 Results indicated that after a single treatment episode, approximately one in four 
clients will maintain abstinence from alcohol during the year following treatment; 
moreover, another one in ten clients will moderate the frequency and quantity of their 
drinking to a point where no alcohol-related problems are experienced in the 
posttreatment year. Taken together, approximately one third of clients have relatively 
clear-cut positive outcomes following treatment (Miller et al., 2001). Substantial 
improvements are also noted for the remaining two thirds of treated clients who continue 
to have some periods of heavy drinking during the year after treatment. Findings 
indicated that the frequency of drinking is reduced, as prior to treatment they were 
drinking about two out of three days whereas after treatment they drink approximately 
one out of four days (Miller et al., 2001). The amount of consumption also decreases. The 
average number of drinks per drinking day is less than half what it was prior to treatment, 
and the average number of drinks per week is reduced by more than 87% (i.e., 77 
standard drinks per week to 10). Moreover, the number of alcohol-related problems 
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decreases by 60% following treatment for these clients (Miller et al., 2001). Overall, 
these results highlight the substantial improvements made by treatment clients who do 
not necessarily maintain complete abstinence or moderation following treatment. 
Unfortunately, such progress is often masked by simplistic, dichotomous posttreatment 
classification of “successful” (i.e., complete abstinence) or “relapsed” (Miller et al., 2001, 
p. 218). Ultimately, the execution of such an investigation provides additional empirical 
support for the effectiveness of alcohol treatment and a unique perspective on the 
assessment of treatment outcomes. 
Summary of Large-Scale Alcohol Treatment Research  
 Despite embedded limitations including the recruitment of homogeneous 
treatment samples and utilization of tightly-controlled treatment conditions, which both 
affect the generalizability of results to actual treatment settings characterized by complex 
clientele and variability in treatment delivery, a substantial amount of empirical evidence 
related to alcohol treatment outcomes has been derived from large-scale, RCTs. Studies 
such as Project MATCH and COMBINE aimed to determine absolute and relative 
efficacy of assorted alcohol abuse treatment approaches, and in accomplishing this feat, 
produced manualized treatment protocols that can be used in the field and demonstrated 
the cost-effectiveness of treatment. Meta-analyses of specific interventions and reviews 
of the nature of the study of alcohol treatment effectiveness have bolstered this scientific 
research base as well. Consequently, simple questions such as “Is treatment effective?” 
and “Which treatment is the best?” have often been answered with a relatively 
convincing, “yes, and they all work about equally as well” (Miller, 1992, p. 99). Similar 
responses to such questions would likely be proffered in the drug abuse treatment field as 
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well, because positive outcomes continue to be detected across a multitude of modalities 
and programs. At the same time, diversity across treatment programs with regards to 
clientele, approaches, and services offered necessitates a further examination of these 
rather broad sweeping generalizations regarding treatment efficacy and effectiveness, 
with a particular focus on attending to the inherent complexities of studying substance 
abuse treatment at a micro-level.  
Translating Large-Scale Treatment Research to Small-Scale Settings 
The Gap Between Research and Practice in Substance Abuse Treatment 
 Generally speaking, despite the strong scientific underpinnings of psychotherapy 
outcome research, the discrepancy between clinical practice and research continues to be 
large (Godfried & Wolfe, 1996). This gap also exists within substance abuse treatment 
field as the integration of science-based treatment into clinical practice remains the 
exception, not the rule, even though pressure from a variety of sources (e.g., increased 
consumer demand for treatment options, greater accountability for expenditures, high 
value placed on the scientific method as the basis for developing effective treatments) 
continues to mount in favor of enhanced integration (Lamb, Greenlick, & McCarty, 1998; 
Marinelli-Casey, Domier, & Rawson, 2002). Explanations for this rift have often been 
attributed to a lack of communication and cooperation between clinicians and 
researchers; divergent perspectives on the relevance and utilization of each other’s 
knowledge and methods of dissemination of this knowledge; and a lack of emphasis on 
the transfer and implementation stages initiatives designed to blend research and practice 
(Marinelli-Casey, Domier, & Rawson, 2002). In examining how the exchange of science 
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and information between drug abuse treatment providers and researchers can be more 
bidirectional, Bowser (1998) outlines a number of conditions that must be met: 
 First, treatment research has to be produced for practitioners and must be useful to  
them. Second, practitioners must want to work with and provide information to 
researchers. Third, researchers must be interested in what practitioners know and 
want to know. And fourth, we assume that better information exchanges between 
practitioners and researchers will improve client outcomes. (p. 136) 
 
Clinicians and researchers who choose to engage in efforts to narrow the science-practice 
gap through collaborative endeavors need to acknowledge that these circumstances are 
met to varying degrees across research and treatment programs and should incorporate 
assessment procedures to appraise these aspects of the partnership. The need for 
collaborations amongst researchers and treatment programs within the field of substance 
use disorders is great and the potential value of these ventures is yet to be fully realized. 
One step individual substance abuse treatment programs can take in an effort to 
strengthen their scientific foundation is to evaluate the utility of extant substance abuse 
treatment literature as it relates to their particular program and the clients they serve. 
Impetus for Applying Large-Scale Research Findings to Individual Programs 
Why is it not only important, but critical to the advancement of the field, to determine 
whether or not the aforementioned substance abuse treatment outcome and retention 
findings can be applied at the local level of individual treatment programs? The reasons 
are three-fold. Such knowledge is critical for the sake of treatment itself. Treatment 
programs ultimately aim to serve clients and help them achieve favorable results as 
defined by both the treatment program and the individual client. Learning more about 
behavioral change processes and the variables related to “successes” (i.e., reduced 
frequency of use, decreases problems related to substance use, improved relationships) 
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and “failures” (i.e., inability to maintain abstinence, treatment dropout, increased 
substance use-related problems) within a particular treatment program will enhance the 
general knowledge base regarding the treatment of substance use disorders through the 
substantiation or refutation of existing empirical evidence. Moreover, “treatment 
practices are best driven by the cumulative evidence from a variety of studies over time” 
(Project MATCH Research Group, 1998a, p. 599). Thus, such program-level 
investigations are necessary to inform and shape general treatment practices, which will 
contribute to diminishing the observed science-practice gap that exists within the field. 
The study of substance abuse treatment and treatment processes at the local level 
is also critical for the sake of the treatment program itself. Such findings can inform 
programs and their providers about the particular aspects of their services and practices 
that may facilitate or impede treatment progress and eventual outcomes. In essence, being 
equipped with this information can assist programs and providers in making decisions 
related to the allocation of resources, including time and money, in order to become more 
efficient and cost-effective (Etheridge et al., 1997). In a similar vein, program-level 
evaluation is critical for the sake of managed care policy. Providing data regarding 
treatment retention and treatment outcomes and their relationship to client variables is 
essential to informing managed care guidelines. As third-party payers continue shaping 
the treatment delivery system and enforcing policies that may not be in the best interest 
of the client, empirical evidence will be a key factor in effectively countering such 
practices and providing education about what factors should be considered when such 
decisions are made (Etheridge et al., 1997; Godfried & Wolfe, 1996). More specifically, 
despite the fact that one of the most consistent findings in the drug abuse treatment 
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literature is that length of treatment stay is a reliable predictor of favorable outcomes 
(Hubbard et al., 1989; Hubbard et al., 1997; Simpson & Sells, 1982), it is this aspect of 
treatment that is often been impinged upon by managed care and third-party payers. From 
a structural standpoint, Etheridge and colleagues (1997) underscore why substance abuse 
treatment programs need to attend to empirical evidence and critically evaluate how it 
pertains to their respective programs: 
A necessary ingredient for efficiency of program operation and for program 
stability, treatment quality, and effectiveness is program-level control and 
regulatory authority over the types and volume of clients coming to treatment and 
control over the type of treatment delivered.  This control seems essential for 
program planning, resource allocation, staffing, and, ultimately, treatment 
effectiveness.  Larger system-level factors such as changes in treatment financing 
and other system-level policy changes appear to be eroding program control over 
the types of clients served, length of stay, treatment and services provided, and 
other clinically relevant dimensions of treatment.  In the absence of research-
informed treatment policy development, there is a danger that these system-level 
forces will limit the options available for matching treatment intensity and type of 
counseling and services to the nature and severity of clients’ presenting 
conditions. (p. 259) 
 
These motives for examining research findings and determining their applicability 
at the local level are bolstered by the Stage Model of Behavioral Therapies Research put 
forth by Onken, Blaine, and Battjes (1997) and later revised by Rounsaville, Carroll, and 
Onken (2001). In this model, Stage Ia consists of the preliminary work that needs to be 
carried out prior to the execution of a well-designed, controlled clinical trial: identifying 
potential behavioral and psychosocial research and clinical findings related to treatment, 
devising new therapies, operationally defining therapies in treatment manuals, developing 
reliable and valid competence and adherence measures, and refining therapies based on 
clinician and client feedback. Stage Ib is where this work undergoes pilot testing (Onken 
et al., 1997; Rounsaville et al., 1997). Stage II involves establishing the efficacy of 
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therapies and its components and has historically been the phase that has received the 
majority of federal funding. It encompasses clinical trials examining the promising 
therapies identified in Stage I, investigations to determine the mechanism(s) of action of 
such therapies, and replication studies. It is Stage III that closely coincides with the 
impetus for carrying out program-level research, as it aims to determine the 
transferability and usefulness of the established efficacious treatment. It is at this 
juncture, between research and practice, where a range of questions are examined and 
evaluated: will the treatment work with real clients, therapists, and treatment settings; 
what kind of training is required for practitioners to execute the new treatment skillfully 
and safely; how should such training be delivered; and what are the costs and benefits of 
employing such a treatment for a particular program(s) (Rounsaville & Carroll, 2001). 
Such investigations are crucial to maintaining a sound scientific basis within the 
substance abuse treatment delivery system, but are often accompanied by assorted 
challenges in determining if an efficacious treatment is indeed effective in a real-world 
setting. 
Inherent Challenges of Applying Large-Scale Research Findings to Individual Programs 
 A noteworthy debate within the field of psychological treatment is if and how 
results from RCTs are useful to practitioners. RCT proponents argue that clinicians 
cannot truly provide the best quality care to patients if they disregard the findings of 
research that determines the absolute and comparative efficacy of interventions. 
Moreover, clinicians have an ethical responsibility to inform patients about treatment 
options, make treatment recommendations, and eventually carry out treatment 
interventions based on the best available scientific evidence, which ought to encompass 
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RCTs (Persons & Silberschatz, 1998). On the contrary, there are numerous reasons why 
RCT findings may not generalize to typical treatment settings. In order to establish 
efficacy and detect “true” effects of an intervention, RCTs require a high level of 
experimental control to curb the number of confounding variables and the extent of their 
impact on outcomes. However, the maximization of internal validity comes at a price: 
reduced external validity. Randomization procedures, strict inclusion and exclusion 
criteria to ensure homogeneity within samples, and manualized treatment interventions 
restrict the ability of RCT findings to inform science-practice linkages because these 
conditions do not reflect “real world” clients and treatment delivery systems (Borkovec, 
1997; Carroll & Rounsaville, 2003; Persons & Silberschatz, 1998; Tucker & Roth, 2006). 
“While such speculative concerns do not diminish the unique strengths of randomized 
trials, it is reasonable to ask (and study) whether patterns of outcomes observed in 
ordinary practice settings parallel those from carefully controlled clinical research” 
(Miller & Wilbourne, 2002, p. 276). 
Although the DARP, TOPS, and DATOS research programs aimed to evaluate how 
drug treatment was typically delivered and utilized a naturalistic methodology, they too 
restricted participants to primarily drug users and carried out comprehensive assessment 
procedures that may not be feasible for an individual treatment program. Particularly in 
substance abuse treatment settings, the case mix is highly diverse, and clients often 
present with multiple problems and/or diagnoses, including concurrent alcohol and drug 
abuse or dependence (Carroll & Rounsaville, 2003; Persons & Silberschatz, 1998; Tucker 
& Roth, 2006). In light of the merged substance abuse treatment systems predominantly 
found in the U.S. private sector, which drew more from the alcohol treatment field 
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(Institute of Medicine, 1990), combined alcohol and drug treatment may not provide 
specific enough treatment for the range of substance use diagnoses present amongst 
clientele in any given treatment program. This observation may suggest that different 
factors may affect dropout and various corresponding approaches may be needed to 
improve retention and, ultimately, outcomes for those who meet criteria for only an 
alcohol use disorder, only a drug use disorder, or a polysubstance use disorder (Mertens 
& Weisner, 2000). 
At the same time, diversity in client composition alone is not an adequate explanation 
for observed differences in treatment program retention rates. As a subset of DATOS 
analyses implied, retention rates would still vary even if all programs within the same 
modality would treat highly similar clientele (Simpson, Joe et al., 1997). Shifting focus to 
the programs themselves, treatment interventions often markedly differ from the 
randomized and highly specified interventions (i.e., certain number of sessions, particular 
techniques used, timing of interventions, emphasis on uniformity and fidelity to the 
protocol) evaluated in RCTs as clinicians tend to favor flexibility and attempt to tailor 
interventions to meet the individual treatment needs of each client. Generally speaking, 
substance abuse treatment is becoming more multi-modal and integrative, making it 
increasingly difficult to operationalize within the confines of RCT investigations and 
quasiexperimental or single group research designs (Persons & Silberschatz, 1998; 
Tucker & Roth, 2006).  
At a broader level, RCT and other large-scale research (e.g., DATOS) often combine 
data across modalities and sites, which can ultimately conceal clinically significant 
programmatic disparities that may be of value to individual treatment programs that are 
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fairly comparable to certain study programs but not to others or not to the “typical” one 
upon which results represent (Etheridge et al., 1997). Likewise, since DARP, TOPS, and 
DATOS were carried out in community-based, publicly-funded treatment programs, 
privately-funded agencies likely encounter difficulties in determining the applicability of 
such research findings because disparities likely exist in clientele served, services 
offered, and structure of treatment entry and delivery. The diversity within the research 
itself, including varied questions of interest, methodologies, population(s) studied, and 
variables examined, also makes it difficult for programs to determine the extent of 
applicability of empirical findings because the likelihood that all of these characteristics 
will match up with a particular program is highly unlikely. Plus, the dynamic quality of 
clientele, treatment delivery processes, and managed care policies necessitates constant 
evaluation as prior findings may become obsolete or less germane to a particular program 
as it evolves and changes. Despite the aforementioned challenges associated with 
ascertaining if and how empirical treatment findings filter down to the individual 
program level, the ability of a program to answer these questions can impact the 
treatment delivery system and ultimately improve treatment outcomes. Fortunately, a 
constructive offshoot from the wealth of evidence derived from large-scale treatment 
efficacy and effectiveness studies and specialized treatment evaluations is that this 
information has been organized into a variety of comprehensive treatment models 
designed to assist researchers and practitioners conceptualize the complex processes of 
substance abuse treatment, describe how it works, and effectively evaluate it. Attention 
will now shift to one such model. 
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A Conceptual Framework for Substance Abuse Treatment Processes and Outcomes 
The Texas Christian University Treatment Model 
As Simpson (2004) noted, “psychotherapy, counseling psychology, and drug 
treatment research has identified important therapeutic issues and domains, but these 
finding have not been integrated efficiently into a conceptual scheme to guide clinical 
application and improvements” (p. 102). Hence, Simpson’s drug treatment process and 
outcome research program at Texas Christian University (TCU) aimed to incorporate 
contributions from psychology and other addiction treatment and adopt both conceptual 
and methodological approaches designed to capture the dynamic, complex, and 
sequential nature of the treatment process over time (Simpson, 2001, 2004). TCU studies 
over the past 20 years have spanned various populations and settings, though they 
adopted corresponding assessment procedures and longitudinal data collection strategies 
in both experimental and naturalistic investigations to allow for the compilation of 
findings across projects to form a general treatment model (Simpson, 2001, 2004). The 
TCU Treatment Model “focuses attention on sequential phases of the recovery process 
and how therapeutic interventions link together over time to help sustain engagement and 
retention, thereby improving patient functioning during treatment and after discharge” 
(Simpson, 2004, p. 102). The primary features of the TCU Treatment Model are 
illustrated in Figure 1. 
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Figure 1. The TCU Treatment Model, representing sequential influences of patient 
attributes, stages of treatment, and evidence-based interventions on post-treatment 
outcomes. From “A Conceptual Framework for Drug Treatment Process and Outcomes,” 
by D. D. Simpson, 2004, Journal of Substance Abuse Treatment, 27, p. 103.  
 
 
 
The leftmost portion of the diagram identifies contextual influences on treatment 
outcomes. Patient attributes including background characteristics, problem severity at 
intake, motivation for change, and readiness for treatment are all factors deemed 
important in making treatment placement and planning decisions. Historically, patient 
sociodemographic variables have been fairly weak, inconsistent predictors of 
posttreatment outcomes. Although the amount of variance accounted for by any one 
client attribute tends to be fairly small, to the extent that a substance use disorder is 
“viewed as a multidimensional dysfunction, no single variable should be expected to 
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account for a large portion of variance” (Project MATCH Research Group, 1998b, p. 
1309). Consequently, more empirical attention has been paid to exploring the complex 
sociodemographic profiles of clients entering substance abuse treatment. With increased 
measurement precision and better analytic techniques, investigators are better able to 
identify the extent to which patient factors and their combinations mediate and moderate 
treatment processes, retention, and eventual outcomes (Simpson, 2004). Indicators of 
problem severity such as substance use history, legal status, social resources, and 
psychological dysfunction, also affect early treatment experiences (i.e., program 
participation, the development of rapport, satisfaction with treatment) and may serve as 
gauges for identifying clients with specific treatment needs and others who may be at a 
greater risk for disengaging and dropping out of treatment.  
Simpson (2004) further elucidates two complementary, yet distinct, patient 
attributes that contribute to early treatment processes: motivation for change and 
readiness for change. The motivation for change concept is grounded in Prochaska and 
DiClemente’s Transtheoretical Model, wherein the client’s position along the behavioral 
change continuum is examined (Prochaska & DiClemente, 1992; Prochaska, DiClemente, 
& Norcross, 1992), and Miller and Rollnick’s (2002) corresponding Motivational 
Interviewing method, wherein the client’s intrinsic motivation to change is enhanced 
through the exploration and resolution of ambivalence. On the other hand, readiness for 
change refers to both a global readiness for personal change and a more specific readiness 
for commencing a treatment program that involves particular treatment interventions. It 
encompasses patient attributes such as motivation level, skills/resources, and 
confidence/self-efficacy (Simpson 2001, 2004). Considering the dynamic quality of these 
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motivational concepts, along with the fluctuating nature of treatment needs, the 
aforementioned patient attributes need to be evaluated at the outset of treatment, 
periodically during treatment, and following treatment. “Patient assessment is crucial not 
only for the purposes of understanding treatment effectiveness, but also for developing 
and maintaining treatment plans and measuring progress” (Joe, Broome, Rowan-Szal, & 
Simpson, 2002, p. 183). Information regarding how pretreatment characteristics, 
psychosocial functioning, and motivation factors affect one another and change over time 
to impact treatment engagement, participation, rapport, satisfaction, and retention is 
critical to deconstructing substance abuse treatment, understanding how treatment 
enhances outcomes, and ultimately improving treatment delivery systems (Joe et al., 
2002; Simpson, 2004). 
Simpson (2001, 2004) acknowledges the fact that client elements are only one 
piece of the therapeutic puzzle as specific programs also possess preexisting 
characteristics that impact how substance abuse treatment unfolds for their clients. 
Although not depicted in Figure1, program attributes such as resources, staff skills, 
climate, and clinical and program information management procedures have been 
identified as factors to consider when examining treatment experiences and therapeutic 
effectiveness, and thus need to be documented and evaluated regularly. Furthermore, 
client characteristics and treatment retention rates vary widely across modalities and 
therapeutic orientations. Even after controlling for these client differences, similar types 
of programs still exhibit differential effectiveness, necessitating a closer examination of 
how client attributes and program features interact at the individual program level to 
influence treatment processes and outcomes (Broome, Simpson, & Joe, 1999; Simpson, 
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Joe et al., 1997). In particular, Simpson (2004) outlines evidence-based interventions 
designed to enhance specific aspects of treatment and recovery processes such as 
improving patient readiness for treatment, program participation, therapeutic 
relationships, early recovery, retention, and transition out of treatment, and posttreatment 
outcomes. These interventions vary depending on the targeted action and are sequential 
in nature (Figure 1). 
Empirical Examination of the TCU Treatment Model  
 A critical component in evaluating the TCU Treatment Model’s potential utility at 
the individual program level is to examine the findings of scientific evidence across 
modalities, programs, treatment approaches, and client populations. The early 
engagement portion of the hypothesized treatment model was tested with a subset of 
DATOS data from clients enrolled in LTR (n=1,362), ODF (n=866), and OMT (n=981) 
treatment programs (Joe et al., 1999). The structural equation modeling analyses 
consisted of two stages. The first phase examined the relationships among treatment 
readiness and three treatment process components: session attributes (i.e., frequency of 
counseling session attendance, number of health topics discussed in session, and number 
of other topics discussed); therapeutic involvement (counsel-patient rapport, patient 
ratings of confidence in treatment that is effective, and patient feelings of commitment to 
treatment); and time in treatment (i.e., 90 days for LTR and ODF clients and 360 days for 
OMT clients). The model proposed that a reciprocal relationship between session 
attributes and therapeutic involvement would emerge, with both of these components 
positively influencing treatment retention. Moreover, treatment readiness was 
hypothesized to positively impact therapeutic involvement (Joe et al., 1999). As 
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expected, all of the hypothesized paths were statistically significant, and treatment 
readiness was a strong positive predictor of therapeutic involvement for the LTR and 
ODF modalities. For the OMT modality, all paths were significant except for the path 
from session attributes to retention. However, the overall amount of variance in retention 
explained by the hypothesized model was low across modalities: LTR (2%), ODF (6%), 
and OMT (2%) (Joe et al., 1999).  
The second phase of the analyses incorporated the impact of additional patient 
pretreatment characteristics on both retention and the treatment process components. The 
reciprocal relationship between session attributes and therapeutic involvement was 
detected again, with both of these components having significant positive effects on 
treatment retention for LTR, ODF, and OMT clients. Treatment readiness was also 
positively related to therapeutic involvement across modalities (Joe et al., 1999). 
Discrepancies emerged among client characteristics, however. For LTR clients, 
depressive symptoms were positively related to session attributes and retention, while 
hostility negatively impacted therapeutic involvement and retention. Other factors 
positively related to treatment retention were alcohol dependence, legal pressure, and 
being a minority, while cocaine use had a negative impact on retention. Furthermore, 
being female and a minority was positively related to therapeutic involvement, suggesting 
that such clients may have fared better in the LTR modality. Approximately 6% of the 
overall variance in LTR retention could be explained by the model (Joe et al., 1999). 
Some similar relationships emerged for ODF clients. Depression was positively related to 
session attributes, while hostility negatively affected both therapeutic involvement and 
retention. Males, Caucasians, and those who used cocaine also did not stay as long in 
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ODF treatment as their respective counterparts. In contrast to LTR clients, alcohol 
dependence was negatively related to treatment retention, and legal pressure had a 
positive effect on session attributes and retention, but a negative effect on therapeutic 
involvement. Approximately 12% of the overall variance in ODF retention could be 
explained by the model (Joe et al., 1999). Negative influences on OMT tenure included 
crack use and legal pressure. White clients also tended to have lower therapeutic 
involvement. Approximately 4% of total retention variance in the OMT modality could 
be explained by the model. Overall, these findings reinforce the hypothesized 
relationships amongst session attributes, therapeutic involvement, treatment readiness, 
and treatment retention and provide general support for the early engagement 
components of the TCU Treatment Model. 
Simpson and Joe (2004) employed more advanced structural equation modeling 
techniques to examine the TCU Treatment Model from a new perspective. Specifically, 
this investigation explored the sequential relationships of the early engagement treatment 
process components (i.e., participation and therapeutic relationship) and the early 
recovery treatment process components (i.e., psychosocial and behavioral changes) that 
contribute to treatment retention and posttreatment outcomes (Simpson & Joe, 2004). 
Participants were patients (n=711) admitted to three not-for-profit, community-based 
OMT programs. Assessments were conducted at intake, throughout treatment, and one 
year after intake. According to the model, it was expected that higher treatment readiness 
would positively affect session attendance and that the cognitive mapping technique 
would positively impact counseling rapport. Reciprocal positive relationships would 
likely be detected between session attendance and counseling rapport (measured at month 
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2), which would be related to lower opiate and cocaine use (measured at month 3). 
Furthermore, it was hypothesized that greater counseling rapport would have direct 
effects on lowered drug use during treatment and indirect effects on in treatment drug use 
via improved psychological and social functioning (Simpson & Joe, 2004). With regards 
to treatment retention, the model suggested that lower drug use during treatment and 
treatment session attendance would positively impact 360-day treatment retention. 
Increased time in treatment and lower in treatment drug use would reduce drug use at the 
one-year follow-up point. Results provided support for the core components and 
suggested sequential pathways of the TCU Treatment Model as all hypothesized 
relationships were statistically significant and in the expected directions (Simpson & Joe, 
2004).  
Drug use following treatment was predicted not only by the time in treatment but 
more importantly by a more detailed picture of dynamic elements that define 
treatment process…Systematic measurement of these elements therefore offers a 
way to monitor patient needs and progress in treatment, including responses to 
interventions and better treatment management. (Simpson & Joe, 2004, p. 94) 
 
Additional empirical investigations have directly and indirectly evaluated the TCU 
Treatment Model and its respective components. Treatment retention, completion, and 
outcomes have been examined in light of client attributes including various 
sociodemographic characteristics (e.g., gender, age, race/ethnicity, education, income), 
substance use severity variables, psychiatric symptoms, motivational factors, and social 
support indicators. Treatment factors such as the therapeutic relationship and service 
delivery elements have also been explored. Please refer to Tables 1 and 2 for a review of 
the empirical findings pertaining to the features of the TCU Treatment Model and their 
relationship to treatment retention/completion and treatment outcomes.  
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Table 1. 
 
TCU Treatment Model Factors Related to Substance Abuse Treatment  
Retention/Completion Identified in the Empirical Literature 
 
Author(s) 
 
Sample Major Finding(s) 
 
 
Patient Attributes 
 
Arfken et 
al. (2001) 
 
2,471 individuals 
referred to publicly 
funded treatment:  
LTR, IOP, or 
standard outpatient 
 
Women comprised 27% of the sample and had sig. greater 
problem severity at intake (lower income, more previous 
treatments, more primary crack use, and higher ASI 
composite scores in all domains except legal); women also 
had sig. lower 30-day retention and treatment completion 
rates across drugs of use and treatment settings 
  
Bride 
(2001) 
 
305 men and 102 
women treated in 
either a mixed- or 
single-gender 
treatment settings 
 
Treatment provided in single-gender settings did not 
significantly increase treatment retention or completion 
rates for either men or women. 
  
Chou et al. 
(1998) 
 
Subset of 907 in 
MM, 673 clients in 
LTR, and 2,184 in 
ODF treatment 
programs from the 
California Alcohol 
and Drug Data 
System 
 
Program funding source interacted with gender for the 
ODF modality: female clients had sig. lower retention 
rates in programs only accepting public funding than those 
that accepted both public and private funding; male clients 
remained in treatment an average of 25 fewer days than 
female clients in programs that only accepted public 
funding, though had roughly the same length of stay in 
programs receiving both public and private funding 
 
Claus & 
Kindleberg
er (2002) 
 
260 clients referred 
for residential or 
outpatient 
treatment 
following an 
central intake unit 
assessment  
 
 
 
 
 
 
 
 
 
Probation status and a history of physical or sexual abuse 
predicted treatment dropout after 1 or 2 sessions, as clients 
who were on probation were three times more likely to 
drop out of treatment than those not on probation; 
likewise, clients with an abuse history were also three 
times more likely to drop out 
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Hser et al. 
(2005) 
 
1,073 
methamphetamine-
abusing 
individuals in 
community-based 
residential and 
outpatient 
treatment 
programs 
 
Treatment retention and completion rates were similar for 
women and men across modalities; improvements from 
baseline to 9-month follow-up were observed across ASI 
domains for both women and men across modalities (with 
only one exception, there was no change observed in 
medical severity for men); women demonstrated sig. 
greater improvements in family relationships and medical 
problems than men, despite the fact that more of them 
were unemployed, had childcare responsibilities, were 
living with someone who used alcohol or drugs, had been 
abused, and reported more psychological symptoms 
 
McCaul et 
al. (2001) 
 
268 individuals in 
a publicly-funded 
substance abuse 
treatment clinic 
with residential, 
IOP, and standard 
outpatient services 
 
Sig. predictors of more session attendance and longer 
treatment duration included being Caucasian, being male, 
and having a high employment ASI composite score; 
substance use status (alcohol-only, drug-only, or alcohol + 
drug) was not predictive of session attendance or 
treatment duration 
  
McKellar 
et al. 
(2006) 
 
3,649 male 
patients entering a 
28-day VA 
residential 
treatment program 
 
Individuals who were younger, reported more frequent 
drug use, reported fewer symptoms of alcohol 
dependence, and had poorer cognitive functioning were at 
sig. greater risk for treatment drop-out; treatment 
environment variables including perceiving less support 
and more staff control sig. increased the odds of drop-out 
  
Maglione 
et al. 
(2000a) 
 
2,337 
methamphetamine 
users in publicly-
funded outpatient 
treatment 
programs in 
California 
 
Sig. predictors of 180-day treatment retention include age 
(being 40+ years old), gender (female), a criminal justice 
referral, and less severe drug use (used less than daily and 
did not inject)  
 
Maglione 
et al. 
(2000b) 
 
2,570 
methamphetamine 
users in publicly-
funded residential 
treatment  
 
Sig. predictors of 90-day treatment retention include age 
(being 25+ years old), gender (female), a criminal justice 
referral, prior drug treatment, and less severe drug use 
(used less than daily and did not inject) 
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Mammo & 
Weinbaum 
(1993) 
 
12,697 outpatients 
and intensive 
outpatient 
admissions for the 
state of New 
Jersey 
 
Likelihood of not completing treatment was sig. higher for 
females, those who are less educated, those employed in 
less-skilled occupations, and the young 
  
Mertens & 
Weisner 
(2000) 
 
317 women and 
599 men in an 
HMO’s outpatient 
alcohol and drug 
treatment program 
 
Fewer and less severe drug problems were sig. predictors 
of retention for both men and women; for women, higher 
retention was also predicted by having higher incomes 
($20,000+), belonging to ethnic categories other than 
African American, being unemployed, and having lower 
levels of psychiatric severity; for men, predictors, higher 
retention was also predicted by being older (40+ years 
old), receiving employer suggestion to enter treatment, 
and having abstinence goals 
 
Mulligan et 
al. (2004) 
 
111 individuals 
from each of two 
trials randomly 
assigned to 
different 
behavioral and 
pharmacotherapies 
 
Few differences were found between African American 
and White participants in terms of demographic 
characteristics and cocaine use outcomes; African 
Americans completed sig. fewer days of treatment than 
Whites; African Americans who received disulfiram 
remained in treatment sig. longer than African Americans 
who did not receive disulfiram 
 
Roffman et 
al. (1993) 
 
212 marijuana-
dependent 
individuals 
engaged in 
outpatient 
treatment 
consisting of 10 2-
hour group 
sessions spaced 
over 12 weeks and 
“booster” sessions 
at 3- and 6-months 
 
 
 
 
Early dropouts (did not attend treatment after fourth 
session) were younger, earned less income, and had a 
higher level of psychological distress at intake than 
completers (attended at least 7 sessions, including one of 
the last two); late dropouts (attended treatment past the 
fourth session but did not meet completion criteria) and 
completers were of similar age, income, psychological 
stress level, and confidence in maintaining future 
abstinence; completers had sig. higher abstinence rates at 
1-, 3-, and 6-month follow-up than the dropout groups 
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Satre et al. 
(2004) 
 
65 patients aged 
55-77, 296 patients 
aged 40-54, and 
564 patients aged 
18-39 who 
participated in a 
managed care 
outpatient 
treatment program 
 
Older adults (55+ group) had sig. longer retention in 
treatment than younger adults (18-39 group); older adults 
were sig. more likely than younger adults to report 
abstinence from alcohol and drugs during the preceding 
month and preceding year at the 5-year follow-up point; 
sig. predictors of abstinence for the preceding month at the 
5-year follow-up were female gender, greater treatment 
retention, and having no close family or friends who 
encouraged alcohol or drug use at 5 years (age was not 
significant)  
 
Sayre et al. 
(2002) 
 
165 individuals 
enrolled in a 12-
week/20-session 
outpatient 
treatment study of 
Relapse Prevention 
for the treatment of 
cocaine 
dependence 
 
Classified as completers – attended all 20 sessions (35%), 
late dropouts – attended 10-19 sessions (15%), or early 
dropouts – attended less than 10 sessions (50%); sig. 
predictors of dropout were being separated from spouse, 
having less education, having more family/social 
problems, and having a less extensive legal history; late 
dropouts had sig. more years of education and poorer 
psychiatric functioning as compared to early dropouts 
 
Siqueland 
et al. 
(2002) 
 
487 cocaine 
dependent patients 
randomized to 4 
psychosocial 
treatments 
spanning across 9 
months 
 
Younger, African American, unemployed, and less 
educated patients stayed in treatment for less time; higher 
psychiatric severity kept men in treatment longer but put 
women at risk for dropping out; unemployed males had 
higher retention than unemployed females; employed 
females had higher retention than employed males  
 
White et al. 
(1998) 
 
138 patients in an 
outpatient 
substance abuse 
program 
 
Discriminant function analyses suggested that ASI 
composite scores and severity ratings were not useful 
predictors of treatment attrition, though individual items 
identified as sig. predictors included: Hispanic ethnicity, 
absence of a professional skill, shorter time since last 
hospitalization, cocaine or cannabis use in the previous 30 
days, total number of family members with drug 
problems, presence of emotional abuse in previous 30 
days, and concern with family problems 
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Wickizer et 
al. (1994) 
 
5,827 client 
records from state-
funded alcohol and 
drug treatment 
programs in 4 
treatment 
modalities 
 
Completion rates were highest for intensive inpatient 
alcohol treatment (75%) and lowest for intensive 
outpatient drug programs (18%); variables most 
consistently related to treatment completion were age and 
education, as older clients and clients with more education 
were more likely to complete inpatient as well as 
outpatient treatment 
   
Substance Use Severity 
 
Alterman 
et al. 
(1996) 
 
95 low SES 
cocaine-dependent 
veteran men from 
a 4-week day 
hospital treatment 
program 
 
Cocaine use in 30 days prior to treatment and a positive 
initial cocaine toxicology screen were sig. predictors of 
dropout; recent and lifetime ASI indices were not sig. 
predictors of dropout 
 
De Leon et 
al. (1997) 
 
1,398 primarily 
African American 
(66%) men (70%) 
entering an LTR 
treatment program 
 
30-day and 10-month retention rates for groups based on 
primary drug of use (cocaine, opiate, marijuana, and 
alcohol) are similar, except the primary alcohol group had 
sig. higher retention rates than the primary opiate and 
marijuana users;  
 
Heil et al. 
(2001) 
 
302 cocaine-
dependent 
individuals 
admitted to a 
university-based, 
outpatient research 
clinic for the 
treatment of 
cocaine 
dependence via 
one of two 
treatment 
conditions 
 
 
 
 
 
No sig. differences emerged for average number of weeks 
retained in treatment between clients with concurrent 
alcohol dependence (alcoholics) and those without 
(nonalcoholics), despite the fact that alcoholics had greater 
problem severity in several domains at intake; a sig. 
interaction was noted between alcohol-dependence status 
and type of treatment received – alcoholics tended to 
remain in treatment longer than nonalcoholics when 
treated with intensive behavioral counseling plus 
incentives, but the reverse was true when treated in control 
conditions  
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Patkar et 
al. (2004) 
 
140 substance-
dependent 
volunteers 
recruited from a 
publicly-funded 
12-week outpatient 
substance abuse 
treatment program  
 
Participants were categorized based on primary 
substance(s) o f use: alcohol, cocaine, or multisubstance; 
multisubstance group reported sig. greater drug, alcohol, 
and psychiatric problems on the ASI, displayed sig. higher 
impulsivity and anxiety scores, and provided a sig. higher 
proportion of dirty urines at admission than other groups; 
overall, 3 groups had equivalent improvements on the 
majority of the during treatment and follow-up outcomes 
at 9 months – substance use, dirty urines, days in 
treatment, session attendance, dropout, symptom 
reduction, benefit ratings 
 
Rawson et 
al. (2000) 
 
Stimulant users 
(500 
methamphetamine, 
224 cocaine) 
entering outpatient 
an treatment clinic 
 
No sig. differences in retention rates between 
methamphetamine and cocaine users, despite sig. 
differences in pretreatment characteristics including 
gender, ethnicity, age, education, marital status, 
employment status, and legal history; most sig. predictor 
of retention was reported years of heavy drug use, with 
each year of use resulting in a longer stay 
 
Rowan-
Szal et al. 
(2000) 
 
900 cocaine-
dependent clients 
from DATOS in 
LTR treatment 
 
Clients who preferred crack cocaine were sig. more likely 
to be female and African American and sig. less likely to 
have a legal history and use alcohol or marijuana on a 
weekly basis; crack preference was a sig. predictor of 90-
day retention as crack users were only about 2/3 as likely 
to stay in treatment for 90 days as were non-crack users  
 
Veach et 
al. (2000) 
 
509 individuals 
admitted to an 
outpatient 
substance abuse 
treatment program  
 
Those retained in treatment, as compared to those who 
dropped out, were more likely to be alcohol-dependent, 
were less likely to be cocaine-dependent, were more likely 
to be employed, and had sig. more problems on their 
treatment plans 
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Psychiatric Symptom Severity 
 
Broome et 
al. (1999) 
 
DATOS subset of 
2,362 LTR clients, 
1,896 ODF clients, 
and 1,011 OMT 
clients  
 
LTR clients with current depressive symptoms were sig. 
more likely to stay in treatment for at least 90 days, while 
those with more hostility were more likely to drop out 
prior to this point; OMT clients with a lifetime Axis I 
depression or anxiety disorder diagnosis were sig. more 
likely to drop out of treatment prior to 360 days; in ODF, 
no consistent or statistically significant predictive pattern 
emerged across programs 
 
Castel et 
al. (2006) 
 
2,784 clients of the 
outpatient 
programs at a 
comprehensive 
addictions 
treatment facility 
in Canada 
 
Overall, 69% of clients screened positive for at least one 
cluster of psychiatric symptoms (depression, anxiety, 
mania, schizophrenia-like, eating, conduct disorder) – 
27% scored positive for one cluster, 19% were positive for 
two clusters, and 22% were positive for three or more 
clusters; multimorbidity (2+ clusters and 2+ substance use 
disorders) was positively associated with being female, 
unemployment, fewer legal problems, less social support, 
and drug use; these clients also attended more visits and 
had a lower attrition rate  
 
Curran et 
al. (2002) 
 
126 consecutively 
admitted males to 
a 3-week VA IOP 
treatment program  
 
BDI scores emerged as a sig. predictor of early attrition 
(within first 5 days/visits); clients scoring 33+ were more 
likely to drop out of treatment early as compared to those 
who scored < 22; polysubstance users had the highest 
mean BDIs; age, race, education, marital status, number of 
prior treatments, severity of use, employment status, 
PTSD symptoms, and a dichotomous measure of meeting 
DSM-IV criteria for major depression were not sig. 
predictors of attrition 
 
Daughters 
et al. 
(2005) 
 
122 primarily 
African-American 
(95%) men (71%) 
entering an LTR 
treatment facility 
 
Early dropouts (completed < 30 days) were sig. less likely 
to persist on psychological stressors than 30-day 
completers; no differences between these groups were 
noted for persistence on physical stressors; lower levels of 
psychological distress tolerance were predictive of 
dropping out prior to 30 days, though were not predictive 
after this point; no sig. differences were noted between 30-
day completers and dropouts on demographic variables, 
legal status, psychiatric status including previous 
diagnoses and current symptomology 
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Psychiatric Symptom Severity 
 
Haller et 
al. (2002) 
 
78 drug-dependent 
women in a 
gender-specific 
day treatment 
program 
categorized into 3 
groups based on 
cluster analysis of 
MCMI-II scores 
 
Group 2 (n = 28) evidenced severe addiction, psychiatric 
(Axis I), and personality (Axis II) problems and had the 
worst treatment completion rate (26%); Group 3 (n = 29) 
was characterized by fewer Axis I problems and 
prominent addiction and externalizing (Cluster B) 
personality deficits and had the highest completion rate 
(76%); Group 1 (n = 21) presented with less severe 
addiction and personality problems and minimal distress 
had an attrition rate between the other two groups (56%)  
 
Justus et al. 
(2006) 
 
596 primarily male 
(96%) veterans 
enrolled in a 
homeless 
rehabilitation 
program  
 
Clients who were younger, female, and currently 
diagnosed with a depressive disorder demonstrated sig. 
higher rates of treatment retention and completion; 
diagnosis of a current personality disorder or history of 
psychiatric treatment was related to sig. poorer rates of 
retention and completion 
 
Ross et al. 
(1997) 
 
308 male and 106 
female with 
moderate-severe 
substance 
dependence 
referred for 
outpatient and 
inpatient treatment 
programs 
 
Somatization scale scores on the SCL-90-R emerged as 
the only sig. predictor of treatment completion, with 
higher levels of somatization being associated with a 
poorer completion rate; tendency noted for clients 
reported more severe symptomatology to not start 
treatment programs to which they had been referred, 
though once clients entered treatment, there was a modest 
positive correlation between length of stay and symptom 
severity  
   
Motivation/Readiness 
 
Ball et al. 
(2006) 
 
24 individuals who 
reported reasons 
for prematurely 
dropping out of 
outpatient 
treatment 
 
 
 
 
 
 
Loss of motivation/hope and interpersonal problems with 
staff were most common reasons cited for dropping out; 
problem severity and logistical conflicts with treatments 
were least often reported  
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Carrol et 
al. (2006) 
 
423 substance 
abusers entering 
outpatient 
treatment in 5 
community-based 
settings 
 
Participants were randomized to receive either the 
standard intake session or the same session in which 
motivational interviewing (MI) techniques were 
integrated; MI group had sig. better retention and attended 
more sessions at the 28-day follow-up point, though sig. 
differences had dissipated by the 84-day follow-up; no sig. 
differences were found between groups on substance use 
outcomes at either follow-up point 
 
Carroll et 
al. (2001) 
 
60 adults referred 
for substance 
abuse evaluation 
by a child welfare 
worker 
 
Participants were randomized to receive either the 
standard intake session or the same session in which MI 
techniques were integrated; rate of participants attending 
at least one treatment session following the evaluation was 
sig. higher for the MI group; no sig. differences were 
detected between groups for percentage of participants 
attending 3+ sessions 
 
De Leon et 
al. (1997) 
 
1,398 primarily 
African American 
(66%) men (70%) 
entering an LTR 
treatment program 
 
Motivation scores were the most consistent predictors of 
short-term (30-day) and long-term (10-month) retention 
for primary cocaine users and opiate users, less consistent 
among primary marijuana users, and not apparent for 
primary alcohol users; demographic variables (age, 
gender, race/ethnicity, legal status) were inconsistently 
related to retention depending on primary drug use 
category and retention length 
 
Demmel et 
al. (2004) 
 
51 patients who 
started a 6-week,  
CBT-focused IOP 
alcohol treatment 
program 
 
Patients were randomly assigned to a motivational (n=24) 
or educational (n=27) procedure at the outset of treatment; 
motivational group had sig. higher Recognition and 
Taking Steps and lower Ambivalence (on the 
SOCRATES) after the intervention (2 weeks) and sig. 
higher Recognition at the end of treatment than the 
education group; no sig. between-group differences were 
noted between for engagement in treatment (attendance) 
or dropout; for the entire sample, low Ambivalence was 
associated with dropout 
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Donovan et 
al. (2001) 
 
654 individuals 
awaiting publicly 
funded drug 
treatment 
 
Motivational attrition prevention intervention designed to 
increase commitment to and motivation for treatment 
while awaiting treatment admission did not have a 
differential effect on treatment entry, completion, or 
outcomes compared to the standard waiting list  
 
Joe et al. 
(1998) 
 
DATOS subset of 
2,265 LTR clients, 
1,791 ODF clients, 
and 981 OMT 
clients  
 
Treatment readiness (i.e., degree of commitment to active 
change process through participation in a treatment 
program) was a sig. predictor of 90-day retention for LTR 
clients and 360-day retention for OMT clients; problem 
recognition (i.e., level of personal acknowledgement of 
drug use problems) was a sig. predictor of 90-day 
retention for ODF clients; these motivation factors were 
more important than socio-demographic, drug use, and 
other background variables 
 
Mullins et 
al. (2004) 
 
71 pregnant 
women referred for 
outpatient drug 
treatment by child 
welfare due to 
prenatal drug use 
 
Participants were randomly assigned to receive 3 MI 
sessions or watch two educational videos and have a home 
visit in addition to treatment as usual; treatment retention, 
group attendance (weekly psychoeducational and 
substance abuse groups), and urinalysis results were not 
sig. different amongst these groups during 8 weeks of 
treatment 
 
Simpson, 
Joe, & 
Rowan-
Szal (1997) 
 
435 OMT patients 
who completed an 
interview 12 
months after 
treatment 
discharge  
 
Sig. predictors of more favorable outcomes (i.e., reduced 
drug use, alcohol use, and criminal involvement) included 
being over 35, having lower injection frequency prior to 
admission, having higher motivation for treatment (i.e., 
desire for help), and being retained in treatment for at least 
360 days; length of treatment stay was predicted by higher 
patient motivation at intake and early program 
involvement (i.e., greater session attendance and higher 
counselor ratings of performance during treatment)  
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Social Support 
 
Broome et 
al. (2002) 
 
748 patients from 
DATOS in short-
term inpatient 
programs 
 
After controlling for pretreatment use, posttreatment 
social support networks were the most consistent 
correlates of outcomes; patients in a deviant peer network 
or who lived with a drug or alcohol user during the 
follow-up year had 3 times the odds of weekly cocaine use 
and 2 ½ times the odds of frequent  (3+ times per week) 
drinking 
 
Dobkin et 
al. (2002) 
 
Consecutive 
admissions to a 
Canadian 
outpatient 
substance abuse 
treatment program 
assessed at intake 
(n=206) and at 6-
month follow-up 
(n=172) 
 
High and low social support groups demonstrated sig. 
declines in negative affect and severity of substance 
abuse, though symptoms of depression and psychological 
stress were sig. higher at intake and at follow-up for the 
low social support group; low social support patients 
reported sig. higher alcohol and drug abuse severity at 
follow-up; after controlling for time in treatment, higher 
levels of social support were a modest predictor (6% of 
variance) of more favorable alcohol-related outcomes (not 
drug),; drop-out rates were sig. higher for patients with 
low social support 
 
Griffith et 
al. (1998) 
 
960 opiod drug 
users admitted to 
three publicly 
funded methadone 
clinics 
participating in the 
DATAR project 
 
Hypothesized model examining how perceived family and 
peer relationships are related to specific treatment process 
variables (motivation and engagement) found support; a 
history of poor family relations was related to perceived 
family dysfunction and peer deviance at treatment entry; 
these 2 factors in turn predicted poor psychosocial 
function, whish was related to higher levels of motivation; 
higher motivation was associated with greater treatment 
engagement, which was associated with reduced opiod use 
and criminality at follow-up (12 months after leaving 
treatment) 
 
Westreich 
et al. 
(1997) 
 
66 patients 
enrolled in a 21-
day, inpatient 
program 
 
 
 
 
 
Homeless status and low initial perceived social support 
from family scores were sig. predictors of completion  
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Treatment Factors 
 
Hser et al. 
(2004) 
 
1,939 patients 
from community-
based residential 
and outpatient 
treatment 
programs 
 
Path analysis results indicated that greater service 
intensity and satisfaction were positively related to either 
treatment completion or longer treatment retention, which 
in turn was related to favorable treatment outcomes (30-
day abstinence period, ASI drug score of 0, no criminal 
activity, and lived in the community) at the 9-month 
follow-up point 
 
Meier et al. 
(2005) 
 
Review of the 
impact of the 
therapeutic 
alliance on drug 
treatment retention 
and outcomes 
 
Early therapeutic alliance appears to be a consistent 
predictor of engagement (session attendance) and 
retention in drug treatment and seems to influence early 
improvements during treatment, though is an inconsistent 
predictor of posttreatment drug use and other outcomes 
 
Simpson et 
al. (1995) 
 
557 clients from 
DATAR who 
completed at least 
3 months of 
outpatient MM 
treatment and 
attended at least 
one session per 
month 
 
Higher session attendance was sig. related to less frequent 
drug use and positive perceptions of therapeutic 
interactions by both counselors and clients; being white, 
being perceived by counselors as having higher treatment 
motivation and better rapport in month 1, and receiving 
counseling that emphasized problem-solving applications 
in month 1 were sig. predictors of higher overall session 
attendance in the first 3 months of treatment 
 
Simpson, 
Joe, 
Rowan-
Szal, & 
Greener 
(1997) 
 
527 daily opiod 
users who 
remained in 
outpatient MM 
treatment for a 
minimum of 3 
months  
 
Participants were randomly assigned to a cognitively 
enhanced (i.e., utilized node-link mapping, a tool for 
improving communication and problem solving) or 
standard treatment condition; counseling enhancement 
was positively related to a stronger therapeutic 
relationship between counselor and patient, which had a 
positive reciprocal relationship with session attendance; 
better therapeutic relationships and higher session 
attendance were sig. predictors of longer retention; better 
treatment relationships was also related to less drug use 
during treatment, which in turn was also a sig. predictor of 
longer retention 
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Table 2. 
 
TCU Treatment Model Factors Related to Substance Abuse Treatment Outcomes  
Identified in the Empirical Literature 
 
Author(s) 
 
Sample Major Finding(s) 
   
Patient Attributes 
 
Fiorentine 
et al. (1999) 
 
302 clients who 
entered outpatient 
drug treatment 
programs in the 
Los Angeles 
metropolitan area 
 
For female clients, 9% of variance in treatment 
engagement (average weekly sessions X weeks in 
treatment) was related to client variables with 
increased engagement related to more pretreatment 
arrests, higher pretreatment alcohol use, and less 
problems with memory and concentration; 21% of 
this variance was attributable to treatment 
experiences including perceived helpfulness of life 
skills and medical services and belief that counselors 
“cared a lot about them”; for men, no pretreatment 
characteristics were associated with engagement 
while 27% of the variance could be accounted for by 
perceived helpfulness of medical and transportation 
services and relapse prevention training  
  
Hser et al. 
(2003) 
 
511 patients 
enrolled in MM, 
residential, 
inpatient, and 
outpatient 
treatment 
programs 
 
No sig. differences between men and women in 
measures of drug and alcohol use at the 1-year 
follow-up point; sig. positive predictors of drug 
abstinence for women included greater readiness for 
treatment and longer time in treatment, and sig. 
negative predictors included being in MM programs 
and multiple drug use; for men, positive predictors 
included being in residential programs (as opposed to 
outpatient) and longer treatment retention, and 
negative predictors included being in MM programs 
and having a spouse who also used drugs 
 
Jarvis 
(1992) 
 
Meta-analysis 
examining the 
magnitude and 
direction of trends 
of sex difference 
in outcomes 
 
 
 
 
 
Women appear to have better results in the first year 
of follow-up, while men have better results after the 
first follow-up year; however, estimated differences 
were small and derived from a heterogeneous sample 
of studies 
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Substance Use Severity 
 
Booth et al. 
(1991) 
 
255 consecutive 
admissions to a 
21-day inpatient 
VA alcohol 
treatment program 
 
For 98 patients readmitted at least once for alcohol-
related problems within 15 months of discharge, 
variables related to chronicity and severity of alcohol 
use were positively related to time to readmission, 
while polysubstance use and other psychiatric 
variables (depression, antisocial personality traits) 
were not predictive 
 
Flannery et 
al. (2004) 
 
Symposium 
examining 
differences in 
demographic 
characteristics and 
treatment 
outcomes in 
alcohol and 
cocaine dependent 
individuals 
 
Individuals with primary cocaine-dependence (CD) 
are more likely to be younger, African American, and 
have experienced more negative consequences than 
those with alcohol-only dependence (AD); CD 
persons responded as well as AD persons to a 
community 12-step oriented outpatient treatment, a 
standardized CBT approach, and a less standardized 
CBT program; individuals dependent on both alcohol 
and cocaine (CAD) experienced more psychological, 
interpersonal, and social problems than those with 
CD only; CAD individuals who participated in an 
aftercare program following 1 month of IOP 
treatment had similar drinking outcomes during the 
aftercare program and at follow-up (9 months) than 
those with AD only, despite seeming more impaired 
before treatment 
   
Psychiatric Symptom Severity 
 
Charney et 
al. (2005) 
 
326 consecutively 
recruited patients 
entering outpatient 
addiction 
treatment in 
Canada 
 
Majority of the sample (63%) presented with 
comorbid psychiatric symptoms – 15% depressive, 
16% anxiety, and 32% combined depressive and 
anxiety; these 3 groups were more likely to abuse 
alcohol and other drugs, than the no psychopathology 
group, who was more likely to abuse alcohol only; 
depression-anxiety group had lowest rate of 
abstinence (40%) at 6 month follow-up; concurrent 
depression-anxiety symptoms at intake had a sig. but 
small effect on outcomes beyond factors that known 
to influence outcome: days in treatment, primary 
drug of abuse, and frequency of use 
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Chen et al. 
(2006) 
 
230 mostly male 
patients (97%) 
with dual 
substance use and 
psychiatric 
disorders who 
received high or 
low service-
intensity care at a 
residential  
substance abuse 
program 
 
43% rated in high-severity category (baseline 
substance use and psychiatric symptoms) while 57% 
were classified as moderate severity; high-severity 
patients treated in high-intensity programs had sig. 
better alcohol use, drug use, and psychiatric 
outcomes, higher service utilization, and greater costs 
by the 1-year follow-up than counterparts treated in 
low-intensity programs; for moderate-severity 
patients, high-intensity programs improved outcomes 
for drug use only and exhibited higher service 
utilization, but did not have greater health care costs 
 
McKay & 
Weiss 
(2001) 
 
Review of alcohol 
and drug treatment 
studies with 
follow-ups of 2+ 
years 
 
Psychiatric severity at baseline was a sig. predictor of 
substance use outcomes in the highest percentage of 
studies, although the nature of the relationship varied; 
stronger motivation and coping at baseline 
consistently predicted better drinking outcomes 
 
Pirard et al. 
(2005) 
 
700 uninsured or 
Medicaid insured 
substance abusers 
in residential or 
day treatment 
 
Abused participants were sig. more likely to be 
women and were more impaired at baseline on ASI 
family/social and psychiatric severity; abuse group 
used heroin and cocaine sig. less frequently in favor 
of alcohol or polydrug abuse: abuse history was not a 
sig. predictor of completion of the intake session; at 
1-year follow-up, abuse group had sig. worse 
psychiatric status and more psychiatric 
hospitalizations and outpatient treatments than the 
nonabused group, though similar alcohol and drug 
severity 
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Author(s) 
 
Sample Major Finding(s) 
   
Motivation/Readiness 
 
Demmel et 
al. (2004) 
 
350 alcohol-
dependent 
German inpatients 
 
Readiness to change, as measured by the Taking 
Steps and Recognition SOCRATES subscales, were 
significant predictors of whether a client relapsed 
within the 3-month follow-up period; these measures 
accounted for 9.4% of the variance while background 
variables and severity of use explained only 6%; 
Taking Steps was also positively related to 
pretreatment self-efficacy 
 
Hewes & 
Janikowski 
(1998) 
 
Nonrandom 
sample of 31 
individuals with 
primary alcohol 
problems who 
completed 
treatment at an 
inpatient or 
outpatient 
program 
 
Participants were categorized into 3 stages of 
readiness for change (Recognition, Ambivalence, 
Taking Steps); all participants showed sig. reductions 
in alcohol use problem severity across a range of  
ASI domains at the 30-day follow-up; no sig. 
differences were noted between these groups for any 
outcome measure 
   
Social Support 
 
Booth et al. 
(1992) 
 
61 consecutive 
admissions to a 
21-day inpatient 
VA alcohol 
treatment program  
 
Patients who received high levels of “Reassurance of 
Worth” from family and friends while in treatment 
were less likely to be readmitted (20%) in the 
subsequent year than patients reporting moderate 
(25%) or low levels (61%) 
   
Treatment Factors 
 
Dearing et 
al. (2005) 
 
208 clients 
voluntarily 
seeking outpatient 
treatment for 
alcohol problems 
 
Positive expectations about therapy, greater session 
attendance, and positive perception of the working 
alliance appeared to predict greater client satisfaction 
and, in turn, more positive 6-month posttreatment 
drinking-related outcomes: abstinent days, drinks per 
drinking day, and drinking-related consequences 
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Author(s) 
 
Sample Major Finding(s) 
 
  
Treatment Factors 
 
Fiorentine 
& Anglin 
(1996) 
 
330 clients who 
entered outpatient 
drug treatment 
programs in the 
Los Angeles 
metropolitan area 
 
Counseling frequency predicts relapse above what is 
predicted by treatment completion status, with more 
frequent group and individual sessions (as opposed to 
family sessions or 12-step meetings) being associated 
with lower levels of posttreatment relapse (drug use 
during the 6 months prior to follow-up interview); 
frequent participants of group and individual 
counseling in treatment who continued to be frequent 
participants in 12-step meetings posttreatment had 
the lowest rates of relapse 
 
Joe et al. 
(2001) 
 
2 cohorts of 
outpatients being 
treated for 
methadone (354 
patients in 
community-based 
nonprofit 
programs and 223 
patients from a 
private for-profit 
program) 
 
During treatment ratings made by counselors of 
therapeutic involvement and relationships with 
patients (i.e., counseling rapport) was a more 
consistent predictor of 1-year treatment outcomes; a 
lower level of rapport was a sig. predictor of more 
cocaine use and criminality, both by itself and after 
adjusting for treatment retention, satisfaction with 
treatment, and post-treatment self-report of drug use, 
illegal activity, and arrests during the prior 6 months 
 
Long et al. 
(2000) 
 
188 consecutive 
admissions to a 
cognitive 
behavioral 
addiction unit 
therapy program 
 
Classification of drinking outcomes included remitted 
drinking (abstinent or nonproblem drinking) and 
relapsed drinking (drinking but improved or 
unimproved); sig. predictors of more favorable 
outcome included higher self-efficacy in positive 
social situations, reduction in psychological 
symptoms during treatment, greater program 
involvement, lower perception of staff control, and a 
greater perception of treatment as helpful  
 
 
 
Utilizing Taxonomic Methods to Narrow the Research-Practice Gap 
Value of Taxonomic Methods  
93 
Despite the range of research questions and methodologies targeting assorted 
treatment modalities and clientele outlined in Tables 1 and 2, results of these inquiries 
have not produced consistent, reliable profiles of clients who are retained in substance 
abuse treatment and achieve a positive treatment outcome and profiles for those who drop 
out of treatment prematurely (McClellan & McKay, 1998; Stark, 1992).  As Carise and 
Gurel (2003) note: 
There is no ongoing, generalizable, descriptive information on such basic 
characteristics as demographics; types and amounts of substances used prior to 
treatment entry; or the nature and severity of addiction-related problems in the 
areas of medical health, employment, criminal activity, family relationships, or 
psychiatric status. The gaps created by this lack of information on the population 
of substance abusing or dependent individuals in our nation’s treatment system, as 
well as limited information at state and local levels on the treatment provided, has 
been recognized as a problem by the Office of National Drug Control Policy. (p. 
181) 
 
Instead, substance abuse treatment research results often merely delineate lists of 
differences between men and women, between older clients and younger clients, between 
clients who primarily use alcohol and those who primarily use other drugs, between those 
who are motivated for treatment and those who are less motivated for treatment, and the 
list can go on (Luke et al., 1996). Consequently, there is a clear need for more 
comprehensive descriptions of clients and their respective attributes, particularly at the 
individual program level, in order for researchers, clinicians, and other key stakeholders 
gain a better understanding of who is participating in substance abuse treatment programs 
across the country. Questions remain regarding what methods would be most suitable and 
valuable for such an endeavor. Particularly in the behavioral health field, where pressure 
exists to individually tailor treatment depending on the distinct needs of clients, clinicians 
often aim to identify groups of individuals that will respond well to similar treatment 
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modalities, approaches, and interventions (Rapkin & Dumont, 2000). Likewise, research 
methods that seek to ascertain the group composition of a heterogeneous sample based on 
the characteristics of the individual cases that comprise it (i.e., taxonomic methods) could 
potentially assist treatment programs in determining if retention rates and outcomes 
systematically vary amongst clients, while also expanding the descriptive knowledge 
base about the characteristics of those presenting for treatment. “The goal is to form 
meaningful systems of classification that can be used to distinguish members of a 
population on important features” (Rapkin & Dumont, 2000, p. S404). In this instance, 
the “important features” would consist of the dimensions of identity and behavior that 
have been linked to substance abuse treatment retention and outcomes.  
 There are several reasons why taxonomic methods are appropriate tools to utilize 
in the study of heterogeneous groups, such as clients in a particular substance abuse 
treatment program. Instead of emphasizing relatively linear associations among variables 
within an aggregated dataset, such methods focus more on the prevalence of occurrence 
of different patterns of variables, which can potentially provide insight into and deeper 
exploration of the complex relationships among these variables (Rapkin & Dumont, 
2000). Additional questions and hypotheses about these groups and the connections 
among variables (i.e., identifying which ones are predictors, covariates, and/or mediators) 
within them may also be raised and tested after the groups are detected. “Ideally, 
taxonomic research may involve a complementary relationship between theory and 
empirical description” (Rapkin & Dumont, 2000, p. S406). Through the application of 
taxonomic methods within theoretical frameworks, the value of such research is enhanced 
because a direct link between science and practice is created.    
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 Consequently, in addition to exploring how clients who complete an intensive 
outpatient chemical dependency treatment program at a nonprofit, freestanding mental 
health clinic differ from clients who do not complete treatment on pretreatment variables 
(e.g., sociodemographic characteristics, substance use history, psychiatric symptoms, 
motivation for treatment, social functioning), this study will determine if  meaningful 
subgroups of this client population be identified. Such analyses are better able to 
accurately capture and describe the composition of a sample because they do not merely 
determine the presence distinct variables, but rather detect the prevalence of patterns of 
variables, which are more representative of the complexity of individuals that comprise 
the sample. Moreover, it is critical for treatment programs to understand how group 
characteristics may relate to successful completion of programs because “group 
composition may play a role in determining participation and treatment outcomes, 
especially if members who are in some regard ‘outsiders’ prove to be more likely to drop 
out (Rapkin & Dumont, 2000, p. S413). At the micro-level, such information regarding 
the presence of a certain pattern(s) of pretreatment characteristics could be used to 
quickly identify clients that may be at risk for dropout, so the treatment team can 
intervene to reduce this risk. At the macro-level, identifying groups of clients that share 
certain commonalities (e.g., sociodemographic characteristics, substance use history, 
motivation for treatment) may help programs identify clientele who may be more or less 
suitable for their program based upon the treatment program’s values, approaches, and 
interventions.  
Taxonomic Research in Alcohol Use Disorders  
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 Research has been undertaken examining potential subtypes of substance abusing 
or dependent individuals, with much work being focused on alcoholism and based upon a 
wide range of dimensions, symptoms, and characteristics. Babor (1997) noted: 
The search for alcoholic subtypes has had a long and varied history, with little to 
guide its progress but clinical intuition during the pre-Jellinek years leading up to the 
modern era of alcohol studies. With the development of multivariate techniques and 
improvement in clinical assessment technology, typology research has experienced a 
renaissance. (pg. 1665-1666).  
 
Characteristics that have been examined include drinking history, pattern(s) of drinking, 
severity of dependence, gender, personality traits, comorbid psychiatric symptoms, 
cognitive impairment, sociopathy, and familial history (Bohn & Meyer, 1999). From 
these inquiries have emerged a variety of subclassifications of individuals with alcohol 
problems.  
Early typology investigations of individuals with alcohol use disorders tended to 
focus on a single, defining characteristic. Babor, Dolinsky, and associates (1992) 
reviewed five unidimensional typologies that had received the majority of attention in the 
empirical literature up to that point in time: gender comparisons, primary vs. secondary 
psychopathology associated with alcoholism, the gamma-delta distinction, familial 
alcoholism, and subtyping by various personality factors. Cumulative gender research 
suggested that female alcoholics tended to have a later onset of alcohol dependence and a 
more rapid course of symptom development as compared to their male counterparts. 
Female alcoholics also generally had a higher prevalence of comorbid psychiatric 
disorders, particularly depression, while male alcoholics were more likely to exhibit 
antisocial personality traits. Additional classification efforts suggested categorizing 
female alcoholics based on if and when comorbid psychopathology developed. Primary 
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alcoholism was a term used to describe individuals who did not experience comorbid 
psychopathology or who began to experience psychiatric symptoms following the onset 
of alcohol dependence, whereas individuals who fall into the secondary alcoholism 
category were persons who experienced psychiatric symptoms prior to the onset of 
alcohol dependence (Schuckit, Pitts, Reich, King, & Winokur, 1969). 
Babor, Dolinsky, et al. (1992) also described Jellinek’s gamma-delta distinction 
which was based on three delineating characteristics in alcohol dependent individuals: 
etiological elements, dependence process, and types of drinking consequences. 
Psychological vulnerability was an underlying factor in the development of dependence 
in gamma alcoholics. Even though gamma alcoholics were generally abstinent between 
drinking episodes, their drinking was characterized by a loss of control and inability to 
stop drinking and often resulted in severe damage to their health and interpersonal 
relationships. On the contrary, delta alcoholics were able to generally limit their 
consumption, but were unable to abstain for even short periods of time. Sociocultural 
elements including ease of access to alcohol and societal encouragement to drink 
regularly were purported as the etiological factors in delta alcohol dependence. 
Familial/genetic theories and personality influences were also reviewed by Babor, 
Dolinsky, and colleagues (1992). In general, alcohol-dependent individuals with a family 
history of alcoholism in first-degree relatives tended to have an earlier onset of problem 
drinking, more intrapersonal and interpersonal problems associated with their drinking, a 
faster course of symptom development, and higher degree of physiological dependence 
than alcohol-dependent individuals without a family history of alcohol problems in first-
degree relatives. Antisocial personality disorder has been considered a cardinal trait of a 
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certain subtype of alcoholic and is associated with earlier age of onset, quicker 
progression to problem drinking, and more severe problems stemming from drinking. 
Poorer treatment prognosis and outcomes have also been linked to antisocial behavioral 
traits. The Minnesota Multiphasic Personality Inventory (MMPI) has also been used to 
classify alcoholics into three subgroups: neurotic, psychotic, and psychopathic. 
Babor, Dolinsky, et al. (1992) subsequently evaluated the discriminative power 
and predictive validity of these five classification schemes with a heterogeneous sample 
of inpatients in three different residential treatment programs. Multiple classification 
analysis, survival analysis, and discriminant function analysis were employed to compare 
the relative discriminative power and predictive validity of these typologies. Results 
encapsulated the shortcomings of unidimensional categorical systems. There was a high 
degree of overlap among certain subtypes across models (i.e., familial alcoholism, 
antisocial personality traits, and impulsivity tended to cluster in men). When significant 
discriminations were detected for a particular typology, they were generally limited to 
areas closely related to the defining characteristics of that particular typology (i.e., the 
gamma-delta typology differentiated significantly on measures of alcohol consumption 
and consequences of drinking). Ultimately, none of the single factors emerged as a strong 
predictor of treatment outcomes including future alcohol consumption, psychological 
functioning, alcohol dependence, and medical status, which is the missing link in the 
study of alcohol typologies that can have the largest impact clinical practice and 
treatment policy. The authors also advocated for the use of empirical grouping strategies 
to explore naturally occurring commonalities, as opposed to theoretically-constructed 
ones, in samples of alcoholics and to identify homogeneous subgroups of this population. 
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Armed with progressively more sophisticated methodological techniques, newer 
generation typology studies of persons with alcohol use disorders have moved beyond 
examining a single defining dimension, such as personality or gender, to exploring 
multifaceted schemes comprised of pluralistic characteristics (Babor, Dolinsky et al., 
1992). Cloninger and his associates (1987, 1988, 1989, as cited in Bohn & Meyer, 1999) 
utilized methods of genetic epidemiology to identify subtypes of alcoholics and long-
term alcohol-related outcomes with a group of Swedish adoptees. Type 1 or milieu-
limited alcoholism affected both men and women, had an onset after the age of 25 years, 
and had a variable course of alcohol-related symptoms and problems. Environmental 
factors, including the atmosphere in which one was raised, usually affected the severity 
of the alcoholism in Type 1 alcoholics. On the other hand, Type 2 or male-limited 
alcoholism transpired only in men, commenced before age 25 years, appeared highly 
heritable, and was characterized by heavy amounts of consumption, an inability to abstain 
from alcohol, and recurrent experience of negative medical and social consequences. 
Cloninger also explored personality features of these individuals, with Type 1 alcoholics 
tending to score high on reward dependence and harm avoidance and low on novelty 
seeking, whereas Type 2 alcoholics generally had low levels of reward dependence and 
harm avoidance and high levels of novelty seeking. 
Similarly, von Knorring and colleagues (von Knorring, Palm, & Anderson, 1985) 
examined a sample comprised of male alcoholics currently in treatment and those in 
remission and classified them into groups based on the age of alcohol onset. Clients with 
onset prior to age 25 were categorized as Type II alcoholics and those whose age of onset 
was after age 25 were classified as Type I alcoholics. Results paralleled Clonginger’s 
100 
findings in many ways. Type II, or early onset, alcoholics had higher rates of 
aggressiveness, criminality, drug abuse, and familial alcoholism than their Type I 
counterparts. In terms of personality functioning (von Knorring et al., 1987, although 
Type II individuals were more extraverted and tended to score higher on impulsiveness 
and adventure-seeking measures, they also endorsed a greater degree of guilt and anxiety 
as compared to Type I individuals.  
Adding to the girth of empirical evidence related to alcoholism typologies, Babor, 
Hofmann, and colleagues (1992) examined 17 characteristics across 4 domains (e.g., 
premorbid risk factors, use of alcohol and other substances, chronicity and consequences 
of drinking, and psychiatric symptoms) in a sample of alcohol-dependent individuals. 
The clustering solution produced two categories. The Type A cluster was characterized by 
fewer childhood risk factors, later age of onset, less severe dependence, and fewer 
previous treatment episodes. Members of this cluster also exhibited fewer alcohol-related 
physical and social problems, less psychopathological dysfunction, and lower levels of 
distress in the areas of work and family, and responded better to standard treatment. On 
the other hand, Type B alcoholics had more familial risk factors, an earlier age of onset, 
greater severity of dependence, increased levels of polydrug use, and more treatment 
episodes. This group also experienced more serious consequences, a greater level of 
psychopathological dysfunction, and more life stress. Not surprisingly, these clients 
demonstrated poorer treatment outcomes. 
At the same time some researchers were describing and defining two subtypes of 
alcoholism, others were questioning if two subtypes sufficiently captured the 
heterogeneity of alcoholics. In an early study, Morey, Skinner, and Blashfield (1984) 
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proposed an alternative classification scheme in a large sample of individuals seeking 
treatment for alcohol problems. Three types of drinkers were identified and were 
distinguishable on measures related to alcohol use, as well as on measures of personality, 
psychopathology, intellectual functioning, and demographic variables. Type A or early-
stage problem drinkers represented a fairly heterogeneous group who showed evidence 
of drinking problems but did not exhibit major symptoms of alcohol dependence. Type B 
or affiliative drinkers were more socially-oriented, tended to drink on a daily basis, and 
displayed moderate levels of alcohol dependence. Type C or schizoid drinkers were more 
socially isolative, tended to drink in binges, and reported the most severe symptoms of 
alcohol dependence. There were consistent differences in symptom severity among the 
three types on measures of psychopathology, cognitive functioning, and social 
adjustment, with Type C exhibiting the highest levels of dysfunction. In the end, the 
authors propose a hybrid model of alcohol abuse that integrates both categorical and 
dimensional elements and superimposes the three identified subtypes of clients on an 
underlying continuum of alcohol dependence.  
Del Boca & Hesselbrock (1996) were particularly interested in gender differences 
and proceeded to reanalyze the data reported by Babor, Hofmann, and colleagues (1992) 
to see if gender-related subtype would emerge. Results suggested that although the two-
cluster solution (i.e., Type A – Type B) effectively represented the sample in terms of risk 
and severity, a functional four-cluster solution could also be derived: low risk–low 
severity (few problems at low levels), internalizing (moderate risk, high depression and 
anxiety), externalizing (moderate risk, high antisocial behavior), and high risk–high 
severity (multiple problems at high levels). In terms of gender dispersion, the low and the 
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high risk subgroups had a relative balance in gender composition, while the two 
intermediate, moderate risk subgroups appeared to be more gender-specific. The 
internalizing group was comprised of 32% of the women in the study and only 11% of 
the men, whereas the externalizing group included 38% of the men versus 7% of the 
women.  Etiological implications of these findings suggest that the development and the 
expression of alcohol problems in the two moderate risk, gender-related groups, likely is 
more strongly influenced by sociocultural factors (i.e., differing behavioral expectations 
and emotional expressions), as opposed to an inherited disposition. 
More recently, Windle and Scheidt (2004) evaluated the adequacy of a range of 
cluster analytical solutions in a large, heterogeneous in terms of gender and ethnicity, 
group of inpatients from five alcohol treatment centers in both rural and urban areas. 
Based on comparison across the two-, three-, and four-cluster solutions, the four-cluster 
solution appeared to represent the data most effectively.  The mild course typology was 
characterized by a later age of onset; fewer years of drinking; lower levels of 
consumption, impairment, and withdrawal symptoms; few childhood conduct problems; 
and low rates of familial history of alcoholism. High levels of polydrug use and 
benzodiazepine use demarcated the polydrug subtype, while the negative affect subgroup 
was distinguished by symptoms of depression and anxiety and high characterological 
vulnerability to a substance use disorder. The chronic/antisocial typology was 
distinguished by high levels of alcohol consumption and impairment, a longer duration of 
drinking, and high levels of adult antisocial behaviors. Generally speaking, this four-
solution model is consistent with Del Boca and Hesselbrock’s (1996) classification 
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scheme and provides further evidence that two-solution typologies may not fully the 
capture the diversity of behavior observed in alcohol use disorders. 
In addition to cluster analytic techniques, other statistical grouping methods have 
been used in alcohol typology research. Peters (1997) employed non-metric multi-
dimensional scaling to explore 102 symptoms linked to various aspects of alcoholism to 
classify individuals voluntarily seeking in- and outpatient alcohol abuse treatment in the 
Netherlands.  Results indicated the presence of a three-dimensional spatial solution. The 
first dimension represented the alcohol dependence syndrome and consisted of symptoms 
related to withdrawal, drinking throughout the day, irresistible urges to drink, and 
drinking to avoid withdrawal symptoms. At one end of the spectrum of the second 
dimension detected was the male-dominated, early onset, antisocial drinker and at the 
other end of the spectrum of this dimension was the female-dominated, isolated home 
drinker. The main pole of the third dimension was comprised of symptoms indicative of 
chronic alcoholism, while the antipole referred to “young persons raised in troubled 
families” (p. 1658).  Taken together, these results suggest that severity, gender, and age 
seem to be principal continuums clients seeking treatment for alcohol problems can be 
positioned along.   
Taxonomic Research in Drug Use Disorders  
Substance use history, pattern of use, familial traits, personality factors, 
psychosocial characteristics, and sociocultural backgrounds have also been examined to 
identify subtypes of drug users. Ball and colleagues (1997) were interested in 
determining whether individuals with a cocaine use disorder could be subtyped according 
to the important characteristics that had already gained empirical support in alcoholism 
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typology research. In particular, this study examined the evidence for the Type A – Type 
B distinction (Babor, Hofmann, et al., 1992) that had emerged with persons with alcohol 
use disorders in a diverse sample of cocaine users (i.e., inpatients, outpatients, and non-
treatment-seeking individuals). Results supported this classification scheme as 
participants in the Type B category exhibited higher heritability, more childhood behavior 
problems, an earlier age of onset, more severe drug and alcohol dependence, a higher 
degree of addiction-related functional impairment, more antisocial behavior, higher 
sensation seeking, and more comorbid psychiatric problems than their Type A 
counterparts. Type B individuals also had poorer treatment outcomes. Adequate construct, 
concurrent, and predictive validity of the Type A – Type B distinction in this sample was 
also demonstrated. However, the authors noted that this typology model seemed to 
portray the inpatient sample more effectively than the outpatient and non-treatment 
seeking participants, suggesting the existence of variability in typology schemes among 
subpopulations of individuals who use cocaine. It should also be noted that the inpatient 
sample had a relatively equal number of participants fall into each subtype, whereas the 
outpatient and community samples had a majority of participants classified as Type A 
(75%).  
Garcia and colleagues (2006) outlined commonalities of Type A and Type B drug 
addicts in a sample of participants receiving outpatient treatment. Type A individuals, or 
functional drug-addicts, tended to report using drugs for fewer years, having more 
alcohol-related problems, and having higher employment rates than their counterparts. 
Conversely, Type B individuals or chronic drug-addicts, tended to report being older, 
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consuming drugs more frequently, and having more medical, employment, legal, family, 
and psychiatric problems than Type A persons.  
Fals-Stewart (1992) examined the personality characteristics of recreational drug 
users treated in a long-term, inpatient, drug-free therapeutic community and how they 
relate to length of stay in treatment and one-year posttreatment outcomes. A hierarchical 
agglomerative cluster analysis was performed on the scale scores of the Millon Multiaxial 
Clinical Inventory (MCMI). Five cluster types cluster emerged, and although this 
investigation neglected to fully describe cluster the characteristics of cluster membership, 
it noted that clusters distinguished by elevations on the avoidant, schizoid, and antisocial 
scales were associated with fewer days in treatment, less abstinence during the one-year 
follow-up period, and earlier time to relapse. Antisocial tendencies were also positively 
related to more major rule violations and avoidant and schizoid tendencies were 
associated with leaving treatment against medical advice. These major findings 
confirmed the hypotheses that suggested that clients who exhibited higher interpersonal 
discomfort and difficulties with authority would likely fare the worst in a therapeutic 
community as this modality of treatment place emphasizes interpersonal interactions and 
a high degree of structure. Along the same lines, forms of antisociality were explored in a 
sample of clients engaged in methadone maintenance treatment (Alterman et al., 1998). 
Results yielded six replicable and temporally stable cluster groups comprised of varied 
degrees of antisociality, configuration of antisociality, and associated psychiatric, 
psychological, and criminal characteristics. Types included early onset, high 
antisociality; late onset, high antisociality; emotionally unstable, moderate antisociality; 
nonantisocial, drug-related antisocial behavior; psychopathic criminal, moderate 
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antisociality, and low antisociality. The diversity in the expression of antisocial 
tendencies in this study further exemplifies the complexity of investigating personality 
traits in substance abusing populations. 
Taxonomic Research in Dual Diagnosis  
The heterogeneity of a dual diagnosis population (i.e., persons diagnosed with a 
substance use disorder and a comorbid Axis I psychological disorder) has been explored 
using cluster analysis (Luke et al., 1996). With hopes of facilitating the planning and 
implementation of individualized treatment programs, this project examined the 
Addiction Severity Index (ASI) severity ratings of dually-diagnosed persons admitted to 
a state psychiatric hospital. The ASI assesses a client’s status in seven domains: medical, 
employment, alcohol, drug, legal, family/social, and psychiatric. Severity ratings are 
subjective ratings given by the interviewer that are based on both objective and subjective 
self-report information provider by the participant. They range from 0 to 9 and reflect the 
degree of the problem and as well as the perceived need for treatment (i.e., no real 
problem, treatment not indicated; extreme problem, treatment absolutely necessary). 
Cluster analysis results produced seven subgroups that were labeled and interpreted based 
on the pattern of severity rating means across ASI domains. It should be noted that these 
subgroups were reliable and had adequate concurrent and predictive validity according to 
longitudinal measures of clinical and community functioning. 
The best functioning cluster had low to moderate severity for each of the ASI 
domains and appeared to have relatively adequate levels of functioning compared to the 
remaining groups. The unhealthy and functioning alcohol abuse groups exhibited high 
alcohol and low drug ratings; however, the unhealthy alcohol abuse cluster demonstrated 
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higher severity ratings in the medical, employment, legal, and social relationship areas 
than those in the functioning alcohol abuse group. The drug abuse cluster showed a high 
drug severity and low alcohol severity pattern, with considerable psychiatric, 
employment, and family problems. Members of the remaining three clusters 
demonstrated high levels of both alcohol and drug problems, but levels of severity varied 
across the remaining domains. The functioning polyabuse group had relatively few 
medical and legal problems. Members of the criminal polyabuse cluster showed the 
highest level of legal problems amongst all clusters and had high problems ratings in all 
of the remaining domains except for medical. The unhealthy polyabuse group had the 
highest psychiatric problem rating, with substantial problems in the medical and 
employment domains and moderate legal and social difficulties. In addition to delineating 
the seven clusters of dually diagnosed individuals, Luke and colleagues (1996) noted that 
the identified groups could be arranged, at a broader level, along the dimensions of level 
of functioning (e.g., good, moderate, poor) and pattern of substance use (alcohol, drug, 
alcohol and drug). Based on where a client exists along these continuums, the authors 
suggest more effective individualized treatment services can be designed and delivered to 
homogeneous subgroups of substance abuse treatment-seeking populations. 
Summary of Taxonomic Research in Substance Use Disorders 
The range of typology studies carried out with substance abusing populations is 
quite broad, as are the classification schemes deduced from these investigations. 
Extensive lists of subgroup attributes and correlates, as opposed to more cohesive 
depictions, often comprise the results sections and are in stark contrast to the fundamental 
goal of these studies: delineating parsimonious subgroups within a certain sample. Such 
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variability in findings can be attributed to diversity in sample characteristics, variables of 
interest, operational definitions of these variables, and the statistical analyses employed. 
At the same time, there exists substantial overlap in much of the research reviewed here. 
Barring the exact label attached (i.e., Type I vs. Type II; Type A vs. Type B; low risk-low 
severity vs. high risk-high severity; functioning vs. unhealthy), individuals with a 
substance use disorder appear to travel different developmental paths that lead to a 
diagnosis of abuse and/or dependence, to engage in different patterns of substance use, 
and to exhibit different types and degrees of consequences related to their substance use. 
There also appears to be some empirical typology evidence that suggests particular 
individuals with a substance use disorder commonly experience symptoms of both Axis I 
(e.g., major depression, anxiety) and Axis II (e.g., antisocial personality disorder) 
psychopathology. At the same time, this apparent redundancy has not been adequately 
investigated and the overlap in the various typologies is unclear – “do these schemas 
represent different methods and labels of describing the (alcohol and drug abusing) 
population in an essentially similar fashion, or do the schemas truly break up the universe 
of (substance abusers) differently” (Epstein, Labouvie, McCrady, Jensen, & Hayaki, 
2002). The answer to this question not only has potential theoretical value in further 
illuminating the etiology and expression of substance abuse disorders, but it also has 
prospective value in refining and tailoring assessment and treatment techniques to align 
with the different types of clients presenting to treatment. 
Applied Utility of Taxonomic Methods  
Essentially, such typology research within the substance abuse field aims to not 
only accurately describe the individuals under study, but to fuse science and practice and 
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identify potential treatment implications. “Regardless of our ability to replicate subtypes, 
the real test of a typological classification lies within its external validity and its 
usefulness for theory development and clinical practice” (Babor, 1997, p. 1666). At the 
individual treatment program level, clients share at least one fundamental commonality: 
they are seeking treatment at the same facility. However, these clients enter treatment 
with divergent backgrounds and possess assorted characteristics that can influence how 
they respond to treatment and how well the treatment program can meet their needs. It 
should be the goal of the treatment program to gain knowledge about their clientele and, 
when possible, detect similarities across clients that may positively or negatively impact 
treatment. With this information, clinicians and researchers alike can begin to postulate 
why certain individuals, or groups of individuals, tend to fare better or worse in their 
particular treatment program. These assumptions can then be empirically tested and 
results can ultimately provide a framework for organizing service delivery and inform 
programmatic decisions regarding admission criteria, treatment planning, interventions, 
and resource allocation, all crucial aspects of improving substance abuse treatment 
outcomes and helping to alleviate the societal strain that substance use disorders 
engender. 
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Chapter III: Method 
 
 
 
Overview 
      The primary purpose of this chapter is to describe the methodology employed in 
this study of characteristics of clients entering an intensive outpatient chemical 
dependency treatment program and their relationship to treatment retention. Descriptions 
of the participants, assessment procedures, assessment instruments, variables of interest, 
and the data analysis plan are provided. This project was retrospective in nature as data 
collection has been completed. It was carried out as part of research collaboration with a 
local substance abuse treatment program that was interested in implementing a 
standardized assessment battery into their intake procedures for a variety of reasons. 
Firstly, as proposed by the TCU Treatment Model, gathering detailed information 
regarding pretreatment client characteristics including problem severity at intake, 
motivation for change, and readiness for treatment is critical for clinicians and clients in 
identifying and clarifying problems, determining treatment needs, making treatment 
planning decisions, and measuring treatment effectiveness as these data serve as a 
baseline measurement of functioning (Simpson 2001; 2004). Secondly, it was anticipated 
that the comprehensive nature of this evaluation process would facilitate the exploration 
of how patient factors and their combinations mediate and moderate treatment processes, 
retention, and eventual outcomes in this particular treatment program (Simpson, 2004). 
Thirdly, standardizing the intake data collection process provided clinicians and 
researchers with a “common language” to speak about and compare clients entering this 
particular program.  
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Participants 
Participants (N = 273) were a sample of clients who entered the intensive 
outpatient chemical dependency program at Rogers Memorial Hospital, a nonprofit, 
freestanding mental health hospital in West Allis, Wisconsin. The assessment protocol 
aimed to evaluate all new clients to the program. However, a variety of practicalities, 
which are detailed later, interfered with the successful accomplishment of this endeavor 
and ultimately produced a sample of convenience. The data collection period spanned 
from January 2005 – November 2006. All participants were 18 years of age or older and 
competent to give consent.  
Program 
 The intensive outpatient chemical dependency program at Rogers Memorial 
Hospital – West Allis utilizes a Minnesota treatment model (Owen, 2003) and 
incorporates components of the 12-step philosophy to provide a framework for clients to 
learn about the nature of substance use disorders and to begin or recommence their 
recovery process. It primarily serves clients who are insured or able to pay out of pocket 
for services. Maintaining abstinence is a chief treatment objective, thus the program 
performs random urine screens for drugs and/or breathalyzer tests for alcohol. Clients are 
expected to comply with these screens, as missed screens are considered “positive” 
screens and refusals could result in discharge from the program. Group therapy is the 
primary method of treatment, which allows clients to receive feedback from both their 
peers and clinicians. Group sessions are held daily from 9:00-12:00, and on Monday, 
Tuesday, and Thursday evenings from 6:00-9:00. Group sessions are augmented with 
weekly individual sessions with a clinician as well as a separate session with the 
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attending physician. Ancillary contact with family members, employers, and others may 
be scheduled. The treatment team consists of a physician/addictionologist, a manager, 
and two primary clinicians. Decisions regarding treatment frequency and duration are 
made collaboratively between the treatment team and the client depending on a variety of 
factors including recommended level of care, treatment goals, scheduling availability, 
and insurance benefits.  
Assessment Procedures 
Assessment Training 
Approximately 14 masters and 2 doctoral students (i.e., this author and a fellow 
senior assessor familiar with the assessment instruments and related procedures) from the 
Department of Counseling and Educational Psychology at Marquette University 
comprised the primary assessment team and administered the standardized assessment 
battery over the course of the data collection period. All assessors received training in 
basic counseling skills, ethical and professional issues, and instruction on the assessment 
battery. More specifically, assessor trainees were provided with reading materials about 
specific policies and procedures related to conducting the intake sessions and the 
assessment battery instruments (i.e., general overview, administration procedures, and 
scoring instructions). Subsequently, trainees attended a minimum of eight hours of formal 
training and completed at least one practice administration and observation. These 
activities were coordinated by this author and the fellow senior assessor under the 
supervision of Todd C. Campbell, Ph.D., licensed psychologist, chair of this project. The 
initial training session presented an overview of the purpose of the intake assessment 
project, reviewed policies and procedures, and discussed ethical issues (i.e., 
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confidentiality, informed consent, suicide protocol, and supervision). The second training 
session focused on the assessment instruments. Administration and scoring procedures of 
each measure were explained and demonstrated, and trainees had the opportunity to ask 
questions and carry out practice administrations.  
  Upon completion of these formal training sessions, trainees administered the 
entire assessment battery to this author or the fellow senior assessor and received 
feedback. Prior to having contact with clients, assessors were required to attend a Rogers 
Memorial Hospital orientation that familiarized them with the organization and its 
policies and provided CPR and self-defense training. Following orientation completion, 
the trainee observed this author or the fellow senior assessor conduct the assessment 
battery with an actual participant. Then, the trainee administered a minimum of two 
assessment batteries with actual participants under the live supervision of this author or 
the fellow senior assessor. A discussion about the trainee’s comfort level and proficiency 
in administering the assessments was then undertaken to determine if s/he was ready to 
administer the battery on her/his own. This process was repeated until the trainee, this 
author and the fellow senior assessor, and Todd C. Campbell were in agreement about the 
trainee’s readiness to perform the assessments without live supervision. Ongoing 
individual and group supervision was provided for the assessors by this author and the 
fellow senior assessor under the direction of Todd C. Campbell. In addition to the 
administration-specific training, the Institutional Review Board at Marquette University 
required trainees to complete an online tutorial about conducting research with human 
participants.  
Administration of Assessment Battery 
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Both treatment providers and researchers are concerned about the appropriate 
timing for the administration of assessment measures. “Demands for quick turnaround to 
aid in triage and treatment planning compete with the clients’ ability to provide accurate 
and reliable information after detoxification. Drastic reductions in clients’ length of stay 
imposed by managed care decisions further complicate the dilemma” (Allen, 2003, p. 9). 
Considering the scant amount of research examining optimal assessment administration 
times (Allen, 2003), the primary investigators consulted with the treatment program and 
determined that the assessment battery was to be administered to the participants within 
48 hours of being admitted to the program. Upon entry into the intensive outpatient 
program, clients should have completed a sufficient amount of detoxification to provide 
reliable information. Thus, immediate assessment completion would not be problematic 
for this reason and would actually aid in the treatment planning process if done at the 
outset. It was also decided that the assessment session would take place during the group 
session time, as potential participants were easily accessed during this period and 
additional scheduling conflicts would not interfere with data collection. Notification and 
referral procedures were as follows. When a new client entered the program, the primary 
clinician called the assessment office and left a message providing the client’s name and 
admission date. This referral information was subsequently recorded on a cumulative 
admissions log kept in a locked filing cabinet. When assessors reported to the research 
office, they consulted the admissions log to see there was a client to be tested. In the 
event that there were numerous clients to be tested, the client with the oldest admission 
date was given precedence. Prior to the beginning of the group treatment session, 
assessors reported to the clinician to inquire whether or not the preferred testing client 
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was in attendance. If the preferred client was available, the clinician introduced the 
assessor to the client, and the assessor proceeded to briefly explain the purpose of the 
assessment session. In the event that the preferred client was not in attendance, the 
assessor inquired about the subsequent client(s) on the admission log until a client was 
available for testing.  
Despite the aforementioned notification and referral procedures, a range of 
practical difficulties interfered with the assessment team’s ability to evaluate each client 
entering the program. Space constraints allowed for the testing of only one individual per 
group session. In particular, intermittent census increases in the program reduced the 
ability of the assessment team to efficiently (i.e., within the target 48 hours following 
admission) complete testing procedures on all clients. Additionally, the assessment team 
was comprised of graduate student volunteers; thus, unforeseen circumstances 
occasionally prevented them from covering for their scheduled assessment slots and 
impeded evaluation efficiency. Timely notification was also an area of concern at various 
points during the data collection period, as clinicians failed to inform the assessment team 
of new clients entering the program. Moreover, poor client attendance and early attrition 
from the program limited access to clients who needed to be tested, further hindering the 
assessment team’s ability to complete all intake evaluations. Such obstacles are not 
unusual when carrying research in applied treatment settings (Joe et al., 1999; Simpson, 
Brown et a, 1997). In recognition of the fact that the obtained sample may not be 
representative of the actual substance abuse treatment-seeking population at Rogers 
Memorial Hospital – West Allis, demographics (e.g., sex, race, and age) and treatment 
information (e.g., treatment completion status, treatment duration, number of treatment 
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days) were obtained for those clients who were not assessed at intake and subsequently 
excluded from the study (N = 171). Comparative analyses were conducted in order to 
determine the equivalency of the obtained sample to the overall population from which it 
was drawn. These results will help determine the external validity or generalizability of 
study findings.  
The treatment program required that all new clients admitted to the program 
complete the assessment battery for clinical purposes, though the client could decide 
whether or not her/his data would be further deidentified and utilized for research 
purposes. An informed consent document outlining these dual objectives was created to 
explicate the procedures (Appendix A). Prior to the administration of the assessment 
battery, a copy of the informed consent was provided to each participant. It contained an 
explanation about why the information was being collected and how it was going to be 
collected. Furthermore, it assured participants that they had the right to refuse 
participation and doing so would not affect their treatment. The informed consent 
document was read to the participants verbatim, and participants were given the 
opportunity to have their questions answered. They initialed the bottom of every page and 
signed the final page to indicate they agreed to participate in the study. They were given a 
copy of the informed consent for their reference.  
 The length of the assessment session generally ranged from 90 to 150 minutes. 
Assessors read both the instructions and individual items to the participant and recorded 
all responses on her/his behalf. Data were collected in a variety of mediums as more 
sophisticated methods became available. The computer-assisted Addiction Severity Index 
(ASI) was utilized throughout the data collection period. These data were directly 
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exported from the program into an SPSS file where all identifying client information was 
removed and replaced with an arbitrary client identification number. The paper-pencil 
version of the Mini-International Neuropsychiatric Interview (M.I.N.I.) was used until a 
computerized version of this instrument became available and was purchased (February 
2006). Since the computerized version of the M.I.N.I. did not have a fully-functioning 
export option, this information, along with the paper-pencil data, was de-identified and 
manually entered into an SPSS file by the senior assessors. Paper-pencil versions of the 
Form 90 Drinking Assessment Interview (Form 90), Inventory of Drug Use 
Consequences (InDUC), and Stages of Change Readiness and Treatment Eagerness Scale 
(SOCRATES) were initially utilized, though electronic forms of these assessments were 
eventually created and implemented (February 2006). The electronic versions allowed 
assessors to access the password-protected forms via the Center for Addiction and 
Behavioral Health Research website. Assessors proceeded to input client answers during 
the interview, which were subsequently directly exported into an SPSS file. Paper-pencil 
Form 90, InDUC, and SOCRATES data were retrospectively entered into the electronic 
forms, as opposed to manually being entered in SPSS, to expedite the data entry process. 
The assessment battery also contained the Alcohol Abstinence Self-Efficacy Scale, 
though data from this measure will not be included in further analyses as it was 
incorporated into the protocol in the middle of the data collection period and data were 
only collected for clients who primarily used alcohol. 
 Upon completion of the assessment battery, the assessor filled out a personalized 
feedback report for the client (Appendix B) containing summary assessment information. 
This report was given to the primary clinician, along with a computer-generated ASI 
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narrative report, for clinical use and became part of the treatment record. All hard copies 
of paper-pencil instruments, scoring sheets, ASI narrative report copies, and personalized 
feedback report copies were deidentified and placed in separate folders arranged by client 
identification number. These files are being kept in a locked filing cabinet at Rogers 
Memorial Hospital in the assessment office. Informed consent documents are being kept 
in a locked filing cabinet at Marquette University. All data will be kept for approximately 
seven years and will then be destroyed. 
Assessment Instruments 
 Accurate client assessment is essential to both treatment of and research on 
substance use disorders. As Allen (2003) notes: 
 Although each of these activities is advanced by informed use of psychometric  
instruments, the needs of professionals in the two endeavors differ. Most notably, 
the practitioner is primarily concerned with the clinical utility of the measure, 
particularly how well it identifies the needs of a given client and guides treatment 
planning. The researcher is likely to explore a broader range of variables that may 
quantify and explain the overall impact of an intervention. (p. 1) 
 
These perspectives, along with the administration ease and acceptability of the measures 
to clients, were taken into account in the selection of the instruments that would comprise 
the assessment battery. Efforts were made to maximize both clinical and research utility 
through the use of reliable and valid assessment tools. In the end, a comprehensive 
battery with a variety of measures evaluating symptoms, diagnosis, risk behaviors (e.g., 
suicidal ideation), functional impairment, problem severity, subjective distress, 
motivation, and self-efficacy was selected. Psychometric properties of each instrument 
are evaluated and reported below.  
Unfortunately, there is a lack of consensus on what constitutes acceptable 
reliability standards within research and practice settings, and such guidelines often differ 
119 
depending upon what the instrument is being used for. For instance, Nunnally and 
Bernstein (1994) purport that increasing reliabilities beyond .80 in basic research (i.e., 
exploring the difference between groups) may waste valuable resources including time 
and money. In contrast, they indicate that when making important decisions based upon a 
particular test score(s), a reliability of .80 is likely not rigorous enough, since much 
weight is placed on the specific score that is obtained (e.g., determining if a child should 
be placed in special education classes based on IQ). In such instances, Nunnally and 
Bernstein (1994) advise that the reliability should be at least .90, though .95 would be 
considered ideal. Along the same lines, Aiken (2003) and Rosenthal and Rosnow (2008) 
recommended reliability estimates of .85 or higher when scores are used in making 
clinical decisions, while Sternberg (1994) asserted that reliability estimates above .80 are 
desirable and above .90 are preferred when using a tool for screening or diagnostic 
purposes. Assuming a more liberal stance, Cicchetti (1994) suggested that reliability 
coefficients (r) below .70 were unacceptable, between .70 and .79 were fair, between .80 
and .89 were good, and those equal to or greater than .90 were excellent. At the same 
time, his interrater reliability standards have been criticized as far too lenient (i.e., κ < .40 
= poor; .40 ≤ κ ≤.59 = fair; .60 ≤ κ ≤ .74 = good; .75 ≤ κ ≤ 1.00 = excellent). 
Fairly consistent with the suggested guidelines, when selecting instruments to be 
included in this particular assessment battery, efforts were made to choose measures with 
reliability estimates of .80 or higher, though values of .70 or higher were considered 
acceptable. Nonetheless, such decisions were impacted by additional factors (i.e., the 
ability of the instrument to provide clinically useful information; administration time), 
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thus there were instances where a measure was selected, despite reliability estimates that 
fell below the preferred level (r < .70).  
Addiction Severity Index, Fifth Edition (ASI) 
 The ASI was developed over 25 years ago by a team of researchers lead by A. 
Thomas McLellan at the University of Pennsylvania’s Center for the Studies of 
Addiction. It is currently in its fifth revision and has emerged as one of the most 
frequently used measures in the substance abuse treatment field due to its usefulness in 
identifying areas of treatment need and measuring treatment outcomes within a 
multidimensional framework (McLellan et al., 1992; McLellan, Luborsky, Woody, & 
O’Brien, 1980; Donovan, 2003). The ASI is a semi-structured interview that can be 
administered in about 50-60 minutes by a trained assessor. Two-day, intensive training 
sessions on administration and scoring procedures are offered by the Treatment Research 
Institute (TRI). These workshops are supplemented with manuals, practice materials, 
quizzes, scripted role plays, videotapes, and vignettes to assist interviewers derive more 
accurate interviewer severity ratings, reduce errors, and improve overall consistency in 
administration and scoring (McLellan et al., 2006; TRI, n.d.). For this project, the fellow 
senior assessor attended the TRI training sessions and subsequently provided training to 
the remaining assessors based on the instruction she received. It is critical that the ASI 
interviewer is able to rephrase questions, adequately summarize responses, and probe for 
more complete information to ensure that the client understands all of the questions and 
provides answers that correspond to the intent of the questions; thus, the ASI training 
employed in this study tended to focus on these particular areas (McLellan et al., 1992). 
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The ASI was designed to measure patient functioning in seven domains: alcohol 
and drug use, medical and psychiatric health, employment and self support, family and 
social relationships, and illegal activity. Within each of these areas, two time frames are 
examined. Lifetime information aims to assess the duration and severity of each problem, 
while knowledge about the frequency and intensity of problems within the past 30 days 
supplements this data and assists in the identification of current treatment needs 
(McLellan, Cacciola, Alterman, Rikoon, & Carise, 2006). Structurally, the ASI is 
comprised of separate modules of domain-related questions. At the end of each module, 
clients are asked to rate how troubled or bothered they have been by problems in a 
particular area and then indicate how important treatment for these problems is to them at 
the present time. Responses are chosen from a 5-point Likert scale ranging from “not at 
all” to “extremely.” The interviewer also has a chance to rate severity of problems in each 
domain on a 10-point scale ranging from “no real problem, treatment not needed” to 
“extreme problem, treatment absolutely necessary” and indicate his or her level of 
confidence that the client has understood and answered the questions truthfully. In 
addition to these subjective ratings, domain-specific composite scores representing 
weighted mathematical combinations of a defined set of items in each area are computed 
to provide a more objective measure of problem severity in the past 30 days. Composite 
scores are only made up of items that are subject to change, making them an ideal method 
for examining change over time (i.e., pretreatment versus posttreatment scores) 
(Donovan, 2003; McLellan et al., 1980; 1992). According to McLellan and colleagues 
(1992) it is often advantageous to create summary measures (i.e., composite scores) to 
aggregate multiple indicators of patient characteristics when conducting research and 
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evaluating treatment outcomes because such scores offer distinct statistical advantages 
such as greater reliability of measurement and increased statistical power when 
measuring change.  
 ASI Psychometrics 
 The ASI has been utilized across a range of substance abuse treatment-seeking 
populations including different gender and ethnic groups (Brown, Alterman, Rutherford, 
Cacciola, & Zaballero, 1993), clients with various primary substances of use across 
treatment settings (McLellan, Luborsky, Cacciola, & Griffin, 1985; McLellan et al. 
1994), clients with psychiatric disorders (Appleby, Dyson, Altman, & Luchins, 1997; 
Carey, Cocco, & Correia, 1997; Zanis, McLellan, & Corse, 1997), and homeless 
individuals with a substance use disorder (Zanis, McLellan, Cnaan, & Randall, 1994). 
Considering the diversity within the population being examined for this project and a lack 
of descriptive information documented about it, a review of such studies involving 
assorted treatment-seeking subgroups is pertinent. Psychometric properties have varied 
considerably depending on the population tested, variables examined, and statistical tests 
executed, making it difficult at times to compare values across studies and determine if 
adequate reliability and validity evidence exists (Makela, 2004).  
All new items that were added to the Fifth Edition of the ASI exhibited 
satisfactory test-retest reliabilities as Cohen’s kappa values were .83 or higher (McLellan 
et al., 1992). These results were consistent with similar studies conducted with previous 
editions of the ASI (McLellan et al. 1985) and another longer-term investigation of the 
test-retest reliability of the ASI lifetime items (Cacciola, Kippenhaver, McKay, & 
Alterman, 1999). In a review of studies examining the test-retest reliability of composite 
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scores, Makela (2004) reported that values ranged from satisfactory to unsatisfactory, 
with most of the deficient values emerging from studies of special subpopulations like 
those who are homeless, in prison, or have comorbid disorders.  
 Interrater reliability coefficients for severity ratings were fairly high (above .80) 
in initial and subsequent investigations among clients entering substance abuse treatment 
(McLellan et al., 1980, 1985; Stoffelmayr, Bertram, Mavis, Brian, & Kasim, 1994). 
Lower levels of interrater consistency have been found in clients with concurrent severe 
and persistent mental illness and substance use disorders; ICCs for severity ratings in this 
sample averaged .66 and ranged from .55 (employment) to .91 (legal) (Zanis et al., 1997). 
In reference to interrater reliability of composite scores, Makela (2004) indicated that 
they have been consistently higher than those found for severity ratings, likely due to the 
fact that they involve less subjective judgment and more objective recording of reported 
information. This observation is corroborated by higher average interrater reliability 
coefficients for composite score as compared to severity ratings in various studies (Carey 
et al., 1997; McLellan et al., 1985; Zanis et al., 1997).  
 According to Makela (2004), composite scores for medical status, alcohol use, 
and psychiatric status generally have acceptable internal consistencies (α > .70), whereas 
the composite scores for employment status, drug use, legal status, and family/social 
relationships tend to have lower consistencies (.60 < α < .70). As with test-retest and 
interrater reliability, it is not unusual to detect low internal consistency estimates with 
particular subpopulations such as those with primary psychiatric disorders (Carey et al., 
1997) and homeless individuals with a substance use disorder (Zanis et al., 1994). In this 
study, the seven ASI composite scores showed generally acceptable internal consistency: 
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medical (α = .85); employment (α = .67); alcohol (α = .89); drug (α = .77); legal (α = 
.68); family/social (α = .75); and psychiatric (α = .83). However, consistent with previous 
research, the internal consistency estimates in the employment and legal domains fellow 
below the desired value of α > .70. 
 ASI validity studies have also examined multiple populations and used diverse 
methodologies to decipher how well the ASI measures what it intends to measure. The 
first independent validation study of the ASI found that within a sample of opiate users, 
the ASI psychiatric, family/social relationships, legal, and employment severity ratings 
had poor to fair concurrent validity with self-report measures of psychological problems, 
social adjustment difficulties, legal trouble, and employment problems (r = .39 – 59, p < 
.001). Furthermore, the combined alcohol and drug severity rating showed limited 
concurrent validity (r = .17, p = .02) and no measures of physical health were available 
for comparison with the medical severity rating (Kosten, Rounsaville, & Kleber, 1983). 
Subsequent comparisons of ASI severity ratings and composite scores among a substance 
abuse treatment-seeking population exhibited evidence of adequate concurrent and 
discriminant validity with a battery of previously validated tests (McLellan et al, 1985). 
The concurrent and discriminant validity of the alcohol, drug, and psychiatric composite 
scores has also been studied in a sample of homeless substance users. Satisfactory 
evidence was detected as these scores were correlated with the Michigan Alcohol 
Screening Test (r = .31), Risk for AIDS Behavior (r = .54), and the Symptom Checklist-
90 (r = .66), respectively, and did not display significant relationships with unrelated 
measures (Zanis et al., 1994). Furthermore, in a sample of persons with severe and 
persistent mental illness and a low degree of current comorbidity, combined validity 
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evidence for both severity ratings and composite scores was acceptable for the alcohol 
and drug domains, weak for the employment and family/social domains, and mixed for 
the psychiatric, medical, and legal domains (Carey et al., 1997). 
Criterion validity has also been explored. Appleby and colleagues (1997) found 
strong relationships between the alcohol and drug composite scores and related measures 
(r = .50 - .73) among substance abusing clients with comorbid psychiatric disorders. 
Sensitivity and specificity analyses have provided further evidence for the predictive 
utility of the ASI as results have compared favorably with related measures. A minimum 
alcohol severity rating of one (i.e., mere recognition of a problem) had a sensitivity of 
93% and corresponding specificity of 59% with respect to a current alcohol use disorder 
as measured by the Structured Clinical Interview for the DSM-III-R (SCID). Similar 
results were found for the drug severity rating, which had a sensitivity of 93% and 
specificity of 55% with respect to a current drug use disorder (Appleby et al., 1997). 
More recently, Rikoon, Cacciola, Carise, Alterman, and McLellan (2006) investigated if 
ASI composite scores could serve as an effective screening tool for DSM-IV substance 
dependence in two separate samples utilizing different diagnostic tools (i.e., ASI 
including the DSM-IV questions and the SCID-DSM-IV). Results indicated that ASI 
alcohol and drug composite scores identified dependent clients with approximately 85% 
sensitivity and 80% specificity. The psychiatric subscale has also been explored. Kosten 
et al. (1983) found that a psychiatric status severity rating of three or greater had a 
sensitivity of 89% and specificity of 67% when identifying depression by research 
diagnostic criteria (RDC), which compared favorably to the Beck Depression Inventory. 
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Considering the breadth of psychometric studies carried out on the ASI, there is 
sufficient evidence to suggest that it is a reliable and valid instrument for the evaluation 
of general populations entering substance abuse treatment. It should be noted though that 
it appears that caution needs to be exercised when using the ASI with other 
subpopulations, as the reliability and validity evidence has not been as strong in such 
investigations. For this particular project, the sample was drawn from a population of 
clients entering an outpatient chemical dependency program, making the ASI an 
appropriate measure for inclusion. Furthermore, in providing reliable and valid 
information across a range of domains that assisted in the identification of treatment 
needs at the outset of treatment, it met the needs of both practitioners and researchers, 
another aim in the construction of this assessment battery.  
Mini-International Neuropsychiatric Interview (M.I.N.I.)\ 
The M.I.N.I. was developed by psychiatrists and clinicians in the United States 
and Europe in response to the need for a brief, structured diagnostic interview that 
primarily assessed for Axis I psychiatric disorders in the DSM-IV and International 
Classification of Diseases (ICD-10). More specifically, it was designed as a short, but 
accurate psychiatric interview for use in multi-center clinical trials and epidemiology 
studies and as an initial outcome tracking measure in nonresearch clinical settings 
(Sheehan et al., 1998). From the outset, the M.I.N.I.’s creators “wanted an instrument to 
have the ability to detect a substantial portion of patients without incorrectly labeling a 
disproportionate number of patients without disorders” (Sheehan et al., 1998, p. 23).   
  M.I.N.I. Psychometrics 
       Validation and reliability studies were executed comparing the M.I.N.I. to the 
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diagnostic standards for the DSM-IV (SCID) and for the ICD-10 (Composite International 
Diagnostic Interview [CIDI]). Concordance rates were characterized by good to very 
good kappa values for the M.I.N.I. – SCID comparison, with only one value (current drug 
dependence) below .50. Kappa values were also good to very good for the M.I.N.I. – 
CIDI comparison, with only two values (simple phobia and generalized anxiety disorder) 
below .50. Moreover, the operating characteristics (e.g., sensitivity, specificity, positive 
predictive values, and negative predictive values) for the majority of the diagnoses were 
adequate to very good (Sheehan et al, 1998). Mean administration time for the M.I.N.I. 
was about half that of the SCID (18.7 ± 11.6 minutes vs. 43 ± 30.6 minutes) and about 
one fourth that of the CIDI (21 ± 7.7 minutes vs. 92 ± 29.8 minutes) (Sheehan et al., 
1998). Reliability estimates were also satisfactory. All kappa values measuring interrater 
reliability for each diagnosis were above .75, with 70% of them being .90 or higher. Test-
retest reliability was relatively adequate, with 61% of the values being above .75 and only 
one value (current mania) below .45.  
   Based on this reliability and validity data, the authors made adjustments to the 
original instrument. Several questions were strengthened, improvements to enhance the 
operating characteristics were made, and all diagnostic modules were updated to reflect 
the DSM-IV and its time frames. A computerized version was also created to ease the 
process of administration The M.I.N.I. can be used by clinicians, after a brief training 
session, though lay interviewers require more extensive training to familiarize themselves 
with diagnostic criteria and procedures (Sheehan et al., 1998). In light its satisfactory 
psychometric properties and practical advantages (i.e., fully-structured, administration 
time, electronic version, brief training), the M.I.N.I. was selected as the primary 
128 
diagnostic tool in this battery of assessments. According to Maisto, McKay, and Tiffany 
(2003), diagnostic information is not only important in delineating severity of substance 
use (i.e., determining if criteria is met for abuse or dependence), but it is also critical in 
the identification of concurrent psychiatric disorders because this information has a 
profound impact on the treatment planning process and often necessitates targeted 
interventions and/or additional services. Furthermore, the M.I.N.I. suicidality module was 
utilized as a supplementary gauge of suicidal ideation and assisted the treatment team in 
providing appropriate care to clients who were potentially in danger of harming 
themselves. A suicide prevention protocol was created, and assessors were instructed 
about what action to take in the event that a client presented with low, moderate, or high 
suicide risk. The primary clinician was notified of the situation assessed in all instances, 
while the attending physician was also informed when clients presented with moderate to 
high risk. 
Form 90 Drinking Assessment Interview (Form 90) 
A primary concern in the study of alcohol and drug treatment is the employment 
of self-report measures to evaluate the extent of use. Sobell and Sobell (2003) reported 
that a number of comprehensive reviews have explored the reliability and validity of 
alcohol users’ self-reports and concluded that this data can be used with confidence, 
particularly when it is gathered under certain conditions: the client is alcohol-free at the 
time of interview, the setting encourages honest reporting, the questions are clearly 
worded and objective, and memory aids are provided. Furthermore, questions about 
heavy and atypical drinking should be included to accurately capture a client’s total 
129 
alcohol consumption. Considering this information, the Form 90 was selected as the 
primary assessment tool utilized to gather substance use data.  
The family of Form 90 instruments was originally developed for Project MATCH 
and aimed to combine the strengths of prior methodologies used to measure use: 
quantity-frequency questionnaires, average consumption grids, timeline follow-back 
calendars, and self-monitoring diaries. All versions are structured, interviewer-
administered, retrospective assessments that yield quantitative data (Miller & Del Boca, 
1994). The Form 90 Drinking Assessment Interview, the one selected for the current 
project, was part of the Project MATCH in-person intake protocol. In addition to 
collecting daily drinking information for the 90 days prior to the last drink, the Form 90 
examines other aspects of client functioning including drug use, participation in medical 
and psychological treatment, institutionalization periods, work activity, school 
involvement, and religious participation (Sobell & Sobell, 2003). Calendars showing all 
the days in the assessment window are used to aid client recall. The identification of 
abstinent periods, drinking patterns, and idiosyncratic drinking episodes also help 
promote accurate reporting.  
Drinking behavior is quantified by estimating daily alcohol consumption (i.e., 
standard drink unit as measured by standard ethanol content [SEC]) and intoxication level 
(i.e., blood alcohol concentration [BAC])  These values are deduced from the amount and 
type of alcohol consumed and drinking episode duration. Supporting software systems 
employed to execute the complex SEC and BAC calculations include the Blood Alcohol 
Concentration Computation System and the updated, more user-friendly, Center on 
Alcoholism, Substance Abuse, and Addiction’s (CASAA) Liquor Database and 
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SEC/BAC Calculator. Both of these programs are in the public domain and can be 
downloaded from CASAA’s website, along with the instrument itself (CASAA, n.d.; 
Miller & Del Boca, 1994). Percentiles indicating where a client ranks in relation to other 
women and men in United States for average SECs per week and frequency of drug use 
are available to bolster the clinical utility of the instrument. This information, along with 
peak BAC levels, can be used within a motivational structure to provide feedback to the 
client regarding the severity of their alcohol and drug use problems. Average 
administration time for the Form 90 is 40 to 60 minutes and scoring time is 20 minutes. It 
is a complex procedure that is subject to numerous errors and distortions if interviewers 
are not properly trained. Thus, in addition to reviewing the Form 90 manual instructions, 
specialized training is advised (Miller & Del Boca, 1994). For this particular project, two 
individuals from a local clinical trials site familiar with Form 90 procedures from their 
participation in Project MATCH conducted a formal Form 90 training session that was 
embedded within the aforementioned assessment training sessions.    
Form 90 Psychometrics 
Sobell and Sobell (2003) reported that there is evidence supporting the stability, 
criterion validity, and construct validity of the Form 90. In reference to reliability, a study 
of 70 treatment-seeking men and women found that the agreement for daily self-report of 
drinking (i.e., yes or no) between the test interview and the retest interview (i.e., 2 days 
later), as measured by kappa coefficients, ranged from .48 to .97 with an average of .77 
(Rice, 2007). Agreement for test-retest was further stratified by gender and assessment 
window (days 1-30, 31-60, 61-88). Results indicated that test-retest agreement was higher 
for women as compared to men, and was best for the most recent period (days 1-30) as 
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compared to more than 31 days prior to testing. In a more comprehensive review, 
Tonigan, Miller, and Brown (1997) several approaches were used to evaluate reliability. 
ICCs and r calculations were carried out for test-retest comparisons, while kappa 
coefficients were used to determine interviewer agreement regarding the presence or 
absence of specific drug use. Results indicated that the Form 90 yielded relatively 
consistent measures of drinking, drug use, and psychosocial functioning as evidenced by 
r ≥ .90 in a large majority of comparisons (57 of 81 variables examined). The more 
conservative standard of reliability (ICC) yielded less consistent reliability estimates, 
though the majority of them fell within the acceptable range (Tonigan et al., 1997). With 
a few exceptions, kappa coefficients of interrater agreement concerning lifetime drug use 
were satisfactory. Grant, Tonigan, and Miller (1995) reported relatively adequate 
convergent validity for the timeline followback calendar approach utilized by the Form 
90. Correlations with similar methods of gathering retrospective drinking information 
yielded values ranging from .59 to .80 for key variables (e.g., drinking days, total SEC, 
peak BAC). 
When selecting alcohol and drug use measures, decisions need to be made about 
the type of information to be collected (e.g., level of precision, assessment period, 
administration length) (Sobell & Sobell, 2003). Since research and clinical utility were at 
the forefront in this project, the Form 90 emerged as a reliable, valid, and valuable 
measure to assess the frequency and intensity of alcohol use, along with the rate of drug 
use and other activities during the period leading up to treatment entry. The ability to 
provide clients feedback regarding their level of substance use as it compares to others 
was a favorable aspect of the instrument that the clinicians particularly liked because they 
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felt it gave them objective information they could relay to clients and often initiated a 
conversation regarding problem recognition and severity. 
Inventory of Drug Use Consequences (InDUC) 
   Exploring the consequences individuals experience in relation to their alcohol and 
drug use is not only useful for diagnostic determinations, but it can also illuminate 
connections between substance use and negative physical and psychosocial consequences 
that clients are not always able to recognize (Maisto et al., 2003). Furthermore, such data 
has proven to be particularly useful in informing motivational and behavioral 
interventions and helping clients move through the stages associated with the behavioral 
change process (Miller & Rollnick, 2002). Nevertheless, there is a paucity of 
standardized measures assessing adverse consequences of substance use. The 
development of the Drinker Inventory of Consequences (DrInC) in 1995 was an initial 
advance in filling this gap (Blanchard, Morgenstern, Morgan, Labouvie, & Bux, 2003). 
This 50-item instrument was designed to evaluate alcohol-related consequences in five 
domains: Physical, Social, Interpersonal, Impulse Control, and Interpersonal. Considering 
the fact that a majority of individuals with substance use disorders have both alcohol and 
drug problems, the DrInC was revised to incorporate consequences of drinking and using 
drugs and the Inventory of Drug Use Consequences (InDUC) was created (Blanchard et 
al., 2003).  
The InDUC is available in two general formats. The lifetime version assesses 
lifetime consequences and utilizes a dichotomous “yes/no” response scale to indicate 
whether or not the respondent has ever experienced a particular event. This version was 
selected for use in this project as it seemed more relevant to gather a more comprehensive 
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history of consequences at the outset of treatment. The recent version inquires about how 
frequently consequences that have been experienced during a particular time period (i.e., 
since treatment entry, in the previous 30 days), making it a suitable instrument to 
examine changes over time. Respondents answer on a 4-point Likert scale ranging from 
“never” to “daily or almost daily” (Blanchard et al., 2003). Scores are summed for each 
subscale and across subscales to produce a total score, with higher scores reflecting more 
severe consequences. The InDUC also employs a control scale comprised of five reverse-
scaled items designed to detect careless or perseverative responding (Blanchard et al., 
2003). Endorsement of at least one of these items suggests that the respondent was 
relatively prudent in their responding. Administration time is approximately 10 minutes, 
and minimal training is required. The instrument is available free of charge and can be 
downloaded from the CASAA website (CASAA, n.d.). 
   InDUC Psychometrics 
Since the lifetime version of the InDUC was utilized in this project, the 
subsequent evidence relates to this form. In a sample of outpatient drug treatment clients, 
Tonigan and Miller (2002) found that three out of the five subscales had acceptable test-
retest stability. ICCs were .92 for Impulse Control, .88 for Social Responsibility, and .73 
for Interpersonal. In contrast, the Physical and Intrapersonal scales had reliabilities falling 
below the preferred level (ICC = .68, ICC = .33, respectively). In a more recent study of 
outpatient clients, Gillaspy and Campbell (2006) reported higher test-retest reliability for 
the entire scale (ICC = .94) and adequate temporal stability for nearly all five subscales: 
Intrapersonal (ICC = .86); Social Responsibility (ICC = .83); Interpersonal (ICC = .82); 
Physical (ICC = .71), and Impulse Control (ICC = .64).   
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Tonigan and Miller (2002) also recruited a larger clinical sample from both 
inpatient and outpatient settings to examine construct validity. A confirmatory factor 
analysis produced a single common factor, which contrasted the proposed structure of the 
InDUC containing five subscales (Tonigan & Miller, 2002). In a sample of outpatient 
substance abuse treatment clients, Blanchard and colleagues (2003) also found support 
for a one-factor solution, and reported high internal consistency for the entire measure (α 
= .96). Gillaspy and Campbell (2006) reported additional internal consistency estimates: 
entire scale (α = .96); Intrapersonal (α = .89); Interpersonal (α = .86); Physical (α = .85); 
Social Responsibility (α = .84); and Impulse Control (α = .84). These authors also note 
high intercorrelations among the five subscales, further challenging the construct validity 
of the InDUC as there seems to be much overlap and redundancy. InDUC scores 
demonstrated positive, yet modest, convergent validity with measures of psychological 
distress, depression, and alcohol and drug use (Gillaspy & Campbell, 2006).  
Although the evidence for construct validity of the InDUC’s five-factor structure 
is lacking, this instrument appears to be a reasonably reliable and valid assessment of 
consequences related to alcohol and drug use. In this study the InDUC demonstrated 
acceptable internal consistency: Total (α = .92); Intrapersonal (α = .80); Interpersonal (α 
= .78); Physical (α = .70); Social Responsibility (α = .76); and Impulse Control (α = .78). 
Its clinical applicability in increasing client awareness and recognition of how substance 
use has affected her/his life and gauging substance abuse/dependence severity further 
supported the selection of this instrument. Ease of access, administration, and scoring 
were also benefits to including this tool in the assessment battery.  
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) 
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The SOCRATES (Miller & Tonigan, 1996) is an instrument designed to assess 
the stage of readiness to change drinking behavior. It is based on the transtheoretical 
model of change (Prochaska & DiClemente, 1992; Prochaska et al., 1992), which 
proposes that people progress through a sequence of stages as they initiate and maintain 
behavior change. Precontemplation is characterized by a state of unawareness of a 
problem or a need for change. As awareness of a problem increases, the person 
progresses to a state of ambivalence or contemplation. At this point, the person often 
weighs the pros and cons of behavior change. Eventually, the decisional balance may tip 
in favor of change, as adverse consequences (cons) of maintaining the status quo 
outweigh the perceived advantages (pros). Once this happens, the person is thought to 
have entered the preparation stage, which involves making and strengthening a 
commitment to change and developing a plan of action. Once these objectives are 
achieved, the person attempts to execute the plan and makes necessary revisions to 
manage difficulties in the action stage. If these initial efforts are successful, the person 
proceeds to the maintenance stage where the focus is primarily on relapse prevention 
(DiClemente, 2003; Prochaska & DiCLemente, 1992; Prochaska et al., 1992). 
The SOCRATES is available in a long version (39 items) and an abbreviated 
version (19 items). The authors recommended the use of the short form because it 
generates scores that converge well with the longer version, and demonstrates greater 
simplicity and clearer factor structure. In accordance with this advice, the 19-item version 
was selected for use in this project (Miller & Tonigan, 1996). Clients are instructed to 
indicate the degree to which they agree or disagree with statements worded specifically 
about changing drinking behavior. Response options are on a 5-point Likert scale ranging 
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from strongly disagree to strongly agree. Administration time is approximately 5 to 10 
minutes, and training is minimal. The SOCRATES and accompanying materials 
including an overview of the instrument and interpretation guidelines can be downloaded 
from the CASAA website (CASAA, n.d.).  
SOCRATES Psychometrics 
  Factor analyses yielded a 3-factor solution amongst responses of a sample of 
1,672 Project MATCH participants seeking treatment for alcohol problems. The first 
factor, Taking Steps (to change drinking behavior), accounted for 27% of the item 
response variance and consisted of eight items (e.g., I am working hard to change my 
drinking; I want help to keep from going back to the drinking problems that I had before). 
The second factor, Recognition (that an alcohol problem exists), explained an additional 
11% of the variance and contained seven items (e.g., I have serious problems with 
drinking; my drinking is causing a lot of harm). The third factor, Ambivalence (about 
whether an alcohol problem exists or not) accounted for a further 7% and consisted of 
four items (e.g., There are times when I wonder if I drink too much; Sometimes I wonder 
if I am in control of my drinking) (Miller & Tonigan, 1996). In light of these findings, it 
appears that the SOCRATES does not fit perfectly within Prochaska and DiClemente’s 
stages of change model, but the scales may be “better understood as continuously 
distributed motivational processes that may underlie stages of change” (Miller & 
Tonigan, 1996, p. 84). Scores are summed according to subscales, and deciles for each 
scale are provided to determine how individuals compare to other people presenting for 
alcohol treatment (i.e., low, average, high). Descriptive interpretation guidelines are also 
provided to further delineate what the scores might signify.  
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The relationship between these motivational dimensions and measures of problem 
severity (e.g., various consumption variables, problem scales derived from the Alcohol 
Use Inventory) was also examined. The strongest correlations, reflecting up to 15% 
common variance, indicate a positive relationship between Recognition and problem 
severity (Miller & Tonigan, 1996). Internal consistency estimates were generally 
acceptable: Taking Steps (α = .83), Recognition (α = .85) and Ambivalence (α = .60). 
Test-retest reliabilities were sound: Taking Steps (α = .96), Recognition (α = .95) and 
Ambivalence (α = .87) (Miller & Tonigan, 1996). In addition to possessing fairly sound 
psychometric properties, the ease of administration and scoring, simplicity of 
interpretation, and fit within a motivational framework (Miller & Rollnick, 2002) made 
the SOCRATES a suitable motivational measure to include in the battery. As Miller and 
Tonigan (1996) noted, the SOCRATES also has clinical utility as a client feedback tool 
that can help initiate a discussion about motivation and readiness for change and provide 
a common language to talk about such topics. Alternative versions of the SOCRATES 
have also been created, included one examining drug use (SOCRATES-D). The items are 
worded exactly the same except for the references to alcohol are substituted with 
references to drugs. Although the drug version has not received adequate attention in the 
literature regarding its psychometric properties, the decision was made to incorporate this 
measure into the battery for clinical purposes. Again, it was anticipated that such 
information would assist clinicians in engaging clients into conversations about their 
level of motivation and readiness for change. Both of the versions of the SOCRATES 
exhibited excellent reliability in this study: Alcohol Recognition (α = .99); Alcohol 
Taking Steps (α = .99); Alcohol Ambivalence (α = .88); Alcohol Total (α = .98); Drug 
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Recognition (α = .99); Drug Taking Steps (α = .99); Drug Ambivalence (α = .91) Drug 
Total (α = .99). These high internal consistency estimates may be the byproduct of how 
face valid the SOCRATES questionnaire is. Anecdotally speaking, participants tended to 
answer in a consistent manner that reflected high treatment eagerness/motivation if they 
endorsed problems with alcohol and/or drugs (i.e., strongly agree with statements) or low 
treatment eagerness/motivation if they did not use that particular substance (i.e., strongly 
disagree with statements). 
Pretreatment Variables 
Table 3 outlines the primary variables that were explored in this study, the 
assessment instruments they were obtained from, and their respective levels of 
measurement. Pretreatment characteristics of interest were selected based on those 
identified in the TCU Treatment Model (Simpson, 2001, 2004).  The ASI domain 
composite scores were also included as they represent more global indicators of overall 
functioning that may be defining characteristics of this sample. 
 
 
Table 3. 
 
Pretreatment Characteristics 
 
Variable 
 
Instrument 
 
Level of Measurement 
 
Patient Attributes 
  
 
Age 
 
ASI 
 
Continuous 
 
Gender 
 
ASI 
 
Categorical 
 
Ethnicity 
 
ASI 
 
Categorical 
 
Marital Status 
 
 
ASI 
 
Categorical 
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Variable 
 
Instrument 
 
Level of Measurement 
 
Patient Attributes 
  
 
Education  
 
ASI 
 
Categorical 
 
Recent Monthly Employment Income  
 
ASI 
 
Continuous 
 
Substance Use Severity 
  
 
Substance Use in Past 30 days  
 
ASI 
 
Continuous 
 
Previous AODA Treatment 
 
ASI 
 
Categorical 
 
SUD  Diagnosis 
 
M.I.N.I. 
 
Categorical 
 
Total Drinking Days in Past 90  
 
Form 90 
 
Continuous 
 
Average Weekly SEC 
 
Form 90 
 
Continuous 
 
Peak BAC for Assessment Window 
 
Form 90 
 
Continuous 
 
Physical Consequences 
 
InDUC 
 
Continuous 
 
Interpersonal Consequences 
 
InDUC 
 
Continuous 
 
Intrapersonal Consequences 
 
InDUC 
 
Continuous 
 
Impulse Control Consequences 
 
InDUC 
 
Continuous 
 
Social Responsibility Consequences 
 
InDUC 
 
Continuous 
 
Psychiatric Symptom Severity 
  
 
Dual Diagnosis  
 
M.I.N.I. 
 
Categorical 
 
Previous Psychiatric Treatment 
 
ASI 
 
Categorical 
  
Been Prescribed Psychotropic(s) 
 
ASI 
 
Categorical 
 
History of Abuse 
 
 
 
 
ASI 
 
Categorical 
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Variable 
 
Instrument 
 
Level of Measurement 
 
Motivation – Alcohol Use 
  
 
Recognition 
 
SOCRATES-A 
 
Continuous 
 
Ambivalence 
 
SOCRATES-A 
 
Continuous 
 
Taking Steps 
 
SOCRATES-A 
 
Continuous 
 
Motivation – Drug Use 
  
 
Recognition 
 
SOCRATES-D 
 
Continuous 
 
Ambivalence 
 
SOCRATES-D 
 
Continuous 
 
Taking Steps 
 
SOCRATES-D 
 
Continuous 
 
General Functioning 
  
 
Medical Composite Score 
 
ASI 
 
Continuous 
 
Employment Composite Score 
 
ASI 
 
Continuous 
 
Alcohol Composite Score 
 
ASI 
 
Continuous 
 
Drug Composite Score 
 
ASI 
 
Continuous 
 
Legal Composite Score 
 
ASI 
 
Continuous 
 
Family/Social Composite Score 
 
ASI 
 
Continuous 
 
Psychiatric Composite Score 
 
ASI 
 
Continuous 
 
 
 
Treatment Variables 
 
The primary treatment variable of interest is treatment completion status. 
Treatment status completion was determined through a variety of methods. Clinicians 
were encouraged to record whether or not clients successfully completed treatment in the 
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program’s census log. However, this data was only available for approximately half of 
the participants. In the event that treatment completion status was not available, the two 
senior assessors accessed the client’s chart and examined the most recent treatment 
progress note(s) to determine treatment status. A client was considered a treatment 
completer if s/he met the majority of treatment goals, as identified by the treatment team, 
was discharged from the program with staff approval, and/or was transferred to a more or 
less intensive level of care. Examples of statements indicating treatment completion 
include: “patient completed treatment assignments and was given a medallion for 
completion of treatment;” “patient was discharged today with staff approval and is seen 
as reaching maximum benefit in treatment;” and “patient discussed her discharge plans 
with group, received feedback from peers, and received her medallion.” On the contrary, 
a client was considered a treatment dropout if s/he did not complete the majority of 
treatment goals and/or was discharged from the program without staff approval. 
Examples of statements indicating treatment dropout include: “patient needs to complete 
the last two assignments in the group and also needs to obtain a temporary sponsor;” 
“patient was discharged due to noncompliance;” and “patient seems disinterested in the 
group, coming in late, on the phone during breaks and away from peers, no meeting 
attendance, and no assignment completion.” Clinicians were also consulted to review 
client charts (n = 12) in situations where the two senior assessors were unable to 
determine if a client successfully completed treatment based on the outlined criteria. The 
treatment status criteria in this study were similar to those outlined in previous treatment 
retention research (Mammo & Weinbaum, 1993; Veach et al., 2000). 
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In accordance with efforts to accurately and adequately describe the treatment 
characteristics of the current sample, the dichotomous treatment status variable was 
expanded to include two additional classifications: treatment stopouts (i.e., treatment 
dropouts who returned for subsequent treatment at the same facility) and treatment 
repeaters (i.e., treatment completers who returned for subsequent treatment at the same 
facility). To determine whether or not clients were stopouts or repeaters, the two senior 
assessors accessed client charts and checked if they were readmitted to the treatment 
facility for inpatient and/or outpatient treatment following their discharge from the main 
treatment episode examined in this study. The designated period that stopouts and 
repeaters were identified was the day following discharge through September, 15, 2007. 
Number of treatment sessions and duration of treatment (i.e., number of days between 
admission and discharge) were also examined to further depict the nature of treatment 
participants received. Treatment characteristics of interest were selected based on 
treatment information available to the researchers. 
Data Analyses 
Sample Characteristics 
All statistical analyses were performed with the Statistical Package for the Social 
Sciences (SPSS). Descriptive statistics (e.g., frequencies, modes, means, and standard 
deviations) were conducted on identified pretreatment and treatment variables to describe 
the basic characteristics of this sample of clients entering an intensive outpatient chemical 
dependency treatment program at Roger Memorial Hospital – West Allis. Considering 
the aforementioned data collection obstacles that were encountered while carrying out 
this research project, the obtained sample may not be representative of the actual 
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chemical dependency treatment-seeking population at this facility. Thus, demographic 
variables and treatment information were obtained for those clients who were not tested 
at intake and subsequently excluded from the investigation (N = 171). Comparative 
analyses were conducted between these persons and the study participants in order to 
determine the equivalency of the obtained sample to the overall population from which it 
was drawn. These results will help to ascertain the generalizability of study findings.  
Treatment Completers vs. Treatment Dropouts 
In order to determine how clients who completed this treatment program differ 
from clients who dropped out prematurely on identified pretreatment variables (research 
question 1), comparative analyses between treatment completers and dropouts were 
performed. Analyses were selected based on the level of measurement of the variables. 
Chi-square analyses were carried out on the categorical variables, and continuous ASI 
variables were examined using independent samples t-tests. Considering the mixed 
evidence regarding how pretreatment characteristics relate to treatment completion status, 
the null hypothesis in each of these tests was that the measure of central tendency (e.g., 
mode, median) is equivalent for treatment completers and dropouts. Groups were 
considered to be significantly different if p < .05. Standardized expected cell residuals 
greater than 1 or less than -1 were used to detect significant cell effects for chi-square 
analyses. 
Continuous variables deduced from the InDUC, Form 90, SOCRATES-A, and 
SOCRATES-D and previous 30-day use of alcohol, opiates, cocaine, and marijuana, the 
most used substances in this sample, were explored using profile analysis. Variables were 
grouped together based on the assessment instrument they were derived from and a 
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separate profile analysis was conducted on each group of instrument variables. By 
grouping the variables in this manner, the clinical utility of this project was enhanced 
because the results of the analyses could potentially be used to assist the treatment 
program in determining if and how the assessment instruments are able to differentiate 
between clients who go on to complete the treatment program and those who drop out of 
the program prematurely. Utilizing such empirically-based methods in adapting the 
intake evaluation process and selecting assessment instruments can aide treatment 
program improvement efforts and, in the end, enhance the program’s retention rates and 
positive treatment outcomes. Raw scores on the InDUC, Form 90, SOCRATES-A, and 
SOCRATES-D were first converted to standardized z scores and then transformed into T 
scores (10z + 50). Outliers were subsequently recoded. Scores deviating from the mean 
by more than 3 standard deviations were recoded to be either 3 standard deviations above 
(T = 80) or below (T = 20) the mean (n = 16). Responses on the ASI previous 30-day use 
variables were all on the same scale (i.e., 0 – 30 days), thus no transformation was 
necessary. 
Identification of Subgroups 
Cluster analysis was conducted to determine if meaningful subgroups of this 
sample could be identified based on important pretreatment characteristics and treatment 
variables (research question 2). Cluster analysis is the general term used to describe a 
class of multivariate techniques whose primary purpose is to assemble objects (e.g., 
participants) based on the characteristics they possess with respect to predetermined 
selection criterion. If classification is successful, the clusters should exhibit high within-
cluster homogeneity and high between-cluster heterogeneity. The three primary 
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objectives of cluster analysis include taxonomy description, data simplification, and 
relationship identification, making it an appropriate technique for use in this study based 
on the identified research questions (Hair & Black, 2000). Dennis, Perl, Huebner, and 
McLellan (2000) indicated that cluster analysis is a recommended analytical method for 
exploring questions regarding who is being served and identifying major client 
subgroups, one of the primary aims of this investigation.   
The cluster analysis in the present study was exploratory in nature. The selection 
of variables, as opposed to the actual methods utilized, may have the strongest impact on 
the results of a classification study, thus careful consideration was undertaken in the 
selection process (Peters, 1997). In addition to appraising the available empirical 
evidence, the utility of the potential interpretation of results in comprehensively capturing 
the complexity of the sample was heavily weighted. Ultimately, age,  ASI composite 
scores, and InDUC subscale scores were chosen as the variables to be included in the 
cluster analysis. It was deemed that these characteristics appeared to be an adequate 
snapshot of participant functioning across multiple domains and had potential to produce 
a parsimonious grouping scheme with applied value in the treatment process (i.e., 
identification of treatment needs at the outset of treatment).  
The specific clustering procedure employed in this study was Ward's method 
(Ward, 1963). Ward’s method is a hierarchical agglomerative clustering technique 
wherein each case starts as its own cluster, and similar clusters are sequentially merged 
until all cases are in one cluster. For each cluster, the means of all variables are calculated 
and then the squared Euclidean distance (i.e., the geometric proximity between two 
cases) to the cluster means is calculated. These distances are then summed for all of the 
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cases within the hypothetical cluster. At each step, the two clusters that merge are those 
that result in the smallest increase in the overall sum of the squared Euclidean distances. 
In other words, clusters are merged so as to minimize the variability within the cluster 
(Borgen & Barnett, 1985; Norusis, 2006). The agglomeration schedule, the dendogram, 
and interpretability of identified clusters were considered in determining the adequacy of 
potential cluster solutions (Clatworthy, Buick, Hankins, Weinman, & Horne, 2005; 
Norusis, 2006). More specifically, the agglomeration coefficient is a dissimilarity 
measure wherein small values suggest that the clusters being combined are fairly 
homogeneous, whereas larger values indicate that fairly dissimilar clusters are being 
combined. The dendogram is a visual representation of how clusters are combined. It is 
read from left to right, with vertical lines demarcating joined clusters. A large distance 
between sequential vertical lines is used to determine at what stage the distances between 
the combined clusters is large (Norusis, 2006). Concurrent and predictive validation 
procedures (e.g., ANOVA, chi-square test) were also completed to demonstrate how the 
identified clusters relate to a range of variables (i.e., demographic characteristics, 
substance use history, psychiatric status, motivation, treatment attributes) that were not 
included in the cluster analysis.  
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Chapter IV: Results 
 
 
 
Overview 
 This chapter details the results of statistical analyses completed. It begins with a 
discussion of how missing data was handled and then delineates how the obtained sample 
compares to the larger population from which is was drawn. Sample characteristics are 
then described, along with significant differences between treatment completers and 
treatment dropouts on these characteristics. Finally, results of the cluster analysis are 
outlined. 
Missing Data 
 How to handle missing data is a common dilemma a researcher encounters as the 
improper handling of missing values can distort statistical analyses and produce a 
remaining data set that is biased. Completing a missing value analysis can help address 
such concerns, thus a qualitative analysis of the missing data was conducted. The data set 
in this study originally contained a total of 298 cases. Upon further examination, 13 cases 
evidenced missing data points due to computer problems wherein responses on the 
InDUC or SOCRATES were lost electronically and could not be retrieved. An additional 
11 cases evidenced missing data points due to incomplete data gathering wherein the 
information collected was not sufficient to make a diagnosis on the M.I.N.I. or to 
compute summary Form 90 statistics (e.g., days of drinking, weekly SEC, Peak BAC) on 
the Form 90. One more case had the race/ethnicity response missing from the ASI. These 
missing data points were spread out across time, variables, and assessors.  Taken 
together, these observations provide evidence to support the decision to classify it as 
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missing completely at random (Allison, 2002). Consequently, listwise deletion, as 
opposed to an imputation method, was chosen to handle the missing data in this study. 
Furthermore, listwise deletion produced a relatively small drop in sample size (8.4%), so 
although statistical power was slightly reduced, the estimated parameters were likely not 
biased by the absence of this data. 
Generalizability 
As previously mentioned, a variety of practical difficulties interfered with the 
assessment team’s ability to evaluate each new client in the treatment program (e.g., 
timing of new client notification, space constraints, inconsistent client attendance at 
treatment groups). In recognition of the fact that the obtained sample (N = 273) may not 
be representative of the actual substance abuse treatment-seeking population at this 
facility, demographics and treatment information were obtained for those clients who 
were not assessed at intake and consequently excluded from the study (N = 171). The 
average age of the entire population (N = 444) was 38.78 years (SD = 12.00). A majority 
were males (62.4%). With regards to ethnicity and race, 84.5% identified as Caucasian, 
9.2% identified as African, 3.5% identified as Hispanic, 1.6% identified as a Native 
American or Alaska Native, and 1.1% identified as Asian or Pacific Islander. The overall 
treatment completion rate was 49%. On average, individuals attended 12.18 group 
treatment sessions (SD = 6.64) and stayed in treatment for just over 3 weeks (M = 22.67 
days, SD = 13.95).  
Comparative analyses were conducted in order to determine the equivalency of 
the obtained sample to the overall population from which it was drawn to help inform the 
generalizability of study findings. Results indicated that study participants and excluded 
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individuals did not significantly differ on sociodemographic characteristics including 
gender, χ2(1, N = 444) = 0.00, p  = .95, and race, χ2(1, N = 444) = 4.71, p  = .32; 
however, treatment participants were significantly older (M = 39.77, SD = 11.80) than 
those who did not participate in the study (M = 37.20, SD = 12.18), t(442) = -2.21, p  = 
.03. Significant differences were also detected on all three treatment variables. Study 
participants were more likely to complete treatment as compared to individuals who were 
not evaluated, χ2(1, N = 444) = 28.94, p < .001. They also attended more treatment 
groups on average (M = 14.19, SD = 5.06) than individuals who were not included in the 
study (M = 8.99, SD = 7.56), t(442) = -7.95, p < .001, and generally stayed in treatment 
for more days (M = 27.05, SD = 11.39) than nonparticipants (M = 15.68, SD = 14.83), 
t(442) = -8.56, p < .001.  
Sample Characteristics 
See Table 4 for sample characteristics. Of the total sample (N = 273), 62.3% were 
male, 86.4% were Caucasian, 44.7% were married, and 91.6% had at least 12 years of 
education. The mean age of the sample was 39.77 years (SD = 11.80). The average 
amount of money earned from employment in the past month was $1977 (SD = 2948). 
This estimate appeared to be impacted by a few participants (n = 6) who earned more 
than $10,000 in the past month. The median monthly income for was $1200. Of the total 
sample, 68.1% had participated in prior substance abuse treatment, 58.1% had received 
previous treatment for psychological problems, and 64.5% had been prescribed 
psychotropic medications. Furthermore, 60.8% of the sample had experienced some type 
of physical, emotional, and/or sexual abuse. Fifty-nine percent of the sample completed 
the treatment program, while 41.0% dropped out prematurely. Again, this estimate 
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represents higher estimate than was found for the population from which the sample was 
drawn (49%). Of the treatment dropouts in the study sample, 25.0% returned for a 
subsequent treatment episode (i.e., treatment stopout), while 18.6% of treatment 
completers also returned for additional treatment at a later date (i.e., treatment repeater). 
Altogether, just over 20% of the study sample returned for a subsequent treatment 
episode in the same program. The number of treatment days for the study sample ranged 
from 2 to 27 days, with an average of 14.2 (SD = 5.1). Total treatment duration for the 
study sample ranged from 1 day to 78 days, with an average of 27.1 (SD = 11.4). 
 
 
Table 4. 
 
Participant Characteristics by Treatment Completion Status 
  
Treatment Completion Status 
 
 
 
Characteristic 
 
Completer 
(n = 161) 
 
Dropout 
(n = 112) 
 
Total Sample 
(N = 273) 
 
Age (M ± SD) 
 
42.32 ± 11.00 
 
36.10 ± 11.98** 
 
39.77 ± 11.80 
 
Gender (%) 
     Male 
     Female 
 
 
63.4 
36.6 
 
 
60.7 
39.3 
 
 
62.3 
37.7 
 
Ethnicity (%) 
     Caucasian 
     African American 
     Native American/Alaska Native 
     Hispanic 
     Asian/Pacific Islander 
 
 
87.6 
8.7 
1.2 
2.5 
0.0 
 
 
84.8 
8.0 
1.8 
4.5 
0.9 
 
 
86.4 
8.4 
1.5 
3.3 
0.4 
 
Marital Status (%) 
     Married 
     Widowed 
     Separated 
     Divorced  
     Never Married 
 
 
52.8 
1.9 
1.9 
17.4 
26.1 
 
 
33.0* 
0.0 
4.5 
17.9 
44.6* 
 
 
44.7 
1.1 
2.9 
17.6 
33.7 
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Characteristic 
 
Completer 
(n = 161) 
 
Dropout 
(n = 112) 
 
Total Sample 
(N = 273) 
 
Education (%) 
     Less than HS 
     HS  
     More than HS 
 
 
6.8 
32.9 
60.2 
 
 
10.7 
42.0 
47.3 
 
 
8.4 
36.6 
54.9 
 
Recent Monthly Employment Income  
 
$2298 ± 3483 
 
$1517 ± 1856* 
 
$1977 ± 2948 
 
Previous AODA Treatment (%) 
 
67.7 
 
68.8 
 
68.1 
 
Previous Psych Treatment (%) 
 
53.4 
 
66.1* 
 
58.6 
 
Been Prescribed Psychotropic(s) (%) 
 
61.5 
 
68.8 
 
64.5 
 
Been Emotionally, Psychologically, 
or Sexually Abused (%) 
 
 
59.6 
 
 
62.5 
 
 
60.8 
* p < .05. ** p < .001. 
 
 
 
In the 30 days prior to the day the assessment was conducted, nearly 80% of the 
sample had used alcohol, 30.8% had used marijuana, almost one-fourth had used a form 
of cocaine, 20.2% had used opiates (e.g., Percocet, Vicadin), 10.3% had used sedatives 
(e.g., Xanax, Valium), 5.9% had used heroin, 2.2% had used amphetamines (e.g., 
Methamphetamine, Ritalin), 2.2% had used a hallucinogen (e.g., LSD, mushrooms), and 
1.5% used barbiturates (e.g., Phenobarbital, Nembutal). It should be noted that 
prescription drug use was only counted above if participants did not use them as 
prescribed (i.e., took twice as much pain medication as was advised).  
Nearly the entire sample (97.4%) met criteria for at least one substance use 
disorder: 48.4% met criteria for only an alcohol use disorder, 23.4% met criteria for only 
a drug use disorder(s), and 25.6% met criteria for both an alcohol and a drug use 
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disorder(s). This diagnostic information was gathered from a self-report instrument 
(M.I.N.I.), thus participants may not have endorsed questions that would qualify for a 
substance abuse or dependence diagnosis, despite seeking treatment for substance use 
problems. With reference to comorbid psychological problems, over half of the sample 
met criteria for at least one substance use disorder and at least one comorbid 
psychological disorder (51.6%). See Table 5 for a breakdown of the most common Axis I 
diagnostic categories that participants met criteria for. It should be noted that one-third of 
the sample also reported having suicidal thoughts.  
 
 
Table 5. 
 
Prevalence of Axis I Disorders by Treatment Completion Status (%) 
  
Treatment Completion Status 
 
 
 
Diagnostic Category 
 
Completer 
(n = 161) 
 
Dropout 
(n = 112) 
 
Total Sample 
(N = 273) 
 
Depression 
 
37.9 
 
49.1 
 
42.5 
 
Anxiety (PTSD, OCD, Panic, Social) 
 
21.1 
 
39.3* 
 
28.6 
 
Alcohol 
 
76.4 
 
70.5 
 
74.0 
 
Marijuana 
 
13.0 
 
17.0 
 
14.7 
 
Opiate 
 
15.5 
 
25.9* 
 
19.8 
 
Cocaine  
 
14.9 
 
32.1* 
 
22.0 
 
SUD Diagnosis  
     No Diagnosis 
     Alcohol Only 
     Drug(s) Only 
     Alcohol and Drug(s) 
 
 
 
 
3.1 
57.1 
20.5 
19.3 
 
 
1.8 
35.7* 
27.7 
34.8* 
 
 
2.6 
48.4 
23.4 
25.6 
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Diagnostic Category 
 
Completer 
(n = 161) 
 
Dropout 
(n = 112) 
 
Total Sample 
(N = 273) 
 
Dual Diagnosis 
     No Diagnosis 
     SUD Only 
     Dual Diagnosis 
 
 
3.7 
51.6 
44.7 
 
 
1.8 
36.6* 
61.6* 
 
 
2.9 
45.4 
51.6 
* p < .05. 
 
 
 
Treatment Completers vs. Dropouts 
Consult Table 4 and Table 5 for results of comparative analyses between 
participants who completed treatment and those who dropped out of treatment 
prematurely. Standardized expected cell residuals greater than 1 or less than -1 were used 
to detect significant cell effects for chi-square analyses. Treatment completers (M = 
42.32, SD = 11.00) were significantly older than treatment dropouts (M = 36.10, SD = 
11.98), t(271) = -4.37, p < .001, and earned significantly more income from employment 
in the past 30 days (M = 2298, SD = 3483) than treatment dropouts (M = 1517, SD = 
1856), t(271) = -2.40, p = .017. Treatment completers were more likely to be married 
(52.8%) than their counterparts (30.0%), while treatment dropouts were more likely to 
never have been married (44.6%) as compared to treatment completers (26.1%),  χ2(4, N 
= 273) = 16.14, p = .003.  
Treatment dropouts were significantly more likely to have participated in previous 
psychological treatment (66.1%) than participants who completed treatment (53.4%), 
χ
2(1, N = 273) = 4.36, p = .037. Diagnostically speaking, treatment completers were 
significantly more likely to have met criteria for only an alcohol use disorder and 
significantly less likely to meet criteria for both an alcohol and at least one drug use 
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disorder than their counterparts who did not complete treatment, χ2(3, N = 273) = 14.42, 
p = .002. Treatment dropouts were significantly more likely to meet criteria for an opiate 
use disorder, χ2(1, N = 273) = 4.47, p = .034, and/or a cocaine use disorder, χ2(1, N = 
273) = 11.44, p = .001. Treatment dropouts also met criteria for both a substance use 
disorder and a comorbid Axis I psychological disorder at higher rates than treatment 
completers, χ2(2, N = 273) = 7.74, p = .021. In particular, treatment dropouts were more 
likely to endorse diagnostic criteria for an anxiety disorder (e.g., obsessive-compulsive 
disorder, social anxiety, post-traumatic stress disorder, and/or panic disorder) than 
treatment completers, χ2(1, N = 273) = 10.68, p = .001. 
Treatment completers attended significantly more treatment groups (M = 16.29, 
SD = 3.54) than treatment dropouts (M = 11.17, SD = 5.40), t(271) = -8.80, p < .001. 
Furthermore, the total duration of treatment for completers was an average of at least 11 
days longer (M = 31.63, SD = 9.52) than dropouts (M = 20.46, SD = 10.65), t(271) = -
8.90, p < .001.  
Profile Analysis 
Profile analysis was conducted to further compare participants who completed 
treatment to participants who dropped out of treatment. A separate profile analysis was 
performed on the selected variables from the following instruments: InDUC, Form 90, 
SOCRATES-A, SOCRATES-D, and ASI. Raw scores on the InDUC, Form 90, 
SOCRATES-A, and SOCRATES-D were first converted to standardized z scores and 
then transformed into T scores (10z + 50). Outliers were subsequently recoded. Scores 
deviating from the mean by more than 3 standard deviations were recoded to be either 3 
standard deviations above (T = 80) or below (T = 20) the mean (n = 16). Responses on 
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the ASI previous 30-day use variables were all on the same scale (i.e., 0 – 30 days), thus 
no transformation was necessary. 
For each profile analysis, two statistical tests were executed to allow for 
comparison of the means of completers and dropouts on the variables of interest, as well 
as the comparison of the pattern of means across each assessment measure (Norusis, 
2006). The parallelism test deduces whether the pattern of means on the variables is the 
same between groups. A multivariate analysis of variance (MANOVA) was executed and 
the parallelism null hypothesis was rejected if a significant group by dependent variable 
interaction effect was detected. Wilks' lambda, the test statistic of interest, is a direct 
measure of the proportion of variance in the combination of dependent variables that is 
unaccounted for by the independent variable (i.e., treatment completion status). The 
equal levels test explores main effects and examines whether one group scored higher, on 
average, across variables on a particular instrument.  
Analyses of parallelism of each assessment measure produced only one 
statistically significant interaction effect. Pattern of performance on the InDUC showed a 
statistically significant difference between treatment completers and dropouts Wilks' Λ = 
.69, F (1, 271) = 2.47, p = .045, η2 = .31. See Figure 2. Higher T scores reflect the 
experience of more negative consequences. More specifically, treatment dropouts 
experienced more negative consequences related to fulfilling social responsibilities (M = 
51.68, SD = 9.37) as compared to their counterparts who completed treatment (M = 
48.83, SD = 10.27), t(271) = 2.37, p = .019.   
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Figure 2. Comparison of InDUC subscale scores. 
 
 
 
 Analyses of equal levels, or main effects, produced statistically significant results 
on two of the assessment measures. Treatment dropouts had significantly higher average 
scores than treatment completers across SOCRATES-D subscales (F (1, 271) = 13.43, p 
< .001), indicating that dropouts demonstrated higher levels of drug problem recognition, 
endorsed a higher degree of ambivalence about changing their drug use, and reported 
they were taking more steps to reduce their drug use. Treatment dropouts also reported 
more days of recent (i.e., past 30 days) alcohol, opiates, cocaine, and marijuana use as 
measured by the ASI, (F (1, 271) = 12.25, p = .001). See Figure 3 and Figure 4 for 
profiles. 
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Figure 3. Comparison of SOCRATES-D subscale scores. 
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Figure 4. Comparison of substance use in the 30 days prior to date of evaluation. 
 
 
 
Identification of Subgroups 
Cluster Analysis 
 Age, ASI composite scores, and InDUC subscale scores were selected as the 
variables to be included in the cluster analysis as they appeared to be a comprehensive 
snapshot of participant functioning across multiple domains at the outset of treatment. 
These variables also had potential to produce a parsimonious grouping scheme with 
clinical value in the treatment planning process by determining prominent areas of 
concern for specific subtypes of clients. The hierarchical agglomerative clustering 
technique known as Ward's method (Ward, 1963) was employed to identify a cluster 
solution. The agglomeration schedule and dendogram were examined to ascertain the 
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most appropriate cluster solution (Clatworthy et al., 2005; Norusis, 2006). More 
specifically, potential cluster solutions were denoted by a prominent increase in the 
agglomeration coefficient as compared to preceding increases. The “jump” between stage 
269 and 270 suggested a greater degree of dissimilarity of clusters being combined at this 
stage as compared to previous stages (see Table 6). The dendogram was also inspected, 
though the figure was too extensive to depict visually. A large distance between 
sequential vertical lines was the marker used to determine what stage the distances 
between the combined clusters was large and that a prospective clustering solution was 
found (Norusis, 2006). Based on these objective indicators, a four-cluster solution was 
identified.  
 
 
Table 6. 
 
Cluster Analysis Agglomeration Schedule 
 
Stage 
 
Agglomeration Coefficient 
 
Coefficient Difference Between Stages 
 
266 2172.02 - 
 
267 2295.48 123.46 
 
268 2427.91 132.43 
 
269 2567.47 139.56 
 
270 2761.16 193.69 
 
271 3008.83 247.66 
 
272 3536.00 527.17 
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The cluster solution is depicted in Table 7 and Table 8. The clusters range in size 
from 51 to 87 participants. The interpretation of each cluster and corresponding label 
were deduced primarily from the pattern of composite score means across ASI domains 
and extent of substance use-related consequences noted on the InDUC. ASI composite 
scores range from 0 to 1, with higher scores reflecting more severe problems. Higher 
scores on the InDUC subscales also reflect more extensive problems in an area. 
 
 
Table 7. 
 
Mean (SD) Age and ASI Composite Scores for Cluster Solution 
 
 
 
 
 
 
Domain 
Pervasive 
Concerns 
Polysubstance 
Use Disorder 
(n = 73) 
 
Serious 
Concerns 
Alcohol 
Use 
Disorder 
(n = 87) 
Moderate 
Concerns 
Drug Use 
Disorder 
(n = 51) 
Minimal 
Concerns 
Alcohol 
Use 
Disorder 
(n = 62) 
Total 
Sample 
(N = 273) 
 
Age 
 
36.62 
(9.23) 
43.92 
(9.74) 
33.14 
(12.41) 
43.11 
(13.28) 
39.78 
(11.80) 
 
Medical .41 (.39) .18 (.25) .09 (.13) .25 (.28) 
 
.24 (.31) 
 
Employment .46 (.25) .36 (.24) .23 (.22) .22 (.18) 
 
.33 (.28) 
 
Alcohol .33 (.30) .61 (.18) .10 (.11) .44 (.23) 
 
.40 (.29) 
 
Drug .21 (.13) .04 (.09) .26 (.08) .03 (.06) 
 
.13 (.14) 
 
Legal .12 (.19) .15 (.22) .08 (.14) .04 (.10) 
 
.10 (.18) 
 
Family/Social .38 (.25) .23 (.21) .26 (.23) .17 (.20) 
 
.26 (.24) 
 
Psychiatric .48 (.21) .32 (.25) .27 (23) .24 (.23) 
 
.33 (.25) 
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Table 8. 
 
Mean (SD) InDUC Subscale Scores for Cluster Solution 
 
 
 
 
 
 
Subscale  
 
 
 
 
 
 
Items 
Pervasive 
Concerns 
Polysub. 
Use 
Disorder 
(n = 73) 
 
Serious 
Concerns 
Alcohol 
Use 
Disorder 
(n = 87) 
Moderate 
Concerns 
Drug Use 
Disorder 
(n = 51) 
Minimal 
Concerns 
Alcohol 
Use 
Disorder 
(n = 62) 
Total 
Sample 
(N = 273) 
Physical 8 
 
6.63 
(1.26) 
5.83  
(1.82) 
5.1 
(1.70) 
3.1 
(1.70) 
5.29 
(2.08) 
Interpersonal 10 
 
8.27 
(1.59) 
7.18  
(2.18) 
6.24 
(2.28) 
4.32  
(2.27) 
6.65 
(2.52) 
Intrapersonal 8 
 
7.60 
(.88) 
7.29  
(1.01) 
6.67 
(1.57) 
4.65  
(2.35) 
6.66 
(1.87) 
Impulse 
Control 12 
 
8.00 
(2.50) 
7.31  
(2.56) 
5.24 
(2.02) 
3.37  
(1.92) 
6.21 
(2.93) 
Social 
Responsibility 7 
 
6.25 
(1.06) 
5.05  
(1.58) 
5.06 
(1.70) 
2.5 
(1.56) 
4.79 
(1.99) 
  
 
 
 The pervasive concerns polysubstance use disorder cluster was characterized by 
the highest average medical, employment, family/social, and psychiatric composite 
scores, paired with considerable alcohol and drug composite score elevations. Cluster 
members reported experiencing more substance use-related consequences across InDUC 
subscales (e.g., physical, interpersonal, intrapersonal, impulse control, and social 
responsibility) than their counterparts, and their age fell below the sample mean by about 
three years (M = 36.62 years). Conversely, the minimal concerns alcohol use disorder 
cluster had the lowest drug, legal, family/social, and psychiatric composite scores, paired 
with the second highest average alcohol and medical composite scores. Members of this 
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category endorsed the fewest number of substance-use related consequences, and their 
age was above the sample mean by about three years (M = 43.11 years). The mean age of 
the serious concerns alcohol use disorder group (M = 43.92 years) was comparable to 
their fellow primary alcohol users. This particular cluster evidenced the most severe 
alcohol and legal problems, significant employment and psychiatric problems (i.e., 
second highest average), and ranked second across InDUC subscales of substance-use 
related consequences. The final cluster, moderate concerns drug use disorder, were the 
youngest cluster (M = 33.14 years) and exhibited the highest average drug composite 
score and significant family/social problems. InDUC subscale scores were third in rank 
compared to the other clusters.    
Validity of the Identified Cluster Solution 
Table 9 presents a summary of the concurrent and predictive validation analyses 
examining the four-cluster solution across a variety of variables: demographics, 
diagnosis, psychiatric status, substance use, motivation for treatment, and treatment 
characteristics. Chi-square tests (χ2) were executed for categorical variables and one-way 
analysis of variance (ANOVA) tests were executed for continuous variables. For χ2 tests, 
standardized expected cell residuals greater than 1 or less than -1 were used to detect 
statistically significant cell effects (i.e., significantly more or fewer observations than 
would be expected by chance alone). For ANOVA tests, Tukey’s HSD post hoc 
comparisons were executed to determine if a cluster was significantly different from any 
other cluster(s). Due to the large number of comparisons statistical tests being 
undertaken, the p value was adjusted with the Bonferroni method to control for type I 
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error. A total of 17 tests were completed, thus values of p < .003 (i.e., .05/17) were 
considered significant.  
 
 
Table 9. 
Cluster Validation Results 
 
 
 
 
 
 
Variable 
Pervasive 
Concerns 
Polysub. 
Use 
Disorder 
(n = 73) 
 
Serious 
Concerns 
Alcohol 
Use 
Disorder 
(n = 87) 
Moderate 
Concerns 
Drug Use 
Disorder 
(n = 51) 
Minimal 
Concerns 
Alcohol 
Use 
Disorder 
(n = 62) 
 
 
 
 
 
 
Statistic 
 
Gender 
     
χ
2 
= 1.66 
 
Ethnicity  
     
χ
2 
= 19.89 
 
Marital Status 
     Married  
     Widowed  
     Separated  
     Divorced  
     Never Married  
 
 
 
 
+ 
 
 
 
 
- 
- 
+ 
- 
 
 
- 
 
 
 
 
 
+ 
 
- 
+ 
 
χ
2 
= 40.55 
p < .001 
 
Education  
     
χ
2 
= 21.62 
 
Depressive Disorder 
 
+ 
   
- 
 
χ
2 
= 33.94 
p < .001 
 
Anxiety Disorder  
 
 
 
 
 
 
 
 
 
 
χ
2 
= 12.51 
 
Alcohol Disorder  
 
- 
 
+ 
 
- 
 
+ 
 
χ
2 
= 80.07 
p < .001 
 
Marijuana Disorder  
 
+ 
 
- 
 
+ 
 
- 
 
χ
2 
= 19.39 
p < .001 
 
Opiate Disorder  
 
 
 
+ 
 
- 
 
+ 
 
- 
 
χ
2 
= 75.89 
p < .001 
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Variable 
Pervasive 
Concerns 
Polysub. 
Use 
Disorder 
(n = 73) 
 
Serious 
Concerns 
Alcohol 
Use 
Disorder 
(n = 87) 
Moderate 
Concerns 
Drug Use 
Disorder 
(n = 51) 
Minimal 
Concerns 
Alcohol 
Use 
Disorder 
(n = 62) 
 
 
 
 
 
 
Statistic 
 
Cocaine Disorder  
 
+ 
 
- 
 
+ 
 
- 
 
χ
2 
= 30.52 
p < .001 
 
SUD Diagnosis      
     Alcohol Only  
     Drug(s) Only  
     Alcohol + Drug(s)  
 
 
- 
+ 
+ 
 
 
+ 
- 
- 
 
 
- 
+ 
 
 
 
+ 
- 
- 
 
χ
2 
= 168.38 
p < .001 
 
Dual Diagnosis  
     SUD only 
     SUD + Psychiatric 
 
 
- 
+ 
 
 
 
 
 
 
+ 
- 
 
χ
2 
= 47.22 
p < .001 
 
SOCRATES-Alcohol 
Total Motivation Score 
 
- 
+ 
 
+ 
 
 
- 
- 
 
- 
+ 
 
χ
2 
= 56.16 
p < .001 
 
SOCRATES-Drug Total 
Motivation Score 
 
+ 
 
- 
 
+ 
 
- 
 
χ
2 
= 79.96 
p < .001 
 
Total Drinking Days in 
Past 90  
 
- 
+ 
 
+ 
+ 
 
 
- 
 
+ 
+ 
 
χ
2 
= 37.18 
p < .001 
 
Average Weekly SEC 
 
+ 
 
+ 
+ 
 
- 
 
 
 
- 
 
χ
2 
= 16.42 
p < .001 
 
Peak BAC for 
Assessment Window 
 
+ 
 
+ 
+ 
 
- 
 
 
 
- 
 
F = 21.44  
p < .001 
 
Treatment Completion 
Status 
     
χ
2 
= 6.44 
 
Treatment Days 
    F = 4.45 
 
Treatment Duration 
    F = 3.01 
Note. Directions of significant effects are indicated using plus and minus signs. For χ2 a plus sign in a 
column indicates that for that cluster, the observed frequency is significantly greater than what would be 
expected by chance alone, and vice versa for a minus sign. For ANOVA, lines should be interpreted 
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horizontally, one line at a time. A plus sign indicates that the mean value of that cluster is greater than the 
mean value(s) of the cluster(s) denoted by the minus sign. 
 
 
 
Concurrent validation procedures provided evidence in support of a four-cluster 
solution, as results revealed that most of the observed relationships were in the 
anticipated direction. Substance use disorder diagnostic categories coincided with the 
primary substance(s) of use of each group. For example, the serious concerns and 
minimal concerns alcohol use disorder groups were more likely to meet diagnostic 
category for only an alcohol use disorder than their moderate concerns drug use disorder 
and pervasive concerns polysubstance use disorder counterparts. The opposite pattern 
was detected for marijuana, cocaine, and opiate use disorder diagnoses: the pervasive 
concerns polysubstance use and moderate concerns drug use disorder clusters were more 
likely to meet criteria for these drug-use disorders than the clusters that primarily used 
alcohol. Furthermore, the pervasive concerns polysubstance use disorder cluster was 
more likely to meet criteria for both an alcohol and at least one drug use disorder, while 
the moderate concerns drug use disorder cluster was more likely to meet criteria for only 
a drug use disorder.  
Frequency of drinking also corresponded to primary substance(s) of use. The two 
alcohol use disorder clusters tended to drink on more days in the 90 days prior to 
treatment than the polysubstance and drug use disorder groups, and the polysubstance 
use disorder cluster drank on more days than the drug use disorder cluster. A slightly 
different pattern emerged for drinking severity indicators. The serious concerns alcohol 
use disorder cluster drank significantly more drinks on a weekly basis and had a higher 
peak BAC during the assessment window than their minimal concerns alcohol use 
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disorder and moderate concerns drug use disorder counterparts. The pervasive concerns 
polysubstance use disorder cluster exhibited a higher average weekly consumption rate 
and a higher peak BAC than the moderate concerns drug use disorder group. 
Level of motivation to change alcohol use and drug use, as measured by a total 
score on the SOCRATES (i.e., higher scores reflect a higher level of motivation to 
change), coincided with group membership. The serious concerns alcohol use disorder 
displayed higher levels of motivation to change their alcohol use than all other groups, 
and the moderate concerns drug use disorder and pervasive concerns polysubstance use 
disorder groups endorsed higher levels of motivation to change their drug use than the 
alcohol use disorder clusters. As evidenced by their labels, the pervasive polysubstance 
use disorder cluster was more likely to be meet criteria for a comorbid psychiatric 
disorder, specifically a depressive disorder, while the minimal concerns alcohol use 
disorder cluster was less likely to meet criteria for a concurrent psychiatric disorder. 
 In addition to examining relationships with concurrent variables, the identified 
clusters were also compared to treatment variables including treatment completion status, 
number of treatment days, and treatment duration to explore the predictive validity of the 
identified cluster solution. No significant statistical findings emerged, though trends were 
detected in the anticipated direction based on the treatment retention literature suggesting 
that clients with alcohol use disorders tend to complete substance abuse treatment at 
higher rates than clients with drug use or polysubstance use disorders (De Leon et al., 
1997; Joe et al., 1999; McKellar et al., 2006). The moderate concerns drug use disorder 
cluster was the only cluster wherein the majority of members did not complete treatment. 
The retention rate for this cluster was 45.1%, compared to 67.7% for minimal concerns 
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alcohol use disorder, 62.1% for serious concerns alcohol use disorder, and 57.5% for 
pervasive concerns polysubstance use disorder. The moderate concerns drug use 
disorder cluster also had the lowest mean number of treatment days (M = 12.94, SD = 
5.05) and shortest average treatment duration (M = 23.98, SD = 11.50), while the serious 
concerns alcohol use disorder cluster had the highest mean number of treatment days (M 
= 15.75, SD = 4.39) and longest average treatment duration (M = 29.52, SD = 9.88). 
Again, these differences were not statistically significant, though appeared to trend in the 
expected direction based on the literature.  
 Taken together, the evidence for the validity of the identified four-cluster solution 
was mixed. Diagnostically speaking, the clusters corresponded well with primary 
substance(s) of use identified by the cluster title (i.e., alcohol use disorder clusters were 
more likely to meet criteria for only an alcohol use disorder as compared to the 
polysubstance use disorder and drug use disorder clusters). Some support was also 
detected for the degree of concern identified by the cluster title. For instance, the 
pervasive concerns cluster was more likely to meet criteria for a comorbid psychiatric 
condition, while the minimal concerns cluster was less likely to meet criteria for a 
comorbid psychiatric condition. Additionally, the pervasive concerns and serious 
concerns groups exhibited a higher degree of substance use severity as evidenced by 
greater average number of weekly drinks and peak BAC level, as compared to the 
minimal concerns and moderate concerns groups. Unfortunately, there was relatively 
poor evidence for the predictive validity of the identified cluster solution as the clusters 
did not produce statistically significant relationships with treatment status, number of 
treatment days, or total treatment duration; however, there were potentially important 
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trends detected that suggested that the moderate concerns drug use disorder group may 
not have fared as well as the other clusters. Moreover, the absence of statistically 
significant findings does not negate the descriptive value of delineating subgroups of this 
particular treatment-seeking population, which will be explored further in the discussion 
section.  
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Chapter V: Discussion 
 
 
 
Overview 
 The purpose of this section is to evaluate the study findings. This chapter will 
begin with an overview of the research questions set forth. A summary of the basic 
characteristics of the sample and how they relate to treatment retention are then reviewed. 
Next, the cluster analysis results will be summarized. The implications of these findings 
will then be discussed along with identified study limitations and future research 
directions.   
Research Questions 
 A primary purpose of this study was to describe the characteristics of a sample of 
clients entering an intensive outpatient chemical dependency treatment program at a 
nonprofit, freestanding mental health clinic and to examine how these variables differ 
between clients who complete treatment and clients who drop out prematurely. 
Additionally, in an effort to accurately depict this particular treatment program 
population, this investigation explored whether a classification system could be used to 
categorize individuals into meaningful groups based on important pretreatment 
characteristics and treatment variables. These areas of inquiry have both applied and 
empirical value.  
Clinically speaking, it is critical for individual treatment programs to examine 
treatment outcomes; however, a treatment program must first learn more about who is 
participating in its program, who is completing its program, and who is prematurely 
dropping out to accurately portray information regarding its treatment outcomes. Upon 
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identifying client characteristics and determining which ones positively and negatively 
relate to retention, a treatment program is better prepared to design assessment 
procedures that allow clinicians to quickly and efficiently detect clients who may be at 
risk for dropout. Considering the well-established relationship between treatment 
retention and the achievement of positive treatment outcomes (Anton et al., 2006; 
Hubbard et al., 1997; Hubbard et al., 1989; Moyer & Finney, 2002; Project MATCH 
Research Group, 1998b; Simpson, 1993; Simpson & Sells, 1982; Weisner et al., 2003), 
such knowledge can inform the design of programmatic interventions to enhance 
retention, which can potentially improve treatment outcomes. Empirically speaking, this 
study will add to the existing literature describing the characteristics of clients who 
participate in intensive outpatient substance abuse treatment programs and provide 
additional evidence related to whether or not different subtypes of individuals with 
substance use disorders exist. Furthermore, study findings can clarify the extent to which 
current scientific research regarding client characteristics and their relationship to 
treatment retention applies to this particular program and the clientele it serves.  
Generalizability 
Due to the practical difficulties that interfered with the assessment team’s ability 
to evaluate each new client in the treatment program, the consequent sample in this study 
(n =273) was only a portion of the target population (N = 444) that entered the treatment 
program during the data collection period. Basic demographic information and treatment 
characteristics were obtained for the individuals who were not included in the study (n = 
171). Study participants and excluded individuals did not significantly differ on 
sociodemographic characteristics including gender and race, though study participants 
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were significantly older than those who were excluded from the study. This difference 
was fairly small though: 39.77 years (SD = 11.80) compared to 37.20 years (SD = 12.18). 
In examining treatment characteristics, it is apparent that the study sample had an 
overrepresentation of treatment completers. The overall treatment completion rate for the 
entire population was 49%, whereas a 59% treatment completion rate was detected within 
the study sample. Study participants also attended significantly more treatment groups on 
average than individuals who were not included in the study and stayed in treatment for a 
longer duration. Consequently, caution needs to be exercised when interpreting results 
because of the evident over-inclusion of individuals who are retained in treatment and 
more research needs to be conducted to confirm or refute its results. However, the 
preliminary and descriptive nature of this project upholds the relevancy of its results and 
implications, particularly as they apply to the treatment program itself. 
Treatment dropout is a common obstacle in substance abuse treatment research 
and barriers to obtaining representative samples need to be considered in the initial stages 
of the research process. Early treatment dropout likely influenced participant accessibility 
in this study. Roffman et al. (1993) reported that 11% of clients dropped out of their 
outpatient treatment for marijuana dependence prior to completing their 5th treatment 
session. Since the average time elapsed between treatment admission and initial 
evaluation was 5 calendar (not treatment) days, it is likely that some of the 
nonparticipants dropped out of treatment prior to the assessment team even having a 
chance to complete the evaluation. This reality is a common challenge of carrying out 
research in an applied setting where resources including space, time, and data collection 
coverage may be limited at times. Thus, researchers and the treatment programs they are 
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collaborating with should be prepared to address such challenges throughout all phases of 
the research project and to make adjustments along the way to reduce protocol 
implementation barriers.  
Treatment Characteristics 
The 49% completion rate detected for the population from which this study 
sample was drawn falls within the range identified by other retention studies in 
(intensive) outpatient settings. At the high end of the range lies White and associates 
(1998) with 74% and Veach and colleagues (2000) with 72%. At the low end of the 
spectrum lies Dobkin et al. (2002), Green et al. (2002), and Mammo and Weinbaum 
(1991) with treatment completion rates equaling 47%. This degree of variability is likely 
influenced by a multitude of factors, including treatment program structure and expected 
length of stay. Consequently, these variables need to be taken into account when 
comparing and contrasting study results. 
Generally speaking, the program in this study adheres to the Minnesota treatment 
model, which suggests that the typical outpatient treatment episode is 5 to 6 weeks of 
intensive therapy (i.e., groups sessions lasting 3 to 4 hours, 3 to 4 nights a week) followed 
by 10 or more weeks of aftercare sessions (i.e., 12-step meetings) (Owen, 2003). Of note, 
these guidelines coincide with the American Society of Addiction Medicine (ASAM) 
intensive outpatient treatment recommendations that advise any combination of group, 
individual, and family counseling at least 3 times per week that total a minimum of 9 
hours of services (American Society of Addiction Medicine, 1996). Although decisions 
regarding treatment frequency and duration in this program are made based on factors 
including recommended level of care, treatment goals, scheduling availability, and 
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insurance benefits, providers indicated that an expected treatment episode would consist 
of attendance at 3 or 4, 3-hour group sessions and at least 1 individual session per week, 
for 4 to 5 weeks. Results of this study coincide: participants who completed treatment 
attended an average of 16 treatment groups and generally stayed in treatment for a total 
of 32 days.  
Based on this information alone, it is not “fair” to compare this study’s retention 
rates and average length of stay estimates to research undertaken in treatment programs 
that have notably longer (expected) lengths of stay: 10 to 11 weeks (Mertens & Weisner, 
2000) and 115 days (Dobkin et al., 2002). Additionally, the 72% treatment retention rate 
detected by Veach and colleagues (2000) was greater than the 49% detected in this study; 
however, they examined participants in an intensive outpatient, Minnesota model-based 
program who received either 16 or 30 hours of treatment contact per week. These values 
vary substantially and are greater than the 10 to 13 hours typically received in this 
program, thus the applicability of the results are questionable. On the other hand, White 
and colleagues (1998) had a similar intensive outpatient program structure, with 10 to 13 
contact hours per week, for 4 weeks. Though their average length of stay for treatment 
completers was equivalent to the length of stay detected in this study (32 days), their 
completion rate was 25% higher (74%) than the rate in this study. The treatment 
programs included in Green et al. (2002) generally adhered to ASAM’s intensive 
outpatient treatment guidelines. Treatment involved four, two and one-half hour sessions 
per week, for five to six weeks. The overall retention rate was comparable (47%) to the 
rate in this study. This significant variation in retention rates among (intensive) outpatient 
programs that have similar program structure and philosophy provides further evidence 
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that research needs to be conducted at the individual treatment program level in order to 
adequately gauge treatment statistics like average length of stay, typical number of 
treatment days, and retention and what influences these variables. 
 From a larger perspective, the average treatment duration for completers in this 
study, as well as in the aforementioned (intensive) outpatient treatment studies, is 
considerably less than the 90-day threshold that has been implicated in the achievement 
of more positive treatment outcomes in previous large-scale drug treatment research 
(Hubbard et al., 1989; Simpson, 1981; Simpson, Brown et al., 1997; Simpson, Joe et al., 
1997; Simpson & Sells, 1982). Recommended length of stay in these studies for 
outpatient treatment was 6 months and the median treatment stays was 3 months 
(Simpson, Joe et al., 1997). These values contrast those delineated by this study, and 
consequently call into question the applicability of these large-scale research findings as a 
90-day treatment stay is well beyond what would be expected, and what is likely possible 
based on existing third-party reimbursement benefits, in this particular program. It is 
evident that past large-scale substance abuse treatment research efforts do not reflect how 
contemporary substance abuse treatment services are actually being delivered. 
With regards to actual treatment stay, treatment completers in this study attended 
about 5 more treatment groups, and were in treatment for a total of 11 more days than 
treatment dropouts. Considering the wealth of research linking positive relationship 
between length of time spent in treatment and favorable outcomes (e.g., increased 
abstinent days, reduced negative substance use-related consequences, improved 
psychological social, and employment functioning) (Hubbard et al., 1997; Hubbard et al., 
1989; McLellan, Luborsky, Woody, O’Brien, & Duley, 1983; Moos & Moos, 2003; 
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Simpson, 1981; Simpson & Sells, 1982), this particular treatment program should further 
examine if the extra 5 treatment groups and 11 days spent in treatment are statistically 
and/or clinically significant differences in treatment outcomes between completers and 
dropouts. Such research could guide the treatment program’s focus and assist in 
determining if treatment completion is the defining factor in accomplishing more 
favorable outcomes or if there is a particular threshold of treatment days or total 
treatment duration wherein clients generally achieve more positive outcomes. Depending 
on the results, the treatment program could design their program to better align with the 
identified time frame. For example, if results indicate that positive treatment outcomes 
plateau at 5 weeks of treatment, the program could design a 5-week curriculum and aim 
to retain clients for at least that length of time. 
Sample Characteristics 
 Considering that substance abuse treatment research is conducted in a range of 
treatment settings (i.e., publicly- vs. privately-funded funding; inpatient vs. outpatient; 
alcohol only vs. drug only vs. polysubstance), the populations from which samples are 
drawn are highly diverse. This variability affects generalizability and applicability of 
results, thus further examination of basic sociodemographic sample characteristics is 
necessary when conducting research at the program level. Nearly two-thirds of the 
sample in this study was male (62%) and the large majority was Caucasian (86%). 
Almost half of the sample (45%) was married. Mean age was 40 years. This sample was 
fairly educated, with about 92% completing high school and 60% of these individuals 
attending some college or earning an advanced degree. Overall, demographic 
characteristics of this sample are relatively consistent with other research in private, 
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managed care (intensive) outpatient substance abuse treatment programs that primarily 
treat insured or self-pay clients (Green et al., 2002; Mertens & Weisner, 2000; Satre et 
al., 2004; Veach et al., 2000; White et al., 1998). Aside from gender, these characteristics 
contrast those detected in research projects undertaken within publicly-funded substance 
abuse treatment agencies. Participants in these studies are generally younger, more 
racially diverse, less likely to be married, and less educated (Arfken et al., 2001; Klaus & 
Kindleberger, 2002; McCaul et al., 2001; Patkar et al., 2004). Such fundamental 
discrepancies in study sample characteristics challenges the applicability of results from 
publicly-funded treatment program research to private treatment agencies since the 
clientele vastly differs. For example, a single African American male in his early 30’s 
who has not earned his high school diploma may have primary treatment goals related to 
maintaining his sobriety and earning his GED. These aims may be in stark contrast to the 
treatment goals to a married Caucasian male in his late 30’s who has earned his 
bachelor’s degree, who may be more focused on exploring how his substance use has 
impacted his marriage and improving his relationship with his wife. Consequently, 
individual treatment programs need to closely scrutinize study characteristics including 
sample demographics and type of treatment program in order to effectively determine if 
results are relevant. 
 In regards to substance use, the ASI substance use variables were fairly consistent 
with diagnostic indicators. In other words, the percentage of participants using a 
particular substance in the 30 days prior to the evaluation was similar to the percentage of 
participants that met DSM-IV diagnostic criteria for either abuse or dependence of that 
substance. Approximately 75% of the sample met criteria for an alcohol use disorder and 
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80% of the sample reported using alcohol in the past 30 days. Nearly 25% of the sample 
reported using cocaine in the past 30 days, while 22% met criteria for cocaine abuse or 
dependence. The percentage of those who used opiates in the previous 30 days and those 
who met criteria for an opiate use disorder was exactly the same (20%). In contrast, a 
slight discrepancy in this pattern emerged for marijuana: 31% of the sample reported use 
while only 15% met criteria for a marijuana abuse or dependence. As compared to Veach 
and colleagues (2000), this sample had comparable rates of cocaine and marijuana use 
disorders, but higher rates of alcohol and opiate use disorders. Similarly, this sample also 
had higher rates of alcohol use disorders and comparable rates of cocaine use disorders as 
Dobkin and associates (2002).  
 In the end, about half of the sample only met criteria for an alcohol use disorder, a 
quarter of the sample only met criteria for a drug use disorder, and the remaining quarter 
met criteria for both an alcohol use and drug use disorder(s). These rates were very 
consistent with Green et al. (2002): 51% of the sample met criteria for only an alcohol 
use disorder, 20% met criteria for only a drug use disorder, and 29% met criteria for both 
an alcohol use and drug use disorder(s). Satre et al. (2004) and Mertens and Weisner 
(2000) separated abuse and dependence diagnoses and found similar prevalence rates: 
just over 40% of their samples met criteria for alcohol dependence, just under 30% met 
criteria for drug dependence, just under 20% met criteria for both alcohol and drug 
dependence, and about 10% met criteria for substance abuse. On the whole, the treatment 
program in this study appears to be serving a range of clients who present with distinct 
types of substance use patterns (i.e., some alcohol only, some drug only, some both 
alcohol and drug). Prevalence rates of substance use disorders is relatively comparable to 
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other (intensive) outpatient treatment programs identified in the literature, thus these 
research findings should be of interest to this particular program. 
 The prevalence of comorbid psychiatric problems in this sample was high. Over 
half of the participants previously participated in psychiatric treatment (58%) and a 
majority (52%) met criteria for at least one substance use disorder and at least one Axis I 
psychiatric disorder at the time of the intake evaluation. More specifically, 43% of the 
sample met criteria for major depression and 29% met criteria for an anxiety disorder 
(e.g., PTSD, OCD, panic disorder, social phobia). These rates parallel the prevalence of 
depressive (39%) and anxiety (29%) symptoms in a large sample (N = 2784) of clients 
attending an outpatient program at a comprehensive addiction treatment center in Canada 
(Castel et al., 2006). Additionally, Charney and associates (2005) found that 63% of 
participants presenting to an addictions treatment unit at a university hospital-based 
treatment program in Canada presented with comorbid psychological symptoms 
including depression (15%), anxiety (16%), or combined depression and anxiety (32%). 
Considering the high level of psychiatric comorbidity detected in this study, the extent to 
which this treatment program is addressing the needs of dually-diagnosed clients is an 
important question to consider and will be further discussed in subsequent sections.   
Treatment Retention 
 Despite the large number of diverse methodological investigations carried out 
across various treatment settings, no consistent “treatment dropout” profile has been 
detected in the literature, In fact, the generalizability of many of these research findings 
are often questioned at the local programmatic level because of the stark differences that 
exist between a particular treatment program and its clientele and those studied. Thus, a 
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series of analyses were carried out in this investigation in order to determine the 
applicability of previous research to the population from which this sample was drawn.   
 Consistent with previous research, age was positively related to treatment 
retention in this study (Green et al., 2002; McKellar et al., 2006; Maglione et al., 2000a; 
Maglione et al., 2000b; Mertens & Weisner, 2000; Roffman et al., 1993; Satre et al., 
2004; Siqueland et al., 2002; Wickizer et al., 1994). Treatment completers (M = 42.32 
years, SD = 11.00) were, on average, 6 years older than treatment dropouts (M = 36.10 
years, SD = 11.98). Though the difference was relatively small (i.e., about one-half of a 
standard deviation), it was detected. Multiple theories have been proposed to explain this 
relationship. Stark (1992) hypothesized that younger adults exhibit greater impulsivity 
and lack self-discipline, which may impact the decision to drop out of substance abuse 
treatment prematurely. Alternatively, McKellar et al. (2006) propose that younger adults 
have shorter substance abuse/dependence histories, thus exhibit less chronicity and fewer 
adverse consequences. These realities in turn lead to a lower perceived need for 
treatment. Stark (1992) also purported that younger adults generally have fewer social 
ties to two potential sources to support their treatment efforts: their families and 
communities. This line of reasoning coincides with the finding that married participants 
in this study were more likely to complete treatment than their never married 
counterparts. Consideration of the observed variation in retention based on age in this 
program should be taken into account during the treatment planning and goal 
identification process. Younger treatment participants may respond more positively and 
stay in treatment longer if there is less emphasis on chronicity and severity of substance 
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use and more stress on building sober social support networks and decision-making 
skills. 
 A higher income was positively associated with treatment retention in the present 
investigation, with treatment completers earning an average of $2298 (SD = $3483) from 
employment in the past month as compared to $1517 (SD = $1856) earned by treatment 
dropouts. This difference may be an artifact of a small number of large earners in the 
treatment completion group. Thus, median monthly income estimates may be a better 
indicator of the strength of the relationship. Median income for treatment completers was 
$1500, while median income for treatment dropouts was $1000. Roffman et al. (1993) 
detected a similar positive relationship between income and retention in a sample of 
outpatients in a marijuana-dependent counseling program, while this trend only emerged 
for female participants in Green et al. (2002) and Mertens and Weisner (2000). A 
common explanation of this positive relationship between socioeconomic indicators and 
substance abuse treatment retention is that a higher income can reduce or offset some of 
the frequently encountered barriers to substance abuse treatment including access to 
treatment (i.e., insurance coverage) and cost of treatment (i.e., child care costs accrued 
during treatment sessions, insurance co-pays). However, since this relationship is not 
consistently detected in the literature, it may also be true that having a higher income may 
increase or intensify some barriers to treatment including lost wages while participating 
in treatment (Stark, 1992). Based on this study’s finding that income was positively 
related to retention, it appears worthwhile for this treatment program to explore clients’ 
financial status and to identify methods to defray treatment costs (i.e., co-pay payment 
plans, funding for child care) if financial barriers to treatment are detected.   
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 Experiencing more severe comorbid psychiatric problems has regularly been 
linked to substance abuse treatment dropout, though gender has often been implicated in 
this relationship. For example, Siqueland et al. (2002) found that higher psychiatric 
severity kept men in substance abuse treatment longer, while Green et al. (2002) 
observed that it put men at risk for dropping out. More severe psychiatric problems and 
greater levels of psychiatric distress have been related to dropout in cocaine-dependent 
women (Siqueland et al., 2002), drug-dependent women (Haller et al., 2002), women in 
an HMO-based outpatient treatment program (Mertens & Weisner, 2000), and marijuana-
dependent individuals (Roffman et al., 1993); however, Castel and colleagues (2006) 
reported that clients endorsing psychiatric symptoms of multiple clusters (e.g., 
depression, anxiety, mania, schizophrenia-like, eating, conduct disorder) attended more 
visits and had a lower attrition rate than clients endorsing fewer psychiatric symptoms 
across clusters. With regards to specific types of psychological problems, depression has 
been positively linked to treatment retention (Joe et al., 1999; Justus et al., 2006), 
positively linked to treatment dropout (Broome et al., 1999), and unrelated to whether or 
not clients remain in treatment (Booth et al., 1991; Curran et al., 2002). Anxiety has also 
been associated with treatment dropout (Broome et al., 1999). In this study, clients who 
had been previously treated for psychological problems (i.e., taken psychotropic 
medications, participated in psychotherapy) or met criteria for an anxiety disorder (e.g., 
PTSD, OCD, panic disorder, social anxiety disorder) were more likely to dropout out of 
treatment.  
 Potential explanations for the tenuous relationship between substance abuse 
treatment retention and psychiatric comorbidity vary. It may be that when clients are 
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experiencing more significant distress, their motivation to stay in substance abuse 
treatment is greater because the desire to reduce psychiatric and substance-related 
symptoms and improve their overall quality of life is at the forefront. Alternatively, if 
psychiatric problems are only mildly upsetting for a particular client, the impetus to 
continue participating in substance abuse treatment to explore and alleviate such 
symptoms may not be a top priority and the perceived need for treatment may be low 
(Castel et al., 2006; Curran et al., 2002). The actual symptoms of psychopathology (e.g., 
unstable and dysphoric mood, delusions, lack of social support, hostile affect, social 
anxiety, poor self-image, low frustration tolerance, lack of trust) can also directly 
interfere with therapeutic processes that facilitate treatment retention and positive 
treatment outcomes (Broome et al., 1999; Haller et al., 2002).  
 For this particular treatment program it appears that the types of psychological 
symptoms, as opposed to general psychological distress, are important markers. 
Participants who meet criteria for PTSD, OCD, panic disorder, or social anxiety disorder 
were more likely to drop out of treatment prematurely than individuals who did not 
endorse considerable anxiety. Of note, this pattern did not emerge for depression. 
Unfortunately, much of the literature regarding the integrated treatment of comorbid 
mood or anxiety disorders and substance use disorders – treating both disorders 
concomitantly – lumps these psychiatric disorders together, suggesting that treatment 
should incorporate pharmacotherapy, cognitive-behavioral techniques, relaxation 
training, stress management, and coping skills training in their treatment (Center for 
Substance Abuse Treatment, 2005; Petrakis, Gonzalez, Rosenheck, & Krystal, 2002). 
Yet, there are unique aspects of anxiety disorders and their treatment that these 
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recommended interventions do not address and substance abuse treatment providers have 
likely not received adequate training in (e.g., trauma, exposure therapy, response 
prevention). For example, substance abuse treatment providers can focus on helping 
clients with PTSD gain control of the self-destructive behaviors associated with trauma 
and develop alternative coping strategies, but detailed exploration of the trauma is 
generally not advised (Center for Substance Abuse Treatment, 2005).  
 A recent review of integrated treatment for substance use disorders and comorbid 
psychological problems provides support for the notion that there may be inherent 
differences between the integrated treatment of substance use disorders and mood 
disorders and substance use disorders and anxiety disorders (Hesse, 2009). A meta-
analysis of five randomized studies providing manual-guided treatment for comorbid 
depressive symptoms and substance use disorders was carried out. Results indicated that 
integrated psychosocial treatment for depression and substance use disorders is a 
promising approach for clients with this comorbidity, as analyses generally favored 
integrated treatment over single-focus treatments for percent days abstinent at follow-up, 
depressive symptoms, and retention in treatment. However, the difference was only 
statistically significant for percent days abstinent at follow-up. A meta-analysis could not 
be carried out for integrated treatment for anxiety and substance use disorders because of 
the high degree of variability in the reporting of outcomes in the original articles; 
however, several studies reported that clients assigned to substance abuse treatment only 
fared better. The author concluded that integrated treatment for comorbid depression and 
substance use disorders is a promising approach, but does not have sufficient empirical 
support at this time. On the other hand, integrated treatment for comorbid anxiety and 
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substance use disorders is not empirically supported at present and there is a definite need 
for the development and evaluation of new treatment options for comorbid anxiety and 
substance use disorders. Ultimately, each substance abuse treatment program must 
determine, on an individual client basis, if it has the knowledge, training, and skills to 
provide adequate treatment for each client presenting with a substance use disorder(s) and 
comorbid psychological problem(s). If not, the client should be referred to a program that 
can provide effective integrated treatment (i.e., the Seeking Safety treatment model for 
PTSD and substance abuse) (Najavits, 2002) or to a specialty psychiatric treatment 
program, either before or after substance abuse treatment. 
 Another important diagnostic indicator that was related to treatment retention in 
this study was the type of substance use disorder(s) clients met criteria for. Clients who 
met criteria for alcohol abuse or dependence were more likely to complete treatment, 
while individuals who met criteria for an opiate use disorder or a cocaine use disorder 
were more likely to drop out of treatment. Such findings have frequently emerged in 
substance abuse treatment retention investigations across treatment settings (Alterman et 
al., 1996; De Leon et al., 1997; Joe et al., 1999; Paraherakis et al., 2000; Rowan-Szal et 
al., 2000). Generally speaking, more frequent drug use and a higher degree of drug 
dependence have also been linked to treatment dropout (Green et al., 2002; McKellar et 
al., 2006; Maglione et al., 2000a; Maglione et al., 2000b; Mertens & Weisner, 2000; 
White et al., 1998). Profile analysis results paralleled this trend and indicated that 
treatment dropouts reported, on average, more frequent use of alcohol, opiate, cocaine, 
and marijuana use in the 30 days prior to treatment. Treatment dropouts also experienced 
more negative consequences related to their substance use than their counterparts. In 
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particular, dropouts tended to report more problems related to fulfilling social 
responsibilities (e.g., missed days of work/school, money problems) than completers. 
Results of motivational analyses suggest that although treatment dropouts demonstrated a 
higher degree of problems recognition and were taking more steps to reduce their use, 
they were generally more ambivalent about making these behavioral changes and were 
unsure whether they needed treatment. This finding is consistent with Joe et al. (1998) 
who noted that treatment readiness, or degree of commitment to active change process 
through participation in a treatment program, was positively related to treatment 
retention. Thus, one would expect that the more ambivalent clients are about changing 
their behavior, the less committed they will be to participating in treatment. It should also 
be noted that clients who did not report drug use would likely demonstrate lower levels of 
motivation because they did not need to change their drug use behavior because they 
were already abstinent. 
An array of conjectures have been put forth about what dynamics may be at play 
in the observed connections between substance(s) of use and substance abuse treatment 
retention. A common hypothesis suggests that since the majority of substance abuse 
treatment programs in the U.S. are rooted in the Minnesota model approach that was 
initially designed to treat alcohol dependency, the needs of treatment participants who are 
presenting with a drug use disorder(s) or both a drug and alcohol use disorder(s) may not 
be adequately met (Luke et al., 1996; Mammo & Weinbaum, 1991; Veach et al., 2000). 
More specifically, the Minnesota model of treatment maintains: 
Chemical addiction is a primary, chronic, and progressive disease. It is primary 
 because it is an entity in itself and not caused by other factors, such as 
 intrapsychic conflict. It is chronic because a client cannot return to “normal” 
 drinking once an addiction is established. It is progressive because symptoms and 
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 consequences continue to occur with increasing severity as use continues. 
 (Owens, 2003). 
 
This view stems from the disease model of alcoholism, which views alcoholism as a 
medical ailment involving an abnormality of structure and/or function of the brain that 
results in behavioral impairment (Jellineck, 1960; Pattison, Sobell, & Sobell, 1977). 
However, etiological research purports that the development of substance use disorders is 
much more complex. Hesselbrock, Hesselbrock, and Epstein (1999) have augmented the 
family disease model with family systems theory (i.e., alcohol stabilizes family 
equilibrium and families strive to sustain alcohol problems despite negative 
consequences) and behavioral family theory (i.e., some familial behaviors are viewed as 
antecedents to and reinforcing consequences of alcohol use). Carroll (1999) applied 
learning theory to the development of alcohol use disorders and suggested acquisition, 
maintenance, and modification of drinking behavior is largely learned, while Sayette 
(1999) suggested the tension-reduction hypothesis, wherein certain groups of people 
under certain circumstances may be motivated to drink in times of stress in order to 
reduce stress. Cultural and sociological factors have also been explored in relation to 
alcohol use disorders (Wilsnack et al., 2000).  
 On the other hand, the etiological picture for drug addiction is less well-
established. Ott, Tarter, and Ammerman (1999) identify a range of factors that may 
influence the transition from drug use to drug addiction: drug availability, route of 
administration, genetics, family history of drug use, family environment, stress, and life 
events. In particular, research has demonstrated that genetic and environmental 
contributions may vary by substance. In a sample of male twins, Kendler, Karkowski, 
Neale, and Prescott (2000) reported that cannabis and hallucinogen use was influenced by 
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both genetic and environmental factors; whereas, genetic factors predominated for 
cocaine, opiate, sedative, and stimulant use. Though additional research is needed in the 
etiology of substance use disorders, it is evident that there is a lack of consensus from 
substance to substance about the impact of biological, psychological, and sociological 
factors. Thus, if a substance abuse treatment program places too much emphasis on the 
disease model of addiction (i.e., addiction is an entity on to itself, inevitable progression 
of disease with continued use), at the expense of other aspects related to the development 
of the disorder (i.e., learned coping strategies, social network), certain clients may be at 
risk for dropping out prematurely because they do not identify with the treatment 
philosophy. For example, it is conceivable that a client in his mid-20’s may be “turned 
off” by or less receptive to the Minnesota treatment model, particularly if he only meets 
criteria for substance abuse, because he may not agree that he is “destined” to be 
dependent and may attribute his problematic use to factors aside from a genetic 
predisposition (e.g., social support network that uses, availability of the substance, 
relaxing effects). Further research that incorporates a comparison group(s) is needed to 
examine this conjecture more precisely. In this study, all individuals participated in the 
same treatment program, so statements regarding the differential effectiveness of the 
Minnesota model with certain individuals (e.g., those who primarily use alcohol vs. those 
who primarily use drugs) remain speculatory. 
 From a psychosocial perspective, individuals who use drugs more frequently may 
be more impulsive, may engage in more illegal activities, and may be involved in a social 
network that thwarts treatment efforts (McKellar et al., 2006; Mertens & Weisner, 2000). 
Additionally, the particular legal ramifications related to drug use may interfere with 
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treatment participation and force clients to drop out more frequently than their alcohol-
using counterparts. For instance, a cocaine-using client who relapses while in treatment 
may be arrested for cocaine possession and jailed, and consequently unable to attend 
treatment session. However, an alcohol-using client who relapses while in treatment, as 
long as s/he is not engaged in reckless behavior while under the influence, will likely not 
experience an equivalent legal barrier to treatment participation. In the end, based on the 
results of this study, it may be worthwhile for this treatment program to further examine 
these notions in clients with opiate and cocaine use disorders because they were more 
likely than their counterparts to drop out of treatment. Areas of exploration may included 
how well the client is identifying with the treatment model and connecting with its 
assumptions, to what extent the client is involved in illegal activities, and what influence 
has the client's social network had on his substance use. 
 A marked methodological drawback of this study was that the relationships 
between pretreatment characteristics and treatment retention were approached in a 
univariate manner: separate t-tests and chi-square analyses were run for each variable. 
Additional examination of the relationship amongst the variables (i.e., covariation) and 
completion of multivariate analyses would be valuable in describing the characteristics 
sample more comprehensively and identifying more precise correlates and predictors of 
treatment retention. For example, age, income, marital status, previous psychiatric 
treatment, meeting criteria for an opiate use disorder, meeting criteria for a cocaine use 
disorder, and meeting criteria for comorbid anxiety disorder were all related to treatment 
retention in this study. Entering these variables into a regression model could determine 
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the amount of variance each of these variables contributes to the observed variance in 
treatment retention. 
Subgroups 
The current study did examine how multiple pretreatment variables could be 
organized to form a coherent taxonomy of a substance abuse-treatment seeking sample. 
Not surprisingly, the sample demonstrated a high degree of heterogeneity across variables 
measuring age, patterns of substance use, comorbid psychiatric problems, social 
functioning, legal standing, health status, and negative consequences related to substance 
use. Even so, cluster analysis results were successful in devising a categorization scheme 
that produced four distinguishable subgroups that varied along two broad dimensions: 
primary substance(s) of use and degree of functional impairment. A comparable 
taxonomy was detected by Luke et al. (1996) in a sample of dually-diagnosed individuals 
using the ASI severity ratings wherein seven clusters were deduced according to level of 
functioning (e.g., good, moderate, poor) and pattern of substance use (e.g., alcohol, drug, 
alcohol and drug). Based on the identified grouping scheme in this study, over half of the 
current sample endorsed problems primarily related to alcohol (55%), about a fifth of the 
sample reported problems primarily related to drugs (19%), and just over a quarter of the 
sample demonstrated considerable problems with both alcohol and drugs (27%). This 
breakdown roughly corresponded to the overall diagnostic classification of the sample 
based on the M.I.N.I.: 49% of the sample met criteria for only an alcohol use disorder, 
23% met criteria for only a drug use disorder(s), and 26% met criteria for both an alcohol 
and a drug use disorder(s).  
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Degree of functional impairment amongst the subgroups in this study ranged from 
severe to minor. As the title implies, the pervasive concerns polysubstance use disorder 
cluster demonstrated high levels of comorbid problems as evidenced by the highest 
average medical, employment, family/social, and psychiatric ASI composite scores 
paired with considerable alcohol and drug composite score elevations. The serious 
concerns alcohol use disorder group demonstrated the highest average alcohol and legal 
composite scores, along with the second highest employment and psychiatric composite 
scores. The moderate concerns drug use disorder individuals fell below the average 
composite score means for the entire sample in all domains except drug problems, where 
they had the greatest degree of problems compared to their counterparts. The minimal 
concerns alcohol use disorder cluster had the lowest average drug, employment, legal, 
family/social, and psychiatric composite scores paired with the second highest alcohol 
and medical composite scores.  
Scores across the physical, interpersonal, intrapersonal, impulse control, and 
social responsibility InDUC subscales aligned with the degree of functional impairment 
of each group. The pervasive concerns group endorsed the greatest number of negative 
consequences in all realms, the serious concerns group ranked second, the moderate 
concerns cluster ranked third, and the minimal concerns group endorsed the least number 
of negative consequences. Interestingly, no specific type(s) of substance-use related 
consequence(s) was associated with a particular cluster. For instance, the scientific 
literature suggests that individuals who use drugs more frequently may be more 
impulsive, may engage in more illegal activities, and may be involved in a social network 
that thwarts treatment efforts (McKellar et al., 2006; Mertens & Weisner, 2000). From 
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this perspective, it would be reasonable to suspect that the moderate concerns drug use 
disorder cluster would report experiencing more consequences contained on the impulse 
control InDUC subscale (e.g., I have been arrested for driving under the influence of 
alcohol or drugs, I have taken foolish risks when I have been drinking or using drugs, I 
have gotten into a physical fight while drinking or using drugs). However, this 
supposition was not supported in this study. Instead, number of consequences across 
domains corresponded with degree of functional impairment implied from the cluster 
label. As a result, the treatment planning process may look different for the various 
clusters. Individuals in the minimal and moderate concerns groups may able to identify a 
few specific problematic areas to concentrate on (e.g., interpersonal conflicts, social 
responsibilities such as employment difficulties), while members of the serious and 
pervasive concerns groups may have to prioritize and select a manageable number of 
domains to focus on in treatment because it is unrealistic for all identified problem areas 
to be adequately addressed in a single, three- to four-week treatment episode in this 
program. 
In addition to the principle distinguishing factors of primary substance(s) of use 
and degree of functional impairment, the clusters could also be differentiated by age. The 
moderate concerns drug use disorder cluster was an average of 10 years younger than 
both of the alcohol use disorder clusters: 33-years-old compared to 43-years-old and 44-
years-old. The pervasive concerns polysubstance use disorder cluster fell in the middle 
and were on average, 37-years-old. As previously noted, younger adults tend to have 
shorter substance abuse/dependence histories and exhibit less chronicity and fewer 
adverse consequences, which may in turn lead to a lower perceived need for treatment 
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and higher treatment dropout rates (McKellar et al., 2006; Stark, 1992). In line with this 
view, the youngest group, moderate concerns drug use disorder, exhibited fewer 
substance-related consequences on the InDUC and less severe comorbid problems on the 
ASI than their older pervasive concerns polysubstance use disorder and serious concerns 
alcohol use disorder counterparts. However, in contrast to this view, the youngest cluster 
endorsed more consequences and demonstrated higher comorbid legal, family/social, and 
psychiatric problems than the older minimal concerns alcohol use disorder group. The 
pervasive concerns polysubstance use disorder group also exhibited the highest degree of 
negative consequences and comorbid problems and was about seven years younger than 
the two alcohol use disorder groups that were less functionally impaired. Accordingly, 
the complex interaction of age with primary substance(s) of use and degree of functional 
impairment needs to be further explored to reveal how these factors relate to and impact 
one another, as well as how they relate to and impact other variables of interest to 
substance abuse treatment researchers (e.g., treatment retention). 
Concurrent and predictive validation procedures suggest that the four-cluster 
solution was a suitable way to identify subgroups of this sample. Substance use disorder 
diagnostic categories coincided with the primary substances of use of each group (i.e., 
serious concerns and minimal concerns alcohol use disorder groups were more likely to 
meet diagnostic category for only an alcohol use disorder than their moderate concerns 
drug use disorder, and pervasive concerns polysubstance use disorder counterparts, 
while the drug use disorder group was more likely to meet criteria for only a drug use 
disorder than both alcohol use disorder groups). With regards to substance use patterns, 
both alcohol use disorder clusters exhibited a higher degree of alcohol use on the 
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drinking indicators (e.g., days of use, average number of weekly drinks, peak BAC) than 
the drug use disorder group. Level of motivation to change alcohol use and drug use also 
coincided with group membership. For example, the serious concerns alcohol use 
disorder displayed higher levels of motivation to change their alcohol use than all other 
groups, and the moderate concerns drug use disorder and pervasive concerns 
polysubstance use disorder groups endorsed higher levels of motivation to change their 
drug use than the alcohol use disorder clusters. Some support was detected for the degree 
of concern identified by each cluster title as well (i.e., the pervasive concerns cluster was 
more likely to meet criteria for a comorbid psychiatric condition, while the minimal 
concerns cluster was less likely to meet criteria for a comorbid psychiatric condition). 
 With regards to treatment outcomes including treatment completion status, 
number of treatment days, and total treatment duration, no significant statistical findings 
emerged between the clusters. However, trends were detected in the anticipated direction 
based on the treatment retention literature suggesting that clients with alcohol use 
disorders tend to complete substance abuse treatment at higher rates than clients with 
drug use or polysubstance use disorders (De Leon et al., 1997; Joe et al., 1999; McKellar 
et al., 2006). The moderate concerns drug use disorder cluster was the only cluster 
wherein the majority of members did not complete treatment. The retention rate for this 
cluster was 45.1%, compared to 67.7% for minimal concerns alcohol use disorder, 62.1% 
for serious concerns alcohol use disorder, and 57.5% for pervasive concerns 
polysubstance use disorder. The moderate concerns drug use disorder cluster also had 
the lowest mean number of treatment days (M = 12.94, SD = 5.05) and shortest average 
treatment duration (M = 23.98, SD = 11.50), while the serious concerns alcohol use 
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disorder cluster had the highest mean number of treatment days (M = 15.75, SD = 4.39) 
and longest average treatment duration (M = 29.52, SD = 9.88). Again, these differences 
were not statistically significant, though appeared to trend in the expected direction based 
on the literature and may be of clinical value to the treatment program.  
 The varying rates of treatment completion deserve further discussion. The clusters 
that primarily used alcohol demonstrated the highest treatment retention, while the 
clusters that primarily used drugs or both alcohol and drugs fell below these rates. This 
particular treatment program’s incorporation of the disease model of addiction and 12-
step principles, which evolved from alcohol addiction research, may better fit the 
treatment needs of those abusing alcohol as opposed to other substances. As previously 
noted, there is a lack of consensus regarding the biological, psychological, and 
sociological factors associated with the development of drug use disorders and these 
dynamics may vary from substance to substance (Kendler et al., 2000; Ott, Tarter, & 
Ammerman, 1999). Thus, a treatment program emphasizing the disease model may 
inadvertently overlook factors related to the etiology of drug addiction that drug-using 
clients consider more important for their recovery (e.g., ineffective coping skills, life 
events). Additionally, treatment programs need to consider that individuals who use 
drugs more frequently tend to be younger and may be more impulsive, may engage in 
more illegal activities, and may be involved in a social network that thwarts treatment 
efforts (McKellar et al., 2006; Mertens & Weisner, 2000). Accordingly, interventions 
aimed at helping clients reduce impulsivity (i.e., CBT focusing on the interconnection 
amongst events, thoughts, emotions, and behaviors) and establish sober social networks 
(i.e., 12-step meetings) may be beneficial. 
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The validity of the current cluster analysis results can also be examined 
comparing the identified classification system with other typologies outlined in the 
scientific literature. Unfortunately, many of the common variables utilized in past 
typology research with individuals with substance use disorders (e.g., family history, age 
of onset, substance use pattern over time, personality characteristics) were not assessed in 
the current study; however, other comparisons can be made to substantiate and refute 
previously outlined taxonomies. The Type A – Type B distinction has been explored in a 
sample of alcohol-dependent individuals (Babor, Hofmann et al., 1992), a diverse sample 
of cocaine users (Ball et al., 1997), and a sample of drug addicts (Garcia et al., 2006). In 
general, the Type A/chronic cluster is characterized by fewer childhood risk factors, later 
age of onset, less severe dependence, fewer substance use-related consequences, fewer 
comorbid psychiatric problems, and lower levels of distress in the areas of work and 
family. In contrast, the Type B/functional cluster has more familial risk factors, an earlier 
age of onset, greater severity of dependence, increased levels of polysubstance use, more 
serious functional impairment, a greater level of comorbid psychiatric dysfunction, and 
more life stress.  
In this study, the serious concerns alcohol use disorder groups seems to fall under 
the Type B/chronic umbrella due to the high level of comorbid concerns and negative 
consequences across functional areas, paired with severe alcohol problems as evidenced 
by the highest ASI alcohol composite score and high Form 90 alcohol use indicators 
(e.g., number of drinking days, average weekly drinks, and peak BAC). The minimal 
concerns alcohol use disorder cluster coincides with the Type A/functional taxonomy as 
these individuals exhibited less severe alcohol problems, a low degree of comorbid 
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problems, and fewer negative substance-use related consequences. Unfortunately, the 
remaining clusters do not fit “neatly” into either of these categories. Although the 
moderate concerns drug use disorder demonstrated the most severe drug use, they 
reported relatively low levels of comorbid concerns as compared to their counterparts. 
Alternatively, the pervasive concerns polysubstance use disorder cluster reported a high 
level of comorbid problems, but had lower alcohol severity than both alcohol use 
disorder groups and a lower drug severity than the drug use disorder cluster. Evidently, 
the dichotomous nature of the Type A – Type B conceptualization does not adequately 
capture the heterogeneity of this particular sample and their presenting problems. 
Expanded taxonomies of substance users also have shortcomings when compared 
to four-cluster solution delineated in this study. Del Boca and Hesselbrock (1996) 
identified groups based on severity and risk: low risk–low severity (few problems at low 
levels), internalizing (moderate risk, high depression and anxiety), externalizing 
(moderate risk, high antisocial behavior), and high risk–high severity (multiple problems 
at high levels). The pervasive concerns polysubstance use disorder and minimal concerns 
alcohol use disorder clusters appear to fall at the opposite ends of this risk-severity 
spectrum, while there is not enough information known about the internalizing and 
externalizing markers in this sample in order to determine if the remaining two clusters 
could align with either of these groups. The serious concerns alcohol use disorder cluster 
does exhibit the highest legal composite score, and a greater degree of negative 
consequences related to their substance use than the moderate concerns drug use disorder 
counterparts, which may indicate more antisocial behavior and provide support for 
categorizing them as the externalizing cluster. However, neither of these groups is more 
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likely to meet criteria for a depressive disorder or an anxiety disorder based on the 
M.I.N.I., suggesting an absence of an internalizing group.  
Windle and Scheidt (2004) investigated a group of inpatients from five alcohol 
treatment centers in both rural and urban areas and purported four subgroups in their 
sample. The mild course subtype was characterized by low rates of familial history of 
alcoholism; few childhood conduct problems; a later age of onset; fewer years of 
drinking; and lower levels of consumption and impairment. High levels of polydrug use 
and benzodiazepine use demarcated the polydrug subgroup, while the negative affect 
subgroup was distinguished by symptoms of depression and anxiety and high 
characterological vulnerability to a substance use disorder. The chronic/antisocial 
typology was distinguished by high levels of alcohol consumption and impairment, a 
longer duration of drinking, and high levels of adult antisocial behaviors. The mild course 
subtype parallels the minimal concerns alcohol use disorder group in this study because 
of the low levels of consumption and impairment, while the serious concerns alcohol use 
disorder group resembles the chronic/antisocial group because of its high levels of 
consumption and impairment. However, this taxonomy diverges from the current 
typology because there are two identified groups with considerable drug problems in the 
current study and a lack of a distinguishable group that is primarily characterized by 
comorbid depression and anxiety to correspond with the polydrug and negative affect 
subtypes.  
Taken together, there appears to be nuances within and across samples of 
substance users that demand programmatic-level inquiry to determine the distinguishing 
characteristics. General trends detected in taxonomy research and in this study suggest 
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that type and severity of substance use, and degree of impairment in other domains of 
functioning often delineate subgroups of substance users (Babor, Hofmann et al., 1992; 
Ball et al., 1997; Del Boca & Hesselbrock, 1996; Garcia et al., 2006; Luke et al., 1996; 
Windle & Scheidt, 2004). More specifically, clusters of individuals positioned at the ends 
of the substance use and functioning spectrums comprise two respective groups (e.g., low 
severity/adequate functioning and high severity/poor functioning), although great 
heterogeneity certainly exists. Further examination of the critical differences amongst 
substance abuse treatment subgroups can enhance a treatment program’s abilities to meet 
the distinctive needs of its consumers.  
Implications and Future Directions 
Theory Building 
 From the wealth of scientific literature reviewed here, and the results of the 
current study, it is evident that the substance abusing population is a heterogeneous 
group. Previous taxonomic research in the substance use disorder field has not produced 
clear-cut, easily identifiable coherent classification systems for individuals who meet 
criteria for substance abuse and dependence; however, it has shed light on commonalities 
of particular subgroups and how such factors relate to pertinent treatment factors such as 
treatment retention. Moreover, according to Peters (1997): 
 Devising optimal treatment and prevention for a disease or disorder is facilitated  
 by knowing the causal process(es) involved. Because a specific causal process 
 often leads to a specific constellation of symptoms in subjects exposed to or 
 involved in that specific causal process, researchers – in their search for causes – 
 often try first to identify the different types of subjects, each type characterized by 
 a unique symptomatology. (p. 1649)  
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According to this line of thinking, typology research with individuals with substance use 
disorders can be viewed as a starting point for generating theoretical hypotheses 
regarding the development, expression, and course of various substance use disorders.  
In this particular sample, the categorization scheme appeared to sort participants 
into groups based on two broad dimensions: substance(s) of use and degree of functional 
impairment. Consequently, further empirical research examining what factors influence 
one’s decision(s) to use certain substances and not others may help better understand the 
observed differences in treatment retention and treatment outcomes between assorted 
persons with substance use disorders and may also aid prevention efforts. For example, if 
a study with in a particular treatment program linked impulsivity to both cocaine use and 
treatment dropout, it could employ treatment interventions with these clients targeting 
this behavior (i.e., anger management training). A more in-depth analysis of what 
dynamics influence general and specific functioning may elucidate how and why 
individuals with substance use disorders differ in their abilities to cope with life 
events/stressors and what role substance use plays in these coping processes. Ultimately, 
typology research has the potential to generate numerous theoretical hypotheses and 
subsequent empirical investigations that could both expand and refine etiological 
considerations in substance use disorders. However, researchers need to keep in mind that 
“it is conceivable that a more parsimonious model would be useful for some purposes 
(e.g., patient placement), whereas a more complex model would be better for other 
purposes (e.g., theory building)” (Ball et al., 1995, p.123). 
Assessment 
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 An obvious shortcoming of typology research and theory in populations with 
substance use disorders has been its relative failure to influence assessment procedures 
and differential diagnosis quandaries (Babor, Dolinsky, et al., 1992). At the individual 
program level in particular, this type of information could be extremely useful as 
programs design and revise their evaluation processes. From the outset of this study, an 
underlying objective was to construct a valuable research protocol that could be 
effectively implemented and would produce clinically-useful data. However, various 
treatment programs employ a variety of assessment methods because the objectives of 
their respective evaluations differ. For example, certain programs may utilize more 
diagnostic tools because a client’s diagnosis or multiple diagnoses are the main factor 
that drives treatment decisions, at least at the outset. Alternatively, a treatment program 
that uses more motivationally-based interventions will likely incorporate more measures 
examining the client’s perceptions of their substance use and their motivation(s) to 
change. Selecting tools that have both empirical and clinical value is the key. In this 
study, the M.I.N.I. was a tool that demonstrated both scientific and applied utility: 
anxiety disorder, opiate use disorder, and cocaine use disorder diagnoses were negatively 
related to treatment completion and these diagnoses were useful in the treatment planning 
process to ensure that comorbid psychiatric conditions were being addressed. By 
adopting an assessment approach that integrates both science and practice, treatment 
programs can remain scientifically-guided when making programmatic decisions. For 
example, when considering whether or not to incorporate auxiliary legal counseling, a 
program can look at its data in this area (i.e., what percentage of clients have legal 
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problems, what types of legal problems do clients commonly enter treatment with, how 
do legal problems relate to treatment completion) to inform its decision. 
 A secondary upshot of this study was that the research team scrutinized how to 
create, implement, and evaluate a particular assessment protocol for an intensive 
outpatient substance abuse program at a nonprofit, freestanding mental health hospital. 
Most of the assessment instruments or components of the instrument proved useful in 
differentiating between clients who completed treatment and those that dropped out 
prematurely. The ASI also demonstrated utility in classifying subgroups of clients that 
exhibited commonalities. Although only one subscale emerged as significantly related to 
retention on the InDUC, this measure may still be a clinically important tool to utilize to 
encourage clients to reflect on how substance use has impacted lives. Anecdotally, clients 
tended to report that the review of these consequences was useful as they did not realize 
how pervasive their substance use-related problems were. Furthermore, although scores 
on the SOCRATES-A were not able to differentiate between completers and dropouts, 
gauging the extent a client recognizes they have a problems with alcohol, what steps s/he 
is taking to change this behavior, and the degree of ambivalence that exists in relation to 
making such changes also has value for a clinician who is attempting to facilitate 
treatment engagement and participation. 
 In this particular treatment program, there appear to be several “red flags” that 
indicate a client may be at risk for premature treatment dropout. From a demographic 
standpoint, clinicians should be aware that younger clients and clients who are not 
married tend to drop out of this program more frequently than their older, married 
counterparts. Diagnostically speaking, clients who meet criteria for an anxiety disorder, 
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opiate use disorder, or cocaine use disorder are also more likely to drop out of treatment 
than other clients. Armed with this information, clinicians in this program may be better 
able to detect and attend to the unique treatment needs of these particular clients by 
consistently checking directly with these clients to see if their needs are being met, 
openly discussing what unmet needs remain, and brainstorming about how to address the 
unmet needs.  
In order to keep the substance abuse treatment field moving forward and tackling 
the complex nature of treatment retention, future research needs to move beyond focusing 
solely on the client and examine interaction between client attributes (e.g., demographic 
characteristics, substances of use, level of functioning), treatment processes (e.g., 
therapeutic alliance, satisfaction with treatment), and the philosophy of the treatment 
program and the services it has to offer (Luke et al., 1996; Mertens & Weisner, 2000; 
Stark, 1992). Assessment also needs to take place throughout the treatment process 
because the decision to stay in treatment or to drop out is not a one-time occurrence; 
rather, it is an ongoing choice that clients make. In addition to actual treatment 
interventions, the dynamics of the treatment process including a positive therapeutic 
alliance and client satisfaction with services have been linked to enhanced treatment 
retention (Meier et al., 2005; Simpson, Brown et al., 1997; Simpson & Joe, 2004; 
Simpson, Joe, Rowan-Szal, & Greener, 1997). More qualitative inquiries may be of 
particular utility in developing a better understanding of these processes and their 
relationship to substance abuse treatment dropout. 
More specifically, prospective studies that follow clients through treatment and 
obtain information including personal characteristics, treatment process factors, and 
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treatment services that impact the client’s decision to stay in treatment or to drop out 
would be beneficial. In an exploratory study of adolescent substance abuse treatment, 
White, Godley, and Passetti (2004) utilized in-depth interviews with 12 adolescents and 4 
parents to examine expectations of treatment compared to actual treatment, reactions to 
different types of treatment sessions, definitions of treatment success, and aspects of 
treatment were regarded as the most and least helpful. The authors noted that in a field 
where a premium is put on treatment engagement and retention, taking the consumer’s 
treatment experience into consideration when designing and enhancing treatment 
programming and increasing consumer input in treatment planning can only improve 
treatment retention and in turn, treatment outcomes.  
Treatment 
Within the behavioral health field as a whole, and in the substance abuse 
treatment field in particular, there has been increasing pressure to move beyond the mere 
description and identification of factors that are associated with treatment retention 
and/or positive treatment outcomes. The focus is slowly shifting to designing, 
implementing, and evaluating individually-tailored treatment interventions that 
correspond to the distinct, yet shared, needs of various subgroups of clients (Castel et al., 
2006; Mertens & Weisner, 2000; Rapkin & Dumont, 2000; Veach et al., 2000). Although 
positive substance abuse treatment outcomes have been detected across a multitude of 
modalities and programs, and it appears that the actual treatment interventions employed 
may not have as much impact as previously thought (Hubbard et al., 1997; Joe et al., 
1999; Miller, 1992; Miller et al., 2001; Project MATCH Research Group, 1998b); 
however, “matching treatment settings, interventions, and services to each individual’s 
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particular problems and needs is critical to his or her success in returning to productive 
functioning in the family, workplace, and society” (NIDA, 1999, p. 3). The components 
of comprehensive drug abuse treatment are outlined in Figure 5 and encompass core 
services (e.g., intake assessment, treatment planning, behavioral therapy) and wraparound 
services (e.g., legal services, child care services, vocational services).  
 
 
 
Figure 5. Components of comprehensive drug abuse treatment. From Principles of Drug 
Abuse Treatment: A Research-Based Guide (2nd ed.) by the National Institute of Drug 
Abuse, 2004, p. 8.  
 
 
 
 Research at the individual program level should guide the program’s decisions 
regarding resource allocation to the delineated core treatment services and wraparound 
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services. For example, this study detected a high rate (52%) of psychological 
comorbidity, thus efforts should be made to integrate mental health treatment into the 
substance abuse treatment program and to establish relationships with specialized mental 
health service providers in the event a referral is necessary. On the other hand, this 
sample was particularly educated, with only about 8% not earning a high school diploma. 
Consequently, apportioning a great deal of resources to secure educational services for 
clients in this program would likely be an ineffective use of provider time and program 
money.  
 The general manner in which treatment services are matched to client needs in 
this particular program could be anchored in the subgroup classification scheme detected 
by this study: pervasive concerns polysubstance use disorder, severe concerns alcohol 
use disorder, moderate concerns drug use disorder, and minimal concerns alcohol use 
disorder. For example, the pervasive concerns polysubstance use disorder cluster had 
considerable elevations on alcohol and drug ASI composite scores, along with multiple 
comorbid issues: highest medical, employment, family/social, and psychiatric composite 
scores. Thus, providers could anticipate that these individuals would require a great deal 
of case management interventions to link them to employment/vocational resources, 
medical services, legal aid, and mental health treatment. On the other hand, individuals 
falling into the minimal concerns alcohol use disorder group would likely need minimal 
adjunct services and providers might focus primarily on the core aspects of substance 
abuse treatment: behavior therapy, substance use monitoring, participating in self-help 
groups, and arranging for aftercare. The moderate concerns drug use disorder reported 
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extensive family/social relationship problems, thus a key treatment component for this 
group would likely be involving a significant other(s) in treatment. 
 Luke et al. (1996) outlined a potential treatment matching heuristic based on their 
cluster analysis results that would align well with the results detected in this study. See 
Table 10. Interventions are organized along two broad dimensions: level of functioning 
and types of substance use. Applied to the clients in this program, the serious concerns 
alcohol use disorder group might respond well to a moderate-length outpatient treatment 
stay and involvement in Alcoholics Anonymous. Due to relatively high employment and 
legal concerns, these clients might also benefit from an approach that links the client to 
specific community resources such as Wisconsin’s Department of Vocational 
Rehabilitation and Legal Action of Wisconsin, an agency that provides legal 
representation to low-income persons. Alternatively, the minimal concerns alcohol use 
disorder group may get their needs met with a shorter outpatient treatment episode 
focused on more proactive measures to avert significant functional decline such as 
relapse prevention and aftercare, while providers may seriously consider a referral to 
residential treatment for the pervasive concerns polysubstance use disorder group due to 
the high degree of concurrent medical, employment, family/social, and psychiatric 
distress. 
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Table 10. 
 
Treatment Matching Heuristic for Substance Use Treatment Clients  
 
General Domain 
 
Specific Category 
 
Characteristics of Treatment Module 
 
Level and 
breadth of 
functioning  
 
Relatively high 
functioning across all 
domains 
 
• Short-term 
• Links to community support 
• Prevention-oriented 
 
Low functioning in 
specific domains 
 
• Moderate length 
• Targeted to specific problem areas 
• Specific community links 
 
Low functioning in 
multiple domains 
 
• Long-term 
• Broad-based focus 
• Most appropriate for residential care 
 
Type of 
substance use 
problem 
 
Minimal substance use 
problems 
 
• Assess for potential substance abuse 
• Prevention 
 
Only alcohol use 
problems 
 
• Alcoholics Anonymous or other 
substance-specific support group 
  
Only drug use 
problems 
 
• Narcotics Anonymous or other 
substance-specific support group 
 
 
Polysubstance use 
problems 
 
• Link to multiple or general substance 
abuse support group 
• Integrative substance abuse treatment 
Note. Adapted from “Exploring the Diversity of Dual Diagnosis: Utility of Cluster Analysis for Program 
Planning,” by D. A. Castel et al., 1996, Journal of Mental Health Administration, 23, p. 312.  
 
 
 
 Such frameworks seem plausible and make theoretical “sense,” but without 
subjecting them to scientific scrutiny, they will merely remain conjecture. Designing and 
carrying out effectiveness investigations based on treatment matching heuristics like the 
one outlined above would assist individual treatment programs in their quest to design 
service delivery programs that are scientifically-driven and empirically-validated. Such 
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research would likely improve the provision of substance abuse treatment, which would 
in turn enhance treatment retention, which would consequently help clients achieve more 
positive treatment outcomes, the ultimate goal of substance abuse treatment research.   
Additional areas of inquiry to consider based on this particular study sample is the 
level of psychiatric comorbidity detected. A further examination of whether or not clients 
are receiving adequate treatment of concurrent psychiatric conditions will be important to 
assess how well this particular program is meeting the needs of its dually-diagnosed 
clientele and whether or not such symptoms are impacting participation in substance 
abuse treatment. Specialized, integrated treatment could also be considered for this 
subgroup; however, further well-controlled research is needed to identify exactly which 
interventions, both psychotherapeutic and pharmacological, are safe and effective 
(Petrakis et al., 2002). Though previous substance abuse treatment research has explored 
treatment retention and found that correlates may differ by gender, this factor did not 
receive much attention in this particular study (Siqueland et al; Green et al.; Mertens & 
Weisner, 2000). Additional inquiry may consider differences in the development and 
identification of substance use disorders between the sexes, and explore how these 
dynamics influence various aspects of substance abuse treatment: treatment-seeking 
behaviors; access and barriers; initiation, engagement, retention, and treatment outcomes 
(Green, 2006). Quality and availability of social support as also been implicated in 
substance abuse treatment processes (Broome et al., 2002; Dobkin et al., 2002), though 
was not thoroughly examined here. Future research in this program may want to explore 
the role of social support and social networks within the context of treatment in order to 
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incorporate ancillary services that may enhance treatment retention and treatment 
outcomes.  
Mammo and Weinbaum (1993) note that “systems that by virtue of their design 
inadvertently neglect particular groups should be corrected to reflect appropriate and 
effective treatment plans for a mix of clients” (p. 101). The dynamic nature of substance 
abuse and dependence and the continuous transformation of substance abuse treatment 
clientele (i.e., prevalence in certain demographic groups, substance(s) of choice, routes of 
administration) call for an ongoing reassessment of treatment participants, treatment 
programs, and treatment systems.  
Limitations of Present Study 
 Important limitations should be considered in interpreting the findings of this 
study. Firstly, various protocol implementation difficulties interfered with the data 
collection process. The timing of new client notification, space constraints, and 
inconsistent client attendance at treatment groups affected the assessment team’s ability 
to evaluate each new client in the treatment program. In particular, treatment participants 
who dropped out of treatment after only a few treatment sessions or had inconsistent 
attendance at the outset of treatment posed problems for the assessment team because the 
client may not have been available for testing during the window of accessibility. 
Consequently, the study sample contained an overrepresentation of treatment completers. 
Study participants were more likely to complete treatment, participated in significantly 
more treatment groups, and stayed in treatment for a longer period of time than 
nonparticipants. The study’s retention rate (59%) was also greater than the retention rate 
detected in the population from which it was drawn (49%). Generally speaking, future 
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investigations with substance abuse treatment outpatients should carefully contemplate 
the logistics of carrying out the investigation, anticipate potential problems, and work 
with the treatment program staff to devise reasonable solutions. More specifically, since 
this study was an initial cooperative attempt to create and execute a comprehensive 
assessment protocol, additional research within this program can improve upon the 
foundation outlined here by addressing the identified logistical concerns. 
 Although the primary aims of this study were to describe the treatment 
characteristics of the current sample and identify differences between those who 
completed treatment and those who dropped out, this dichotomy was likely too narrow of 
a categorization to adequately encapsulate treatment status. An alternative classification 
scheme could consist of the following: completion (i.e., client accomplishes the initially 
agreed upon treatment plan or revised treatment plan), dropout (i.e., client leaves 
treatment against staff advice or client contact is lost), therapeutic discharge (i.e., 
treatment is discontinued for reasons such as nonadherence with program rules), and 
other (i.e., medical or psychiatric hospitalization) (Mammo & Weinbaum, 1993). Of note, 
the current study did attempt to expand the dichotomous treatment status, to an extent, by 
reporting the incidence of clients who returned to the same treatment program for a 
subsequent treatment episode. Of the treatment dropouts, 25% returned for a subsequent 
treatment episode (i.e., treatment stopout), while about 19% of treatment completers also 
returned for additional treatment at a later date (i.e., treatment repeater). However, no 
additional statistical analyses were carried out to determine the distinguishing 
characteristics of these subgroups to better describe this sample of substance abuse 
treatment participants and ascertain potential elements that impact reengagement in this 
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treatment program. Furthermore, the treatment dropout group in this study included both 
clients who were expelled from the program due to violation of treatment rules and 
clients who stopped attending treatment. As Rabinowitz and Sergio (1998) highlight, 
there are likely fundamental differences between these subgroups of dropouts that should 
be examined to enhance understanding of the substance abuse treatment dropout 
phenomenon.   
 One variable that was not examined in this study that has been linked to treatment 
retention and treatment outcomes, and has become a driving force in contemporary 
substance abuse treatment, is third-party reimbursement. The power of managed care 
entities to control the type and quantity of substance abuse treatment calls for a more in-
depth investigation of the impact of insurance coverage on substance abuse treatment 
processes. For this particular program, future research should consider insurance carrier 
status and respective benefits (i.e., approved number of treatment sessions) when 
examining treatment retention and dropout. Moreover, employer referrals, psychiatric 
services, and drug-related services may enhance retention among insured populations 
(Mertens & Weisner, 2000), thus exploring how available supplementary services can 
impact substance abuse treatment may be a worthy area of inquiry. This treatment 
program also serves a number of self-pay clients and should consider if the treatment 
needs and outcomes of these clients differ from those who utilize insurance benefits.  
 An additional variable that was virtually neglected in this study that has been 
positively linked to treatment entry and retention in previous research is external legal 
pressures and sanctions (Green et al., 2002; Hiller, Knight, Broome, & Simpson, 1998; 
Hubbard et al., 1989; Joe et al., 1999; Simpson, 1993). Although being prompted to 
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complete treatment was an element of the ASI legal composite score, it did not receive 
any individual attention in the analyses. The criminal justice system has utilized 
substance abuse treatment as part of their efforts to control illicit drug use and reduce 
alcohol abuse for much of the past century (Hiller et al., 1998). External pressure from 
the criminal justice system may be directly tied to a particular charge or sentence, such as 
court-mandated substance abuse treatment as part of a sentence for driving while 
intoxicated or a provision of one’s probation or parole. In these instances, violations of 
the stipulation would result in a legal ramification such as jail time, thus clients have high 
external motivation to complete substance abuse treatment. Alternatively, a client may 
seek to be more proactive and complete a substance abuse treatment program in order to 
obtain a more lenient sentence in an outstanding legal matter, such as a driving while 
intoxicated charge or a drug possession charge (Hiller et al., 1998). In both instances, the 
likelihood of entering and completing substance abuse treatment his often enhanced by 
the existing pressure from the criminal justice system. Consequent investigations should 
examine this variable more closely to better describe the attributes of individuals entering 
substance abuse treatment and this factor’s impact on treatment retention. 
 Finally, not unlike the large majority of existing substance abuse treatment 
research, this study employed quantitative methods to answer the research questions of 
interest. Within the substance use disorder field, “qualitative techniques have played an 
important role in complementing quantitative research by helping to interpret, illuminate, 
illustrate, and qualify empirically-determined statistical relationships” (Neale, Allen, & 
Coombes, 2005, p. 1591). Researchers have advised that qualitative methods should be 
employed both independently and in conjunction with quantitative investigations to 
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elucidate factors that facilitate and hinder treatment entry; treatment engagement; lapses 
and relapses to substance use during and following treatment; planned and unplanned 
treatment termination; and treatment readmission. Further examination of the existing 
treatment system in terms of the services provided and their suitability for the populations 
served has also been suggested (Battjes, Onken, & Delany, 1999; Neale et al., 2005). A 
fitting follow-up to this study could explore the reasons and factors related to remaining 
in substance abuse treatment or dropping out, which could potentially validate the 
findings from the present investigation and expand the conceptualization of the relatively 
elusive phenomenon of substance abuse treatment dropout (Neale et al., 2005). 
Conclusion 
 
 Despite the limitations outlined above, this study was a successful initial step in 
describing the clientele served in the intensive outpatient drug-free chemical dependency 
program at Rogers Memorial Hospital. Furthermore, it identified client attributes that 
relate to treatment retention, including age, marital status, income, psychological 
comorbidity, substance(s) of use, and extent of use. It also delineated subgroups of clients 
based on age, negative consequences related to substance use, and ASI composite scores 
across medical, employment, alcohol and drug, legal, social, and psychiatric domains. 
Identified subgroups appeared to vary along two broad dimensions: degree of functional 
impairment and type(s) of substance use. Hopefully, these results will serve as a catalyst 
for future investigations within this treatment program as it continues to design, 
implement, and evaluate clinically-relevant and empirically-driven assessment 
procedures and subsequent interventions aimed at improving treatment retention and 
treatment outcomes.  
214 
  
215 
REFERENCES 
 
 
Ahmadi, J., Kampman, K., Dackis, C., Sparkman, T., & Pettinati, H. (2008). Cocaine  
withdrawal symptoms identify “Type B” cocaine-dependent patients. American 
Journal of Addictions, 17, 60-64. 
 
Aiken, L. R. (2003). Psychological testing and assessment (11th ed.). Boston: Allyn &  
Bacon.Allen, J. P. (2003). Assessment of alcohol problems: An overview. In J.  
 
Allen & V. Wilson (Eds.), Assessing alcohol problems: A guide for clinicians and  
researchers (2nd ed.). (NIH Publication No. 03-3745, pp. 1-11). Bethesda, MD: 
National Institute on Alcohol Abuse and Alcoholism. 
 
Allen, J. P. & Kadden, R. M. (1995). Matching clients to alcohol treatments. In R. K.  
Hester & W. R. Miller (Eds.), Handbook of alcoholism treatment approaches: 
Effective alternatives (pp. 278-292). Boston: Allyn and Bacon.   
 
Allison, P. D. (2002). Missing Data. Thousand Oaks, CA: Sage Publications. 
 
Alterman, A. I., McDermott, P. A., Cacciola, J. S., Rutherford, M. J., Boardman, C. R.,  
McKay, J. R., & Cook, T. G. (1998). A typology of antisociality in methadone 
patients. Journal of Abnormal Psychology, 107, 412-422. 
 
Alterman, A. I., McKay, J. R., Mulvaney, F. D., & McLellan, A. T. (1996). Prediction of  
attrition from day hospital treatment in lower socioeconomic cocaine-dependent 
men. Drug and Alcohol Dependence, 40, 227-233. 
 
American Psychiatric Association (2000).  Diagnostic and statistical manual of mental  
disorders (4th ed., text revision).  Washington, DC: American Psychiatric 
Association. 
 
American Society of Addiction Medicine. (1996). Patient placement criteria for the  
treatment of substance-related disorders (2nd ed.). Chevy Chase, MD: American 
Society of Addiction Medicine.  
 
Anglin, M. D., Hser, Y., & Grella, C. E. (1997). Drug addiction and treatment careers  
among clients in the Drug Abuse Treatment Outcomes Study (DATOS). 
Psychology of Addictive Behaviors, 11, 308-323. 
 
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M.,  
et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol 
dependence: The COMBINE study: A randomized controlled trial. Journal of the 
American Medical Association, 295, 2003-2017. 
 
Appleby, L., Dyson, V., Altman, E., & Luchins, D. J. (1997). Assessing substance use in  
216 
multiproblem patients: Reliability and validity of the Addiction Severity Index in a 
mental hospital population. Journal of Nervous and Mental Disease, 185, 159-165. 
 
Arfken, C. L., Klein, C., di Menza, S., & Schuster, C. R. (2001). Gender differences in  
problem severity at assessment and treatment retention. Journal of Substance Abuse 
Treatment, 20, 53-57. 
 
Babor, T. F. (1997). When cluster analysis fails: method and theory in the search for  
alcoholic subtypes. Addiction, 92, 1665-1666. 
 
Babor, T. F., Dolinsky, Z. S., Meyer, R. E., Hesselbrock, M., Hofmann, M., & Tennen,  
H. (1992). Types of alcoholics: Concurrent and predictive validity of some common 
classification schemes. British Journal of Addiction, 87, 1415-1431. 
 
Babor, T. F., Hofmann, M., Del Boca, F. K., Hesselbrock, M., Meyer, R. E., Dolinsky, Z.  
S., et al. (1992). Types of alcoholics, I: Evidence for an empirically derived 
typology based on indicators of vulnerability and severity. Archives of General 
Psychiatry, 49, 599-608. 
 
Ball, S. A., Carroll, K. M., Babor, T. F., & Rounsaville, B. J. (1995). Subtypes of cocaine  
abusers: Support for Type A – Type B distinction. Journal of Consulting and 
Clinical Psychology, 63, 115-124. 
 
Ball, S. A., Carroll, K. M., Canning-Ball, M., & Rounsaville, B. J. (2006). Reasons for  
dropout from drug abuse treatment: Symptoms, personality, and motivation. 
Addictive Behaviors, 31, 320-330. 
 
Barkham, M., Connell, J., Stiles, W. B., Miles, J. N. V., Margison, F., Evans, C., et al.  
(2006). Does-effect relations and responsive regulation of treatment duration: The 
good enough level. Journal of Consulting and Clinical Psychology, 74, 160-167. 
 
Battjes, R.J., Onken, L.S., & Delany, P.J. (1999). Drug abuse treatment entry and  
engagement: Report of a meeting on treatment readiness. Journal of Clinical  
Psychology, 55, 643-657. 
 
Berghofer, G., Schmidl, F., Rudas, S., Steiner, E., & Schmitz, M. (2002). Predictors of  
treatment discontinuity in outpatient mental health care. Social Psychiatry and 
Psychiatric Epidemiology, 37, 276-282. 
 
Bergmark, A. (2008). On treatment mechanisms – what can we learn from the  
COMBINE study? Addiction, 103, 703-705. 
 
Blanchard, K. A., Morgenstern, J., Morgan, T. J., Labouvie, E. W., & Bux, D. A. (2003).  
Assessing consequences of substance use: Psychometric properties of the Inventory 
of Drug Use Consequences. Psychology of Addictive Behaviors, 17, 328-331. 
 
217 
Bohn, M. J., & Meyer, R. E. (1999). Typologies of addiction. In M. Galanter, & H.  
Kleber (Eds.), The American Psychiatric Press textbook of substance abuse 
treatment (pp. 97-108). Washington, DC: American Psychiatric Press. 
 
Booth, B. M., Russell, D. W., Soucek, S., & Laughlin, P. R. (1992). Social support and  
outcome of alcoholism treatment: An exploratory analysis. American Journal of 
Drug and Alcohol Abuse, 18, 87-101. 
 
Booth, B. M., Yates, W. R., Petty, F., & Brown, K. (1991). Patient factors predicting  
early alcohol-related readmissions for alcoholics: Role of alcoholism severity and 
psychiatric co-morbidity. Journal of Studies on Alcohol, 52, 37-43. 
 
Borgen, F. H., & Barnett, D. C. (1987). Applying cluster analysis in counseling  
psychology research. Journal of Counseling Psychology, 34, 456-468. 
 
Borkovec, T. D. (1997). On the need for a basic science approach to psychotherapy  
research. Psychological Science, 8, 145-147. 
 
Bowser, B. P. (1998). Drug treatment programs and research: The challenge of  
bidirectionalilty. In S. Lamb, M. Greenlick, & D. McCarty, D. (Eds.), Bridging the 
gap between practice and research: Forging partnerships with community-based 
drug and alcohol treatment (pp. 135-146). Washington, DC: National Academy 
Press. 
 
Brewer, D. D., Catalano, R. F., Haggerty, K., Gainey, R. R., & Fleming, C. B. (1998). A  
meta-analysis of predictors of continued drug use during and after treatment for 
opiate addiction. Addiction, 93, 73-92. 
 
Bride, B. E. (2001). Single-gender treatment of substance abuse: Effect on treatment  
retention and completion. Social Work Research, 25, 223-232. 
 
Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999). Psychiatric comorbidity  
measures as predictors of retention in drug abuse treatment programs. Health 
Services Research, 34, 791-798. 
 
Broome, K. M., Simpson, D. D., & Joe, G. W. (1999). Patient and program attributes  
related to treatment process indicators in DATOS. Drug and Alcohol Dependence, 
57, 127-135. 
 
Broome, K. M., Simpson, D. D., & Joe, G. W. (2002). The role of social support  
following short-term inpatient treatment. The American Journal on Addiction, 11, 
57-65. 
 
Brown, L. S., Alterman, A. I., Rutherford, M. J., Cacciola, J. S., & Zabellero, A. R.  
(1993). Addiction Severity Index scores of four racial/ethnic and gender groups of 
methadone maintenance patients. Journal of Substance Abuse, 5, 269-279. 
218 
 
Cacciola, J. S., Koppenhaver, J. M., McKay, J. R., & Alterman, A. I. (1999). Test-retest  
reliability of the lifetime items on the Addiction Severity Index. Psychological 
Assessment, 11, 86-93. 
 
Carey, K. B., Cocco, K. M., & Correia, C. J. (1997). Reliability and validity of the  
Addiction Severity Index among outpatients with severe mental illness. 
Psychological Assessment, 9, 422-428. 
 
Carise, D., & Gurel, O. (2003). Benefits of integrating assessment technology with  
treatment: The DENS project. In J. Sorensen, R. Rawson, J. Guydish, & J. E. 
Zweben (Eds.). Drug abuse treatment through collaboration: Practice and research 
partnerships that work (pp. 181-196). Washington, DC: American Psychological 
Association. 
 
Carroll, K. M. (1999). Behavioral and cognitive behavioral treatments. In B. S. McCrady  
& E. E. Epstein (Eds.), Addictions: A comprehensive guidebook (pp. 250-267). New 
York: Oxford University Press. 
 
Carroll, K. M., Ball, S. A., Nich, C., Martino, S., Frankforter, T. L., Farentinos, C., et al. 
(2006). Motivational interviewing to improve treatment engagement and outcome 
in individuals seeking treatment for substance abuse: A multisite effectiveness 
study. Drug and Alcohol Dependence, 81, 301-312. 
 
Carroll, K. M., Libby, B., Sheehan, J., & Hyland, N. (2001). Motivational interviewing to  
enhance treatment initiation in substance abusers: An effectiveness study. The 
American Journal of Addictions, 10, 335-339. 
 
Carroll, K. M., & Rounsaville, B. J. (2003). Bridging the gap: A hybrid model to link  
efficacy and effectiveness research in substance abuse treatment. Psychiatric 
Services, 54, 333-339. 
 
Castel, S., Rush, B., Urbanoski, K., & Toneatto, T. (2006). Overlap of clusters of  
psychiatric symptoms among clients of a comprehensive addiction treatment 
service. Psychology of Addictive Behaviors, 20, 28-35. 
 
Center on Alcoholism, Substance Abuse, and Addictions. (n.d.) Retrieved  
September 7, 2007, from http://casaa.unm.edu/.  
 
Center for Substance Abuse Treatment. (2005). Substance abuse treatment for persons  
with co-occurring disorders: Treatment improvement protocol (TIP) series 42 
(DHHS Publication No. (SMA) 05-3992). Rockville, MD: Substance Abuse and 
Mental Health Services Administration. 
 
Chambless, D. L., & Hollon, S. D. (1998). Defining empirically supported therapies.  
Journal of Clinical and Consulting Psychology, 66, 7-18. 
219 
 
Charney, D. A., Palacios-Boix, J., Negrete, J. C., Dobkin, P. L., & Gill, K. J. (2005).  
Association between concurrent depression and anxiety and six-month outcome of 
addiction treatment. Psychiatric Services, 56, 927-933. 
 
Chen, S., Barnett, P. G., Sempel, J. M., & Timko, C. (2006). Outcomes and costs of  
matching the intensity of dual-diagnosis treatment to patients’ symptom severity. 
Journal of Substance Abuse Treatment, 31, 95-105. 
 
Chou, C., Hser, Y., & Anglin, M. D. (1998). Interaction effects of client and treatment  
program characteristics on retention: An exploratory analysis using hierarchical 
linear models. Substance Use & Misuse, 33, 2281-2301. 
 
Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed  
and standardized assessment instruments in psychology. Psychological Assessment, 
6, 284-290. 
 
Clatworthy, J., Buick, D., Hankings, M., Weinman, J., & Horne, R. (2005). The use and  
reporting of cluster analysis in health psychology: A review. British Journal of 
Health Psychology, 10, 329-358. 
 
Claus, R. E., & Kindleberger, L. R. (2002). Engaging substance abusers after centralized  
assessment: Predictors of treatment entry and dropout. Journal of Psychoactive 
Drugs, 34, 25-31. 
 
Craddock, S. G., Rounds-Bryant, J. L., Flynn, P. M., & Hubbard, R. L. (1997).  
Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 
1969 to 1993. American Journal of Drug and Alcohol Abuse, 23, 43-59. 
 
Curran, G. M., Kirchner, J. E., Worley, M., Rookery, C., & Booth, B. M. (2002).  
Depressive symptomology and early attrition from intensive outpatient substance 
use treatment. The Journal of Behavioral Health Services and Research, 29, 138-
143. 
 
Del Boca, F. K., & Hesselbrock, M. N. (1996). Gender and alcoholic subtypes. Alcohol  
Health and Research World, 20, 56–62. 
 
De Leon, G. (1991). Retention in drug-free therapeutic communities. NIDA Research  
Monograph, 106, 225-251. 
 
De Leon, G., Melnick, G., & Kressel, D. (1997). Motivation and readiness for therapeutic  
community treatment among cocaine and other drug abusers. American Journal of 
Drug and Alcohol Abuse, 23, 169-189. 
 
Dennis, M. L., Perl, H. I., Huebner, R. B., & McLellan, A. T. (2000). Twenty-five  
220 
strategies for improving the design, implementation, and analysis of health services 
research related to alcohol and other drug abuse treatment. Addiction, 95 (Suppl. 3), 
S281-S308. 
 
DiClemente, C. C. (2003). Addiction and change: How addictions develop and addicted  
people recover. New York: Guilford Press. 
 
Daughters, S. B., Lejuez, C. W., Bornovalova, M. A., Kahler, C. W., Strong, D. R., &  
Brown, R.A. (2005). Distress tolerance as a predictor of early treatment dropout in a 
residential substance abuse treatment facility. Journal of Abnormal Psychology, 
114, 729-734. 
 
Dearing, R. L., Barrick, C. B., Dermen, K. H., & Walitzer, K. S. (2005). Indicators of  
client engagement: Influences on alcohol treatment satisfaction and outcomes. 
Psychology of Addictive Behaviors, 19, 71-78. 
 
Del Boca, F. K., & Hesselbrock, M. N. (1996). Gender and alcoholic subtypes. Alcohol  
Health and Research World, 20, 56-62. 
 
De Leon, G., Melnick, G., & Kressel, D. (1997). Motivation and readiness for therapeutic  
community treatment among cocaine and other drug abusers. American Journal of 
Drug and Alcohol Abuse, 23, 169-189. 
 
Demmel, R., Beck, B., Richter, D., & Reker, T. (2004). Readiness to change in a clinical  
sample of problem drinkers: Relation to alcohol use, self-efficacy, and treatment 
outcome. European Addiction Research, 10, 133-138. 
 
Dobkin, P. L., De Civita, M., Paraherakis, A., & Gill, K. (2002). The role of functional  
social support in treatment retention and outcomes among outpatient adult 
substance abusers. Addiction, 97, 347-356. 
 
Donovan, D. M. (2003). Assessment to aid in the treatment planning process. In J. Allen  
& V. Wilson (Eds.), Assessing alcohol problems: A guide for clinicians and 
researchers (2nd ed.) (NIH Publication No. 03-3745, pp. 125-188). Bethesda, MD: 
National Institute on Alcohol Abuse and Alcoholism. 
 
Donovan, D. M., & Mattson, M. E. (1994). Alcoholism treatment matching research:  
Methodological and clinical issues. Journal of Studies on Alcohol, Suppl. 12, 5-14.  
 
Donovan, D. M., Rosengren, D. B., Downey, L., Cox, G., & Sloan, K. L. (2001).  
Attrition prevention with individuals awaiting publicly funded drug treatment.  
Addiction, 96, 1149-1160. 
 
Epstein, E. E., Labouvie, E., McCrady, B. S., Jensen, N. K., & Hayaki, J. (2002). A  
multi-site study of alcohol subtypes: classification and overlap of unidimensional 
and multi-dimensional typologies. Addiction, 97, 1041-1053. 
221 
 
Etheridge, R. M., Hubbard, R. L., Anderson, J., Craddock, S. G., & Flynn, P. M. (1997).  
Treatment structure and program services in the Drug Abuse Treatment Outcome 
Study (DATOS). Psychology of Addictive Behaviors, 11, 244-260. 
 
Fals-Stewart, W. (1992). Personality characteristics of substance abusers: An MCMI  
cluster typology of recreational drug users treated in a therapeutic community and 
its relationship to length of stay and outcome. Journal of Personality Assessment, 
59, 515-527. 
 
Fiorentine, R., & Anglin, M. D. (1996). More is better: Counseling participation and the  
effectiveness of outpatient drug treatment. Journal of Substance Abuse Treatment, 
13, 341-348. 
 
Fiorentine, R., Nakashima, J., & Anglin, M. D. (1999). Client engagement in drug  
treatment. Journal of Substance Abuse Treatment, 17, 199-206. 
 
Flannery, B. A., Morgenstern, J., McKay, J., Wechsbert, W. M., & Litten, R. Z. (2004).  
Co-occuring alcohol and cocaine dependence: Recent findings from clinical and 
field studies. Alcoholism: Clinical and Experimental Research, 28, 976-981. 
 
Fletcher, B. W., Tims, F. M., & Brown, B. S. (1997). Drug abuse treatment outcome  
study (DATOS): Treatment evaluation research in the United States. Psychology of 
Addictive Behaviors, 11, 216-229. 
 
Garcia J.J., Collado, E.N., Gomez, J.L., & Arias, R.M. (2006). Subtypes of drug-addicts  
in treatment: Empirical support for a distinction between Type A and Type B. 
Psicothema, 18, 43-51. 
 
Gillaspy, Jr., J. A., & Campbell, T. C. (2006). Reliability and validity of scores from the  
Inventory of Drug Use Consequences. Journal of Addictions & Offender 
Counseling, 27, 17-27. 
 
Godfried, M. R., & Wolfe, B. E. (1996). Psychotherapy practice and research: Repairing  
a strained alliance. American Psychologist, 51, 1007-1016. 
 
Grant, K. A., Tonigan, J. S., & Miller, W. R. (1994). Comparison of three alcohol  
consumption measures: A concurrent validity study. Journal of Studies on Alcohol, 
56, 168-172. 
 
Green, C. A. (2006). Gender and use of substance abuse treatment services. Alcohol  
Research & Health, 29, 55-62.   
 
Green, C. A., Polen, M. R., Dickinson, D. M., Lynch, F. L., & Bennett, M. D. (2002).  
222 
Gender differences in predictors of initiation, retention, and completion in an HMO-
based substance abuse treatment program. Journal of Substance Abuse Treatment, 
23, 285-295. 
 
Griffith, J. D., Knight, D. K., Joe, G. W., & Simpson, D. D. (1998). Implications of  
family and peer relations for treatment engagement and follow-up outcomes: An 
integrative model. Psychology of Addictive Behaviors, 12, 113-126. 
 
Griffith, J. D., Rowan-Szal, G. A., Roark, R. R., & Simpson, D. D. (2000). Contingency  
management in outpatient methadone treatment: A meta-analysis. Drug and 
Alcohol Dependence, 58, 55-66. 
 
Hair, J. F., & Black, W. C. (2003). Cluster analysis. In L. Grimm & P. Yarnold (Eds.),  
Reading and understanding more multivariate statistics (147-205). Washington, 
DC: American Psychological Association.  
 
Haller, D. L., Miles, D. R., & Dawson, K. S. (2002). Psychopathology influences  
treatment retention among drug-dependent women. Journal of Substance Abuse 
Treatment, 23, 431-436. 
 
Harwood, H. (2000). Updating estimates of the economic costs of alcohol abuse in the  
United States: Estimates, update methods, and data. Report prepared by the  
Lewin Group for the National Institute on Alcohol Abuse and Alcoholism. 
Retrieved from http://pubs.niaaa.nih.gov/publications/economic-2000/.  
 
Harwood, H. J., Collins, J. J., Hubbard, R. L., Marsden, M. E., & Rachal, J. V. (1988).  
The costs of crime and benefits of drug abuse treatment: A cost benefit analysis 
using TOPS data. In C. Leukefeld & F. Tims (Eds.), Compulsory treatment of drug 
abuse: Research and clinical practice (pp. 209-235; NIDA Research Monograph, 
86, NIH Publication No. 94-3713). Washington, DC: U.S. Government Printing 
Office. 
 
Heil, S. H., Badger, G. J., & Higgins, S. T. (2001). Alcohol dependence among cocaine- 
dependent outpatients: Demographics, drug use, treatment outcome and other 
characteristics. Journal of Studies on Alcohol, 62, 14-22. 
 
Hesse, M. (2009). Integrated psychological treatment for substance use and co-morbid  
anxiety or depression vs. treatment for substance use alone: A systematic review of 
the published literature. BMC Psychiatry, 9. 
 
Hesselbrock, M. N., Hesselbrock, V. M., & Epstein, E. E. (1999). Theories of etiology of  
alcohol and other drug use disorders. In B. S. McCrady & E. E. Epstein (Eds.), 
Addictions: A comprehensive guidebook (pp. 50-72). New York: Oxford University 
Press. 
 
Hewes, R. L., & Janikowski, T. P. (1998). Readiness for change and treatment outcome  
223 
among individuals with alcohol dependency. Rehabilitation Counseling Bulletin, 
42, 76-93. 
 
Hiller, M.L., Knight, K., Broome, K.M., & Simpson, D.D. (1998). Legal pressure and  
treatment retention in a national sample of long-term residential programs. Criminal 
Justice and Behavior, 25(4), 463-481. 
 
Hser, Y., Evans, E., & Huang, Y. (2005). Treatment outcomes among women and men  
methamphetamine abusers in California. Journal of Substance Abuse Treatment, 28, 
77-85. 
 
Hser, Y., Evans, E., Huang, D., & Anglin, M. D. (2004). Relationship between drug  
treatment services, retention, and outcomes. Psychiatric Services, 55, 767-774. 
 
Hser, Y., Huang, D., Teruya, C., & Anglin, M. D. (2003). Gender comparisons of drug  
abuse treatment outcomes and predictors. Drug and Alcohol Dependence, 72, 255-
264. 
 
Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997).  
Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome 
Study (DATOS). Psychology of Addictive Behaviors, 11, 261-278. 
 
Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H.J., Cavanaugh, E. R., &  
Ginzburg, H.M. (1989). Drug abuse treatment: A national study of effectiveness. 
Chapel Hill: University of North Carolina Press.   
 
Huck, S. W. (2000). Reading statistics and research (3rd ed.). New York: Addison  
Wesley Longman. 
 
Institute of Medicine. (1990). Broadening the base of treatment for alcohol problems.  
Washington, DC: National Academy Press.  
 
Jarvis, T. J. (1992). Implications of gender for alcohol treatment research: A quantitative  
and qualitative review. British Journal of Addiction, 87, 1249-1261. 
 
Jellinek, E. M. (1960). Alcoholism: A genus and some of its species. Canadian Medical  
Association Journal, 83, 1341-1345. 
 
Joe, G. W., Broome, K. M., Rowan-Szal, G. A., & Simpson, D. D. (2002). Measuring  
patient attributes and engagement in treatment. Journal of Substance Abuse 
Treatment, 22, 183-196. 
 
Joe, G. W., Simpson, D. D., & Broome, K. M. (1998). Effects of readiness for drug abuse  
treatment on client retention and assessment of process. Addiction, 93, 1177-1190. 
 
Joe, G. W., Simpson, D. D., & Broome, K. M. (1999). Retention and patient engagement  
224 
models for different treatment modalities in DATOS. Drug and Alcohol 
Dependence, 57, 113-125. 
 
Joe, G. W., Simpson, D. D., Dansereau, D. F., & Rowan-Szal, G. A. (2001).  
Relationships between counseling rapport and drug abuse treatment outcomes. 
Psychiatric Services, 52, 1223-1229. 
 
Justus, A. N., Burling, T. A., & Weingardt, K. R. (2006). Client predictors of treatment  
retention and completion in a program for homeless veterans. Substance Use & 
Misuse, 41, 751-762. 
 
Kendler, K. S., Karkowski, L. M., Neale, M. C., & Prescott, C. A. (2000). Illicit  
psychoactive substance use, heavy use, abuse, and dependence in a U.S. population-
based sample of male twins. Archives of General Psychiatry, 57, 261-269. 
 
Kosten, T. R., Rounsaville, B. J., & Kleber, H. D. (1983). Concurrent validity of the  
Addiction Severity Index. Journal of Nervous and Mental Disease, 171, 606-610. 
 
Lamb, S., Greenlick, M. R., & McCarty, D. (1998). Bridging the gap between practice  
and research: forging partnerships with community-based drug and alcohol 
treatment. Washington, DC: National Academy Press. 
 
Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science, 278, 45-47. 
 
Leshner, A. I. (1997). Introduction to the special issue: The National Institute on Drug  
Abuse’s (NIDA’s) Drug Abuse Treatment Outcome Study (DATOS). Psychology 
of Addictive Behaviors, 11, 211-215.   
 
Long, C. G., Williams, M., Midgley, M., & Hollin, C. V. (2000). Within-program factors  
as predictors of drinking-outcome following cognitive-behavioral treatment. 
Addictive Behaviors, 25, 573-578. 
 
Longabaugh, R., Wirtz, P. W., DiClementer, C. C., & Litt, M. (1994). Issues in the  
development of client-treatment matching hypotheses. Journal of Studies on 
Alcohol, Suppl. 12, 46-59.  
 
Luke, D. A., Mowbray, C. T., Klump, K., Herman, S. E., & BootsMiller, B. (1996).  
Exploring the diversity of dual diagnosis: Utility of cluster analysis for program 
planning. The Journal of Mental Health Administration, 23, 296-316. 
 
McCaul, M. E., Svikis, D. S., & Moore, R. D. (2001). Predictors of outpatient treatment  
retention: patient versus substance use characteristics. Drug and Alcohol 
Dependence, 62, 9-17. 
 
McKay, J. R., & Weiss, R. V. (2001). A review of temporal effects and outcome  
225 
predictors in substance abuse treatment studies with long-term follow-ups. 
Evaluation Review, 25, 113-161. 
 
McKellar, J., Kelly, J., Harris, A., & Moos, R. (2006). Pretreatment and during treatment  
risk factors for dropout among patients with substance use disorders. Addictive 
Behaviors, 31, 450-460. 
 
McLellan, A. T., Alterman, A. I., Metzger, D. S., Grissom, G. R., Woody, G. E.,  
Luborsky, L., et al. (1994). Similarity of outcome predictors across opiate, cocaine, 
and alcohol treatments: Role of treatment services. Journal of Consulting and 
Clinical Psychology, 629, 1141-1158. 
 
McLellan, A. T., Cacciola, J. S., Alterman, A. I., Rikoon, S. H., & Carise, D. (2006). The  
Addiction Severity Index at 25: Origins, contributions, and transitions. American 
Journal of Addiction, 15, 113-124. 
 
McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., et al.  
(1992). The fifth edition of the Addiction Severity Index. Journal of Substance 
Abuse Treatment, 9, 199-213. 
 
McLellan, A. T., Luborsky, L., Cacciola, J. S., & Griffin, J.E. (1985). New data from the  
Addiction Severity Index: Reliability and validity in three centers. Journal of 
Nervous and Mental Disease, 163, 412-423. 
 
McLellan, A. T., Luborsky, L., Woody, G. E., & O’Brien, C. P. (1980). An improved  
diagnostic evaluation instrument for substance abuse patients: The Addiction 
Severity Index. Journal of Nervous and Mental Disease, 168, 26-33. 
 
McLellan, A. T., Luborsky, L., Woody, G. E., O’Brien, C. P., & Duley, K. A. (1983).  
Predicting response to alcohol and drug abuse treatments: Role of psychiatric 
severity. Archives of General Psychiatry, 40, 620-625.  
 
McLellan, A. T., & McKay, J. R. (1998). The treatment of addiction: What can research  
offer practice? In S. Lamb, M. Greenlick, & D. McCarty, D. (Eds.), Bridging the 
gap between practice and research: forging partnerships with community-based 
drug and alcohol treatment (pp. 147-185). Washington, DC: National Academy 
Press. 
 
Maglione, M., Chao, B., & Anglin, M. D. (2000a). Correlates of outpatient drug  
treatment drop-out among methamphetamine users. Journal of Psychoactive Drugs, 
32, 221-228. 
 
Maglione, M., Chao, B., & Anglin, M. D. (2000b). Residential treatment of  
methamphetamine users: Correlates of drop-out from the California Alcohol and 
Drug Data System (CADDS), 1994-1997. Addiction Research, 8, 65-79. 
 
226 
Maisto, S. A., McKay, J. R., & Tiffany, S. T. (2003). Diagnosis. In J. Allen & V. Wilson   
(Eds.), Assessing alcohol problems: A guide for clinicians and researchers (2nd ed) 
(NIH Publication No. 03-3745, pp. 55-73). Bethesda, MD: National Institute on 
Alcohol Abuse and Alcoholism. 
 
Makela, K. (2004). Studies of the reliability and validity of the Addiction Severity Index.  
Addiction, 99, 398-410.  
 
Mammo, A., & Weinbaum, D. F. (1993). Some factors that influence dropping out form  
outpatient alcoholism treatment. Journal of Studies on Alcohol, 54, 92-101. 
 
Marinelli-Casey, P., Domier, C. P., & Rawson, R. A. (2002). The gap between research  
and practice in substance abuse treatment. Psychiatric Services, 53, 984-987. 
 
Marsch, L. A. (1998). The efficacy of methadone maintenance interventions in reducing  
illicit opiate use, HIV risk behaviors, and criminality: A meta-analysis. Addiction,  
93, 515-532. 
 
Mattson, M. E., Allen, J. P., Longabaugh, R., Nickless, C. J., Connors, G. J., & Kadden,  
R. M. (1994). A chronological review of empirical studies matching alcoholic 
clients to treatment. Journal of Studies on Alcohol, Suppl. 12, 16-29.   
 
Mattson, M. E., Del Boca, F. K., Carroll, K. M., Cooney, N. L., DiClemente, C. C.,  
Donovan, E., et al. (1998). Compliance with treatment and follow-up protocols in 
Project MATCH: Predictors and relationship to outcome. Alcoholism: Clinical 
and Experimental Research, 22, 1328-1339. 
 
Meichenbaum, D., & Turk, D. C. (1987). Facilitating treatment adherence: A  
practitioner’s guidebook. New York: Plenum. 
 
Meier, P. S., Barrowclough, C., & Donmall, M. C. (2005). The role of the therapeutic  
alliance in the treatment of substance misuse: A critical review of the literature. 
Addiction, 100, 304-316. 
 
Mertens, J. R., & Weisner, C. M. (2000). Predictors of substance abuse treatment  
retention among women and men in an HMO. Alcoholism: Clinical and 
Experimental Research, 24, 1525-1533. 
 
Miller, W. R. (1992). The effectiveness of treatment for substance abuse. Journal of  
Substance Abuse Treatment, 9, 93-102. 
 
Miller, W. R., & Del Boca, F. K. (1994). Measurement of drinking behavior using the  
Form 90 family of instruments. Journal of Studies on Alcohol, Suppl. 12, 112-118. 
 
Miller, W. R., & Rollnick, S. (2002).  Motivational interviewing: Preparing people for  
change (2nd ed.). New York: Guilford. 
227 
 
Miller, W. R., & Tonigan, J. S. (1996). Assessing drinkers’ motivation for change: The  
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). 
Psychology of Addictive Behaviors, 10, 81-89. 
 
Miller, W. R., Walters, S. T., & Bennett, M. E. (2001). How effective is alcoholism  
treatment. Journal of Studies on Alcohol, 62, 211-220. 
 
Miller, W. R., & Wilbourne, P. L. (2002). Mesa Grande: A methodological analysis of  
clinical trials of treatments for alcohol use disorders. Addiction, 97, 265-277. 
 
Milligan, C. O., Nich, C., & Carroll, K. M. (2004). Ethnic differences in substance abuse  
treatment retention, compliance, and outcome from two clinical trials. Psychiatric 
Services, 55, 167-173. 
 
Moos, R. H., & Moos, B. S. (2003). Long-term influence of duration and intensity of  
treatment on previously untreated individuals with alcohol use disorders. Addiction, 
98, 325-338. 
 
Moyer, A., & Finney, J. W. (2002). Randomized versus nonrandomized studies of  
alcohol treatment: Participants, methodological features and posttreatment 
functioning. Journal of Studies on Alcohol, 63, 542-550. 
 
Mullins, S. M., Suarez, M., Ondersma, S. J., & Page, M. C. (2004). The impact of  
motivational interviewing on substance abuse treatment retention: A randomized 
control trial of women involved with child welfare. Journal of Substance Abuse 
Treatment, 27, 51-58. 
 
National Institute of Drug Abuse (1999). Principles of drug addiction treatment: A  
research-based guide (2nd ed.) (NIH Publication No. 09–4180). Washington, DC: 
Government Printing Office. 
 
Navajits, L.M. (2002). Seeking safety: A treatment manual for PTSD and substance  
abuse. New York: Guilford Press. 
 
Neale, J., Allen, D., & Coombes, L. (2005). Qualitative research methods within  
addictions. Addiction, 100, 1584-1593. 
 
Norusis, M. (2006). SPSS 15.0 statistical procedures companion. Upper Saddle River,  
NJ: Prentice Hall. 
 
Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York:  
McGraw-Hill. 
 
Nurco, D.N., Hanlon, T.E., O’Grady, K.E., & Kinlock, T.W. (1997). The early  
228 
emergence of narcotic addict types. American Journal of Drug and Alcohol Abuse, 
23, 523-542. 
 
Office of National Drug Policy. (2004). The economic costs of drug abuse in the United  
States: 1992-2002 (Publication No. 207303). Washington, DC: Executive Office of 
the President.  
 
Onken, L. S., Blaine, J. D., & Battjes, R.J. (1997). Behavioral therapy research: A  
conceptualization of a process. In S. Henggeler and A. Santos (Eds.), Innovative 
approaches for difficult-to-treat populations (pp. 477-485). Washington, DC: 
American Psychiatric Press.  
 
Ott, P. J., Tarter, R. E., & Ammerman, R. T. (1999). Sourcebook on substance abuse:  
Etiology, epidemiology, assessment, and treatment. Boston: Allyn & Bacon. 
 
Owen, P. (2003). Minnesota model: Description of counseling approach. Retrieved May  
26, from http://www.drugabuse.gov/ADAC/ADAC11.html.  
 
Paraherakis, A., Charney, D. A., Palacios-oix, J., & Gill, K. (2000). An abstinence- 
oriented program for substance use disorders: Poorer outcome associated with 
opiate dependence. Canadian Journal of Psychiatry, 45, 927-931. 
 
Patkar, A. A., Thornton, C. C., Mannelli, P., Hill, K. P., Grottheil, E., Vergare, M. J., et  
al. (2004). Comparison of pretreatment characteristics and treatment outcomes for 
alcohol-, cocaine-, and multisubstance-dependent patients. Journal of Addictive 
Diseases, 23, 93-109. 
 
Pattison, E. M., Sobell, M. B., & Sobell, L. C. (1977). Emerging concepts of alcohol  
dependence. New York: Springer. 
 
Peters, D. (1997). A natural classification of alcoholics by means of statistical grouping  
methods. Addiction, 92, 1649-1661. 
 
Petrakis, I. L., Gonzalez, G., Rosenheck, R., & Krystal, J. H. (2002). Comorbidity of  
alcoholism and psychiatric disorders: An overview. Alcohol Research & Health, 26, 
81-89.  
 
Persons, J. B., & Silberschatz, G. (1998). Are results of randomized controlled trials  
useful to psychotherapists? Journal of Consulting and Clinical Psychology, 66, 
126-135. 
 
Pirard, S., Sharon, E., Kang, S. K., Angarita, G. A., & Gastfriend, D. R. (2005).  
Prevalence of physical and sexual abuse among substance abuse patients and impact 
on treatment outcomes. Drug and Alcohol Dependence, 78, 57-64. 
 
Prendergast, M. L., Podus, D., Chang, E., & Urada, D. (2006). Erratum to the  
229 
effectiveness of drug abuse treatment: A meta-analysis of comparison group 
studies. Drug and Alcohol Dependence, 84, 133. 
 
Prendergast, M. L., Podus, D., Chang, E., & Urada, D. (2002). The effectiveness of drug  
abuse treatment: A meta-analysis of comparison group studies. Drug and Alcohol 
Dependence, 67, 53-72. 
 
Prochaska, J. O., & DiClemente, C. C. (1992). Stages of change in the modification of  
problem behaviors. Progress in Behavior Modification, 28, 183-218. 
 
Prochaska, J. O., DiClemente, C. C., Norcross, J.C. (1992). In search of how people  
change: Applications to addictive behaviors. American Psychologist, 47, 1102-
1114. 
 
Project MATCH Research Group. (1997a). Matching alcoholism treatments to client  
heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of 
Studies on Alcohol, 58, 7-29. 
 
Project MATCH Research Group. (1997b). Matching alcoholism treatments to client  
heterogeneity: Treatment main effects and matching effects on drinking during 
treatment. Journal of Studies on Alcohol, 59, 631-639. 
 
Project MATCH Research Group. (1997c). Project MATCH secondary a priori  
hypotheses. Addiction, 92, 1671-1698. 
 
Project MATCH Research Group. (1998a). Matching patients with alcohol disorders to  
treatments: Clinical implications from Project. Journal of Mental Health, 7, 589-
602. 
 
Project MATCH Research Group. (1998b). Matching alcoholism treatments to client  
heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical 
and Experimental Research, 22, 1300-1311. 
 
Rabinowitz, J., & Marjefsky, S. (1998). Alcohol and drug abuse: Predictors of being  
expelled from and dropping out of alcohol treatment. Psychiatric Services, 49, 187-
189. 
 
Rapkin, B. D., & Dumont, K. A. (2000). Methods for identifying and assessing groups in  
health behavior research. Addiction, 95 (Suppl. 3), S395-S417. 
 
Rawson, R., Huber, A., Brethen, P., Obert, J., Gulati, V., Shoptaw, S., et al. (2000).  
Methamphetamine and cocaine users: differences in characteristics and treatment 
retention. Journal of Psychoactive Drugs, 32, 233-238. 
 
Rice, C. (2007). Retest reliability of self-reported daily drinking: Form 90. Journal of  
Studies on Alcohol, 68, 615-618. 
230 
 
Rikoon, S. H., Cacciola, J. S., Carise, D., ALterman, A. I., & McLellan, A. T. (2006).  
Predicting DSM-IV dependence diagnoses from Addiction Severity Index 
composite scores. Journal of Substance Abuse Treatment, 31, 17-24. 
 
Roffman, R. A., Klepsch, R., Wertz, J. S., Simpson, E. E., & Stephens, R. S. (1993).  
Predictors of attrition from an outpatient marijuana-dependence counseling 
program. Addictive Behaviors, 18, 553-566. 
 
Rosenthal, R. (1995). Writing meta-analytic reviews. Psychological Bulletin, 118, 183- 
192. Rosenthal, R., & Rosnow, R.L. (2008). Essentials of behavioral research: 
Methods and data analysis (3rd ed.). Boston: McGraw-Hill. 
 
Ross, H. E., Cutler, M., & Sklar, S. M. (1997). Retention in substance abuse treatment:  
Role of psychiatric symptom severity. Journal on Addictions, 6, 293-303.  
 
Rounsaville, B. J., & Carroll, K. M. (2001). Methodological diversity and theory in the  
stage model: Reply to Kazdin. American Psychologist, 8, 152-154. 
 
Rounsaville, B. J., Carroll, K. M., & Onken, L. S. (2001). A stage model of behavioral  
therapies research: Getting started and moving from stage I. Clinical Psychology: 
Science and Practice, 8, 133-142. 
 
Rowan-Szal, G. A., Joe, G. W., & Simpson, D. D. (2000). Treatment retention of crack  
and cocaine users in a national sample of long-term residential clients. Addiction 
Research, 8, 51-64. 
 
Satre, D. D., Mertens, J. R., Areán, P. A., & Weisner, C. (2004). Five-year alcohol and  
drug treatment outcomes of older adults versus middle-aged and younger adults in a 
managed care program. Addiction, 99, 1286-1297. 
 
Sayette, M. A. (1999). Does drinking reduce stress? Alcohol Health and Research World,  
23, 250-255. 
 
Sayre, S. L., Schmitz, J. M., Stotts, A. L., Averill, P. M., Rhoades, H. M., & Grabowski,  
J. J. (2002). Determining predictors of attrition in an outpatient substance abuse 
program. American Journal of Drug and Alcohol Abuse, 28, 55-72. 
 
Sheehan, D., Lecrubier, Y., Sheehan, K., Amorim, P., Janavas, J., Weiller, E., et al.  
(1998). The Mini-International Neuropsychiatric Interview (MINI): The 
development and validation of a structured diagnostic psychiatric interview for 
DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59 (Suppl. 20), 22-33. 
 
Schuckit, M., Pitts, F. N., Reich, T., King, L., & Winokur, G. (1969). Alcoholism: Two  
types of alcoholism in women. Archives of General Psychiatry, 20, 301-306. 
 
231 
Simpson, D. D., (1981). Treatment for drug abuse: Follow-up outcomes and length of  
time spent. Archives of General Psychiatry, 38, 875-880.   
 
Simpson, D. D. (1993). Drug treatment evaluation research in the United States.  
Psychology of Addictive Behaviors, 7, 120-128. 
 
Simpson, D. D. (2001). Modeling treatment process and outcomes. Addiction, 96, 207- 
211.  
 
Simpson, D. D. (2004). A conceptual framework for drug treatment process and  
outcomes. Journal of Substance Abuse Treatment, 27, 99-121. 
 
Simpson, D. D., Brown, B. S., & Joe, G. W. (1997). Treatment retention and follow-up  
outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of 
Addictive Behaviors, 11, 294-307. 
 
Simpson, D. D., Chatham, L.R., & Brown, B. S. (1995). The role of evaluation research  
in drug abuse policy. Current Directions in Psychological Science, 4, 123-126. 
 
Simpson, D. D., & Joe, G. W. (2004). A longitudinal evaluation of treatment engagement  
and recovery stages. Journal of Substance Abuse Treatment, 27, 89-97. 
 
Simpson, D. D., Joe, G. W., & Bracy, S. A. (1982). Six-year follow-up of opiod addicts  
after admission to treatment. Archives of General Psychiatry, 39, 1318-1323.   
 
Simpson, D. D., Joe, G. W., & Broome, K. M. (2002). A national 5-year follow-up of  
treatment outcomes for cocaine dependence. Archives of General Psychiatry, 59, 
538-544.   
 
Simpson, D. D., Joe, G. W., Broome, K. M., Hiller, M. L., Knight, K., & Rowan-Szal, G.  
A. (1997). Program diversity and treatment retention rates in the Drug Abuse 
Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11, 279-
293. 
 
Simpson, D. D., Joe, G. W., & Rowan-Szal, G.A. (1997). Drug abuse treatment retention  
and process effects on follow-up outcomes. Drug and Alcohol Dependence, 47, 
227-235. 
 
Simpson, D. D., Joe, G.W., Rowan-Szal, G., & Greener, J. (1995). Client engagement  
and change during drug abuse treatment. Journal of Substance Abuse, 7, 117-134. 
 
Simpson, D. D., Joe, G. W., Rowan-Szal, G. A., & Greener, J. M. (1997). Drug abuse  
treatment process components that improve retention. Journal of Substance Abuse 
Treatment, 14, 565-572. 
 
Simpson, D. D., & Sells, S. B. (1982). Effectiveness of treatment for drug abuse: An  
232 
overview of the DARP research program. Advances in Alcohol and Substance 
Abuse, 2, 7-29.   
 
Siqueland, L., Crits-Christoph, P., Gallop, R., Barber, J., Griffin, M. L., Thase, M. E., et  
al. (2002). Retention in psychosocial treatment of cocaine dependence: Predictors 
and impact on outcome. The American Journal on Addictions, 11, 24-40. 
 
Sobell, L. C., & Sobell, M. B. (2003). Alcohol consumption measures. In J. Allen & V.  
Wilson (Eds.), Assessing alcohol problems: A guide for clinicians and researchers 
(2nd ed.). (NIH Publication No. 03-3745, pp. 75-99). Bethesda, MD: National 
Institute on Alcohol Abuse and Alcoholism. 
 
Sobell, M. B., Wagner, E. F., & Sobell, L. C. (2003). Substance-related use disorders:  
alcohol. In M. Hersen & S. Turner (Eds.), Adult psychopathology and diagnosis 
(192-225). Hoboken, NJ: John Wiley & Sons.  
 
Stanton, M. D., & Shadish, W. R. (1997). Outcome, attrition, and family-couples  
treatment for drug abuse: A meta-analysis and review of the controlled, 
comparative studies. Psychological Bulletin, 122, 170-191. 
 
Stark, M. J. (1992). Dropping out of substance abuse treatment: A clinically oriented  
review. Clinical Psychology Review, 12, 93-116. 
 
Sternberg, R.J. (Ed.) (1994). Encyclopedia of human intelligence (Vol. 2). New York:  
Macmillan. 
 
Stoffelmayr, B. E., Mavis, B. E., & Kasim, R. M. (1994). The longitudinal stability of the  
Addiction Severity Index. Journal of Substance Abuse Treatment, 11, 373-378. 
 
Substance Abuse and Mental Health Services Administration. (2007). Results from the  
2006 National Survey on Drug Use and Health: National findings (Office of 
Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293). 
Rockville, MD. 
 
Swearingen, C. E., Moyer, A., & Finney, J. W. (2003). Alcoholism treatment outcome  
studies, 1970-1998: An expanded look at the nature of the research. Addictive 
Behaviors, 28, 415-436. 
 
The COMBINE Study Research Group. (2003). Testing combined pharmacotherapies  
and behavioral interventions in alcohol dependence: Rationale and methods. 
Alcoholism: Clinical and Experimental Research, 27, 1107-1122. 
 
Tonigan, J. S., & Miller, W. R. (2002). The Inventory of Drug Use Consequences  
(InDUC): Test-retest stability and sensitivity to detect change. Psychology of 
Addictive Behaviors, 16, 165-168. 
 
233 
Tonigan, J. S., Miller, W. R., & Brown, J. M. (1997). The reliability of Form 90: An  
instrument for assessing alcohol treatment outcome. Journal of Studies on Alcohol, 
58, 358-364. 
 
Treatment Research Institute. (n.d.) ASI training. Retrieved September 7, 2007, from  
http://www.tresearch.org/training/asi_train.htm.  
 
Tucker, J. A., & Roth, D. L. (2006). Extending the evidence hierarchy to enhance  
evidence-based practice for substance use disorders. Addiction, 101, 918-932. 
 
VandenBos, G.R. (2007). APA dictionary of psychology. Washington, DC: American  
Psychological Association. 
 
Veach, L. J., Remley, Jr., T. P., Kippers, S. M., & Sorg, J. D. (2000). Retention predictors  
related to intensive outpatient programs for substance use disorders. American 
Journal of Drug and Alcohol Abuse, 26, 417-428. 
 
von Knorring, L., Palm, V., Andersson, H. E. (1985). Relationship between treatment  
outcome and subtype of alcoholism in men. Journal of Studies on Alcohol, 46, 388-
391. 
 
 von Knorring, L., von Knorring, A. L., Smigan, L., Lindberg, et al. (1987). Personality  
traits in subtypes of alcoholics. Journal of Studies on Alcohol, 48, 523-527. 
 
Ward, J.H. (1983). Hierarchical grouping to optimize an objective function. Journal of 
American Statistical Association, 58, 236-244. 
 
Weisner, C., Matzger, H., & Kaskutas, L. A. (2003). How important is treatment? One- 
year outcomes of treated and untreated alcohol-dependent individuals. Addiction, 
98, 901-911. 
 
Westermeyer, J. (2005). Historical and social context of psychoactive substance use  
disorders. In R. Frances, S. Miller, & A. Mack (Eds.), Clinical textbook of addictive 
disorders (pp. 16-36). New York: Guilford Press. 
 
Westreich, L., Heitner, C., Cooper, M., Galanger, M., & Guedj, P. (1997). Perceived  
social support and treatment retention on an inpatient addiction treatment unit. The 
American Journal on Addictions, 6, 144-149. 
 
White, M. K., Godley, S. H., & Passetti, L. L. (2004). Adolescent and parent perceptions  
of outpatient substance abuse treatment: A qualitative study. Journal of 
Psychoactive Drugs, 36, 65-74. 
 
White, J. M., Winn, K. I., & Young, W. (1998). Predictors of attrition from an outpatient  
chemical dependency program. Substance Abuse, 19, 49-59. 
 
234 
Wickizer, T., Maynard, C., Atherly, A., Frederick, M., Koepsell, T., Krupski, A., et al.  
(1994). Completion rates of clients discharged from drug and alcohol treatment 
programs in Washington State. American Journal of Public Health, 84, 215-221. 
 
Wierzbicki, W., & Pekarik, G. (1993). A meta-analysis of psychotherapy dropout.  
Professional Psychology: Research and Practice, 24, 190-195. 
 
Wilsnack, R. W., Vogeltanz, N. D., Wilsnack, S. C., Harris, T. R., Ahlstrom, S., Bonday,  
S., et al. (2000). Gender differences in alcohol consumption and adverse drinking 
consequences: Cross-cultural patterns. Addiction, 95, 251-265. 
 
Windle, M., & Scheidt, D. M. (2004). Alcoholic subtypes: Are two sufficient. Addiction,  
99, 1508-1519. 
 
Zanis, D. A., McLellan, A. T., Cnaan, R. A., & Randall, M. (1994). Reliability and  
validity of the Addiction Severity Index with a homeless sample. Journal of 
Substance Abuse Treatment, 11, 541-548. 
 
Zanis, D. A., McLellan, A. T., & Corse, S. (1997). Is the Addiction Severity Index a  
reliable and valid assessment instrument among clients with severe and persistent 
mental illness and substance abuse disorders? Community Mental Health Journal, 
33, 213-227. 
235 
Appendix A 
 
Marquette University Agreement of Consent for Research Participants 
 
RESEARCH SUBJECT INFORMATION AND SUBJECT CONSENT FORM 
 
Rogers Memorial Hospital, West Allis, WI 
Marquette University, Milwaukee, WI 
 
TITLE:  Rogers Memorial Hospital Chemical Dependency Program   
  Assessment Project, Phase 2 
 
SPONSOR: Rogers Memorial Hospital,  
Center for Addiction and Behavioral Health Research - Marquette 
University 
 
PRINCIPAL INVESTIGATOR: Todd C. Campbell, Ph.D., CADCIII, CCSII 
 
PURPOSE OF STUDY 
When I sign this statement, I am giving consent to the following basic considerations: 
I understand clearly that the purpose of this study is to evaluate the treatment processes 
and treatment outcomes for the Chemical Dependency Program at Rogers Memorial 
Hospital-West Allis. I understand that all patients admitted into the Chemical 
Dependency Program are required to participate in the standard clinical intake procedure 
and that the information obtained is kept in my medical record. The information in the 
medical record is utilized by the treatment staff and subject to state and federal 
regulations regarding confidentiality.  I understand the standard clinical intake Session 
will last approximately 2 to 4 hours. I understand that I may be asked to complete several 
questionnaires about my age, education level, my alcohol and other drug use history, 
health history, mental health history, and perceptions regarding treatment. I understand 
that I will be contacted when I am discharged from the Chemical Dependency program 
and by telephone or mail at one-month, 3 months, 6 months, and 12 months post-
discharge to complete an interview assessment regarding my drug and alcohol use and 
progress in my recovery. I understand that these follow-up interviews/assessments will 
last approximately 30 minutes. I also understand that this study is ongoing and there will 
be approximately 208 participants in this study during any given year. 
 
AUDIOTAPING 
Session I and Session II may be audiotaped. The audiotapes will be used to supervise the 
research assistants who are conducting the sessions. The research assistants will be 
supervised by the primary investigator, Todd C. Campbell, Ph.D. All audiotapes will be 
erased utilizing a large magnet designed to fully erase audiotapes after feedback has been 
provided by the primary investigator (a process which is expected to take approximately 
1-2 weeks following the sessions). The tapes will then be destroyed and thrown away. 
 
Participant Initials _________ 
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CONFIDENTIALITY 
I understand that there are two purposes for collecting the assessment information: 1. 
Clinical purposes to inform the treatment team regarding my treatment plan, and 2. 
Research purposes to assist in the evaluation of the program’s treatment processes and 
outcomes.  
 
I understand that for the clinical purposes the assessment information is contained in my 
medical record, is available to appropriate treatment staff, and is protected by all relevant 
state and federal regulations pertaining to medical records. 
   
I understand that for the research purposes of this research project, the data from the 
standard intake assessment will be copied and the copies will be placed in the research 
file. These copies will be de-identified (i.e., my name and other identifying information 
will be removed) and assigned an arbitrary code. I understand that if I choose to 
participate in this study that all information I reveal in this study will be kept confidential. 
Your name will not be publicly disclosed at any time, and the records will be strictly 
maintained according to current legal requirements. When the results of the study are 
published, I will not be identified by name.  I have been promised that any information 
obtained from this study that can be identified with me will remain confidential. 
However, I am in agreement that scientific data not identifiable with me resulting from 
the study may be presented at meetings and published so that the information can be 
useful to others. No references to individual participants, or any identifying information 
will be released to anyone other than the investigative professionals at Rogers Memorial 
Hospital or Marquette University without my express written consent, unless required by 
law.  I understand that once the data is no longer of use it will be destroyed and will be 
held no longer than 7 years. 
 
This applies to the audiotapes of treatment sessions as well as to any written records 
obtained. Only authorized study personnel will have access to the session audiotapes and 
records. This protection, however, is not absolute.  It does not, for example, apply to any 
state requirement to report certain communicable diseases.  In addition, the investigators 
will report certain cases of child or elder abuse to appropriate authorities.  Furthermore, if 
you indicate that you are in imminent danger of hurting yourself or others, the 
investigators may need to reveal this in order to protect you or that person. However, it is 
the policy of these agencies and of the investigators that every attempt will be made to 
resist demands to release information that identifies you.  
 
RIGHT TO REFUSE OR WITHDRAW FROM THE STUDY 
Your participation in this study is voluntary. Thus, you may refuse to participate or 
withdraw at any time once the study has started.  I have been informed that my decision 
about whether or not to participate will not change my present or future relationship with 
Rogers Memorial Hospital or the staff of this institution; nor will it change the quantity or 
quality of care that is otherwise available to me. If I participate, I understand that I am  
free to withdraw at any time without prejudice, and that withdrawal would not in any way 
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affect the nature of the care or treatment otherwise available to me. Information collected 
on participants who choose to withdraw will remain in the study files. 
 
The primary investigators have the right to stop your participation in the study at any 
time. This could be because you have had an unexpected reaction, or have not followed 
instructions, or because the entire study has been stopped.  Regardless of whether you 
choose to withdraw or if your participation in the study is terminated, certain procedures 
must be followed in ending your participation in the study in order to protect your safety.  
You may be asked questions about any reactions you may have had with this project. 
 
PAYMENTS TO PARTICIPANTS 
There are no payments for participation in this study. Should you need further treatment 
for alcohol-related problems after leaving Rogers Memorial Hospital, you and your 
insurance provider will be responsible for such costs in the same way that you would if 
you did not participate in this study. 
 
RISKS 
I understand that there are no known risks associated with participation in this study. I 
also understand that the only benefit of my participation is to help improve scientific 
understanding of the intake assessment process, treatment processes, and treatment 
outcomes. I understand that participating in this study is completely voluntary and that I 
may stop participating in the study at any time without penalty or loss of benefits to 
which I am otherwise entitled. I am not involved in any agreement for this study, whether 
written or oral, which includes language that clears Marquette University or its 
representatives from liability for negligence, if any, which may arise in the conduct of the 
research project. 
 
NEW INFORMATION 
Participation in this study could have risks that we cannot anticipate.  If new information 
is found during the study that might influence your willingness to continue to participate, 
we will inform you as soon as possible. 
 
OFFER TO ANSWER QUESTIONS AND CONTACTS FOR INFORMATION 
If you have any questions about the general nature of the study, you may contact Dr. 
Todd C. Campbell at (414) 288-5889 or Mr. Mickey Gabbert at (414) 327-3000.   
 
INSTITUTIONAL REVIEW BOARD REVIEW: 
This project has been reviewed by the Rogers Memorial Hospital Human Subjects 
Committee and the Marquette University Institutional Review Board for the Protection of 
Human Subjects.  All my questions about this study have been answered to my 
satisfaction. I understand that if I later have additional questions concerning this project, I 
can contact Todd C. Campbell. If you believe that there is any infringement upon your 
rights or if you have any questions about your rights as a research subject, you may 
contact the Rogers Memorial Hospital Human Subjects Committee at (414) 327-3000 
and/or you may contact Marquette University's Office of Research Compliance at 414-
288-1479.  Participant Initials _________ 
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I, ________________________________________, have read the information provided 
above.  I voluntarily agree to participate in this study.  My signature also indicates that I 
have been given a copy of this documented informed consent, and may request an 
additional copy at any time.  I know that this research has been reviewed by the Rogers 
Memorial Hospital Human Subjects Committee and the Marquette University 
Institutional Review Board for the Protection of Human Subjects and has been found to 
meet the federal, state, and the Rogers Memorial Hospital Human Subjects Committee 
and the Marquette University Institutional Review Board for the Protection of Human 
Subjects guidelines for the protection of human subjects.  Finally, I understand that if the 
principal investigator decides it is wise to limit or terminate my participation in the study, 
he can do so without my consent. 
 
I agree to have my intake session(s) audiotaped, as described above: 
 
____________________________________________     ______________________  
Signature of Subject or Authorized Representative                Date  
  
____________________________________________     ______________________  
Signature of Witness                                                               Date  
 
 
 
I have defined and fully explained the study as described herein to the subject.  
TYPE OR PRINT:  
   
___________________________________________________________  
Name of Principal Investigator or Authorized Representative  
 
 
TYPE OR PRINT:  
 
___________________________________________  
Position Title   
 
____________________________________________     ______________________  
Signature       Date  
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Appendix B 
 
 
Personal Feedback Report for: 
Date Completed: 
 
Client Perception of Problem/Need for Treatment 
 
Medical Employ Alcohol Drug Legal Family Social Psych 
A B A B A B A B A B A B A B A B 
4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Legend: 
A= Perceived Problems, B= Desire for Treatment 
0=Not all, 1=Slightly, 2=Moderately, 3=Considerably, 4=Extremely 
 
Interview Severity Ratings 
 
Medical Employ Alcohol Drug Legal Family Psych 
9 9 9 9 9 9 9 
8 8 8 8 8 8 8 
7 7 7 7 7 7 7 
6 6 6 6 6 6 6 
5 5 5 5 5 5 5 
4 4 4 4 4 4 4 
3 3 3 3 3 3 3 
2 2 2 2 2 2 2 
1 1 1 1 1 1 1 
0 0 0 0 0 0 0 
Legend: 
0-1: No Real Problem, 2-3: Slight Problem, 4-5: Moderate Problem, 6-7: Considerable 
Problem, 8-9: Extreme Problem 
 
Treatment Problem List 
 
According to the ASI interview, the following are possible problem statements that could 
be addressed on the treatment care plan: 
 
Medical: 
Employment: 
Alcohol/Drug: 
Legal: 
Family/Social: 
Psychiatric: 
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Alcohol Use 
 
 
 
Other Drug Use 
 
Percentiles (US Adults)      
Your use (days) in last 90                  
Drug Tobacco Marijuana Stim./Amph. Cocaine Opiates         
  
 
Preparation for Change 
 
Socrates Profile Very Low Low Medium High Very High 
Recognition _______ 7-26 27-30 31-33 34-35 N/A 
Ambivalence ______ 4-8 9-13 14-15 16-17 18-20 
Taking Steps ______ 8-25 26-30 31-33 34-36 37-40 
*Alcohol Use: 
 
Socrates Profile Very Low Low Medium High Very High 
Recognition _______ 7-26 27-30 31-33 34-35 N/A 
Ambivalence ______ 4-8 9-13 14-15 16-17 18-20 
Taking Steps ______ 8-25 26-30 31-33 34-36 37-40 
*Drug Use: 
 
 
Inventory of Drug Use Consequences Scores 
 
Physical Inter-
personal 
Intra-
personal 
Impulse 
Control 
Social 
Responsibility 
Total 
Score 
Control 
Scale* 
       
Out of 8 Out of 10 Out of 8 Out of 12 Out of 7 Out of 
45 
Out of 5 
*This score is separate, and does not contribute to the Total InDUC score. Scores on 
Control Scale items may indicate careless or dishonest responding. 
 
YOUR DRINKING 
 
Last 90 days:   _____ days abstinent     
                        _____ days light drinking  (1-4 standard drinks)                                                      
                        _____ days heavy drinking (5+ standard drinks) 
 
Typical week:  _____ standard drinks 
Your drinking compared to American adults:  _________ percentile (same sex) 
Estimated BAC level on heaviest drinking day: _________ mg% 
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Alcohol Abstinence Efficacy Scale: Temptation to Drink 
 
Negative 
Affect Social/Positive 
Physical and Other 
Concerns 
Cravings and 
Urges Total 
     
0-Not at all 1-Not very 2-Moderately 3-Very 4-Extremely 
 
Alcohol Abstinence Efficacy Scale: Confidence in Ability to Abstain 
 
Negative 
Affect Social/Positive 
Physical and Other 
Concerns 
Cravings and 
Urges Total 
     
0-Not at all 1-Not very 2-Moderately 3-Very 4-Extremely 
 
 
Diagnostic Criteria Met (Mini International Neuropsychiatric Interview) 
 
DSM-IV-TR Axis I: 
_____________________________________________________________ 
           
_____________________________________________________________ 
           
_____________________________________________________________ 
 
 
Client Strengths 
1. 
 
 
2. 
 
 
3. 
 
 
Components of Interview or Results Processed with Client (i.e. percentiles, peak BAC): 
 
 
 
Overall Impression of Client: 
 
 
 
 
 
